gene,snp,text
AANAT,Rs28936679,"{{Rsnum
|rsid=28936679
|Gene=AANAT
|Chromosome=17
|position=76469731
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.007805
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AANAT
|StabilizedOrientation=plus
}}[[rs28936679]], also known as Ala129Thr or A129T (and also G619A), is a SNP in the aralkylamine N-acetyltransferase [[AANAT]] gene. The [[AANAT]] protein plays a unique role in vertebrate biology by controlling rhythmic production of melatonin in the pineal gland. Its activity increases 10- to 100-fold at night, leading to increased production and release of melatonin.

In a 2003 report about Japanese patients with a [[sleep disorder]] known as susceptibility to delayed sleep phase syndrome, patient genotypes had a higher frequency of the [[rs28936679]](A) allele.{{PMID|12736803}}

A later report based on Brazilian (primarily Caucasian) patients including those with delayed sleep phase syndrome found no variation at this SNP.{{PMID|17503170}}

{{omim
|desc=DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO
|id=600950
|rsnum=28936679
|variant=0001
}}

{{ClinVar
|rsid=28936679
|Reversed=0
|FwdREF=G
|FwdALT=A
|REF=G
|ALT=A
|RSPOS=74465813
|CHROM=17
|GMAF=0.0078
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05040036110100
|GENEINFO=AANAT:15
|GENE_NAME=AANAT
|GENE_ID=15
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000017.10:g.74465813G>A
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=600950.0001
|CLNSIG=255
|CLNCUI=C0393770
|CLNDBN=Sleep-wake schedule disorder, delayed phase type
|Disease=Sleep-wake schedule disorder
|CLNACC=RCV000009162.3
|Tags=PM;PMC;S3D;NSM;REF;ASP;VLD;KGPhase1;KGPhase3;LSD;OM
|CAF=0.9952; 0.004792
|CLNDSDB=Gene:MedGen:OMIM:SNOMED_CT
|CLNDSDBID=107048980:C0393770:614163:80623000
|COMMON=1
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v2}}"
AANAT,Rs3760138,"{{Rsnum
|rsid=3760138
|Gene=AANAT
|Chromosome=17
|position=76467027
|Orientation=plus
|GMAF=0.3962
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=AANAT
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 23.1 | 50.8 | 26.2
| HCB | 57.8 | 37.8 | 4.4
| JPT | 52.3 | 36.4 | 11.4
| YRI | 60.3 | 34.9 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 57.8 | 37.8 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20459461
|Title=Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility
}}

{{PMID|18663240|OA=1
}} Genetic differences in human circadian clock genes among worldwide populations.

{{PMID|19184136|OA=1
}} Examination of association of genes in the serotonin system to autism.

{{PMID Auto
|PMID=23822714
|Title=Analysis of polymorphisms in the circadian-related genes and breast cancer risk in the Norwegian nurses working night shifts
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
AANAT,Rs4238989,"{{Rsnum
|rsid=4238989
|Gene=AANAT
|Chromosome=17
|position=76467306
|Orientation=plus
|GMAF=0.4256
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=AANAT
|StabilizedOrientation=plus
}}{{PMID Auto
|PMID=20459461
|Title=Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility
}}

{{PMID|18663240|OA=1
}} Genetic differences in human circadian clock genes among worldwide populations.

{{PMID Auto
|PMID=23822714
|Title=Analysis of polymorphisms in the circadian-related genes and breast cancer risk in the Norwegian nurses working night shifts
|OA=1
}}

{{on chip | HumanOmni1Quad}}"
AANAT,Rs8150,"{{Rsnum
|rsid=8150
|Gene=RHBDF2
|Chromosome=17
|position=76470935
|Orientation=minus
|GMAF=0.3898
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=AANAT,RHBDF2
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 48.7 | 41.6 | 9.7
| HCB | 11.7 | 52.6 | 35.8
| JPT | 13.3 | 46.0 | 40.7
| YRI | 62.6 | 33.3 | 4.1
| ASW | 70.2 | 29.8 | 0.0
| CHB | 11.7 | 52.6 | 35.8
| CHD | 18.3 | 40.4 | 41.3
| GIH | 35.0 | 41.0 | 24.0
| LWK | 68.2 | 27.3 | 4.5
| MEX | 25.9 | 48.3 | 25.9
| MKK | 63.5 | 32.7 | 3.8
| TSI | 49.0 | 41.2 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20459461
|Title=Resequencing and association analysis of arylalkylamine N-acetyltransferase (AANAT) gene and its contribution to major depression susceptibility
}}

{{PMID Auto
|PMID=19184136
|Title=Examination of association of genes in the serotonin system to autism.
|OA=1
}}

{{PMID Auto
|PMID=25229211
|Title=Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study
}}

{{ClinVar
|ALT=A,C
|CAF=0.6152; 0.3848
|CHROM=17
|CLNACC=RCV000284468.1
|CLNALLE=2
|CLNDBN=Howel-Evans syndrome
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1835664:148500:ORPHA2198
|CLNHGVS=NC_000017.10:g.74467017G>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Howel-Evans syndrome
|FwdALT=G,T
|FwdREF=C
|GENEINFO=RHBDF2:79651
|GENE_ID=79651
|GENE_NAME=RHBDF2
|REF=G
|RSPOS=74467017
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;U3;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050128800005170537000101
|WGT=1
|dbSNPBuildID=52
|rsid=8150
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}"
AARS,Rs1064795664,"{{Rsnum
|rsid=1064795664
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=16
|position=70268357
|Gene_s=AARS
|Gene=AARS
}}
{{ClinVar
|ALT=A
|CHROM=16
|CLNACC=RCV000480998.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000016.9:g.70302260G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|REF=G
|RSPOS=70302260
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064795664
}}"
AARS,Rs143370729,"{{Rsnum
|rsid=143370729
|Chromosome=16
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=AARS
|position=70255763
|Gene_s=AARS
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CAF=0.9998; 0.0001997
|CHROM=16
|CLNACC=RCV000170342.4; RCV000236870.2
|CLNALLE=1
|CLNDBN=Epileptic encephalopathy, early infantile, 29; not specified
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C4225361:616339; CN169374
|CLNHGVS=NC_000016.9:g.70289666T>C
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; single
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=601065.0004; P49588#VAR_073720
|COMMON=0
|Disease=Epileptic encephalopathy; not specified
|FwdALT=C
|FwdREF=T
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|REF=T
|RSPOS=70289666
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050028000a05040036000100
|WGT=1
|dbSNPBuildID=134
|rsid=143370729
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS,Rs267606621,"{{Rsnum
|rsid=267606621
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS
|position=70268356
|Gene_s=AARS
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=T
|CHROM=16
|CLNACC=RCV000008987.3; RCV000168406.1; RCV000192253.1
|CLNALLE=1
|CLNDBN=Charcot-Marie-Tooth disease, type 2N; Charcot-Marie-Tooth disease, type 2; Charcot-Marie-Tooth disease
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen; MedGen:Orphanet:SNOMED_CT
|CLNDSDBID=C2750090:613287:ORPHA228174; CN043576; C0007959:ORPHA166:50548001
|CLNHGVS=NC_000016.9:g.70302259C>T
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=601065.0001; P49588#VAR_063527
|Disease=Charcot-Marie-Tooth disease; Charcot-Marie-Tooth disease; Charcot-Marie-Tooth disease
|FwdALT=A
|FwdREF=G
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|REF=C
|RSPOS=70302259
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|VC=SNV
|VP=0x050268000a05000002110100
|WGT=1
|dbSNPBuildID=137
|rsid=267606621
|CLNORIGIN=9
|CLNREVSTAT=single; no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS,Rs387906792,"{{Rsnum
|rsid=387906792
|Orientation=minus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=AARS
|position=70277088
|Gene_s=AARS
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Chromosome=16
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=A
|CHROM=16
|CLNACC=RCV000023068.4
|CLNALLE=1
|CLNDBN=Charcot-Marie-Tooth disease, type 2N
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C2750090:613287:ORPHA228174
|CLNHGVS=NC_000016.9:g.70310991T>A
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=601065.0002; P49588#VAR_067084
|Disease=Charcot-Marie-Tooth disease
|FwdALT=T
|FwdREF=A
|REF=T
|RSPOS=70310991
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|VC=SNV
|VP=0x050068000a05000002110100
|WGT=1
|dbSNPBuildID=137
|rsid=387906792
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
AARS,Rs786205157,"{{Rsnum
|rsid=786205157
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=AARS
|position=70277057
|Gene_s=AARS
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G
|CHROM=16
|CLNACC=RCV000170341.4; RCV000236174.1
|CLNALLE=1
|CLNDBN=Epileptic encephalopathy, early infantile, 29; not provided
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C4225361:616339; CN221809
|CLNHGVS=NC_000016.9:g.70310960T>G
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; single
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=601065.0003; P49588#VAR_073719
|Disease=Epileptic encephalopathy; not provided
|FwdALT=C
|FwdREF=A
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|REF=T
|RSPOS=70310960
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|VC=SNV
|VP=0x050068000a05000002110100
|WGT=1
|dbSNPBuildID=144
|rsid=786205157
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS,Rs797044801,"{{Rsnum
|rsid=797044801
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=AARS
|position=70254688
|Gene_s=AARS
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G
|CHROM=16
|CLNACC=RCV000192254.1
|CLNALLE=1
|CLNDBN=Charcot-Marie-Tooth disease
|CLNDSDB=MedGen:Orphanet:SNOMED_CT
|CLNDSDBID=C0007959:ORPHA166:50548001
|CLNHGVS=NC_000016.9:g.70288591T>G
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|Disease=Charcot-Marie-Tooth disease
|FwdALT=C
|FwdREF=A
|GENEINFO=AARS:16
|GENE_ID=16
|GENE_NAME=AARS
|REF=T
|RSPOS=70288591
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=146
|rsid=797044801
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs1085307969,"{{Rsnum
|rsid=1085307969
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=6
|position=44302821
|Gene_s=AARS2
|Gene=AARS2
}}
{{ClinVar
|ALT=A
|CHROM=6
|CLNACC=RCV000489182.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44270558G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44270558
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1085307969
}}"
AARS2,Rs138119149,"{{Rsnum
|rsid=138119149
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS2
|position=44304512
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=6
|CLNACC=RCV000023929.3; RCV000196012.2
|CLNALLE=1
|CLNDBN=Combined oxidative phosphorylation deficiency 8; not provided
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C3279793:614096:ORPHA319504; CN221809
|CLNHGVS=NC_000006.11:g.44272249G>A
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=612035.0001; Q5JTZ9#VAR_065957
|Disease=Combined oxidative phosphorylation deficiency 8; not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44272249
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD;LSD;OM
|VC=SNV
|VP=0x050068000a05040402110100
|WGT=1
|dbSNPBuildID=134
|rsid=138119149
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; single
}}

{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs200105202,"{{Rsnum
|rsid=200105202
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS2
|position=44311148
|Gene_s=AARS2
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=6
|CLNACC=RCV000239768.2
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44278885G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|CLNSRC=UniProtKB (protein)
|CLNSRCID=Q5JTZ9#VAR_071840
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44278885
|Reversed=0
|SAO=0
|SSR=0
|Tags=S3D;NSM;REF;ASP;VLD;HD
|VC=SNV
|VP=0x050200000a05040402000100
|WGT=1
|dbSNPBuildID=137
|rsid=200105202
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs200781477,"{{Rsnum
|rsid=200781477
|Chromosome=6
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=AARS2
|position=44301382
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C,T
|CHROM=6
|CLNACC=RCV000200375.1
|CLNALLE=2
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44269119G>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=C,T
|FwdREF=G
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44269119
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSN;REF;ASP;KGPhase1;LSD
|VC=SNV
|VP=0x050060000605000016100100
|WGT=1
|dbSNPBuildID=137
|rsid=200781477
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs387907061,"{{Rsnum
|rsid=387907061
|Chromosome=6
|position=44311507
|Orientation=minus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=AARS2
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=C
|CHROM=6
|CLNACC=RCV000023930.3
|CLNALLE=1
|CLNDBN=Combined oxidative phosphorylation deficiency 8
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C3279793:614096:ORPHA319504
|CLNHGVS=NC_000006.11:g.44279244A>C
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=612035.0002; Q5JTZ9#VAR_065956
|Disease=Combined oxidative phosphorylation deficiency 8
|FwdALT=G
|FwdREF=T
|REF=A
|RSPOS=44279244
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSM;REF;ASP;VLD;LSD;OM
|VC=SNV
|VP=0x050068000a05040002110100
|WGT=1
|dbSNPBuildID=137
|rsid=387907061
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
AARS2,Rs543267101,"{{Rsnum
|rsid=543267101
|Chromosome=6
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=AARS2
|position=44300612
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CAF=0.9998; 0.0001997
|CHROM=6
|CLNACC=RCV000132555.2
|CLNALLE=1
|CLNDBN=Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C4014588:615889
|CLNHGVS=NC_000006.11:g.44268349C>T
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=612035.0006; Q5JTZ9#VAR_071843
|COMMON=0
|Disease=Leukoencephalopathy
|FwdALT=T
|FwdREF=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=C
|RSPOS=44268349
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;KGPhase3;LSD;OM
|VC=SNV
|VP=0x050068000a05040026110100
|WGT=1
|dbSNPBuildID=142
|rsid=543267101
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs587777589,"{{Rsnum
|rsid=587777589
|Chromosome=6
|Orientation=plus
|geno1=(-;-)
|geno2=(-;C)
|geno3=(C;C)
|Gene=AARS2
|position=44311096
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=GC
|CHROM=6
|CLNACC=RCV000132552.4; RCV000320263.1
|CLNALLE=1
|CLNDBN=Combined oxidative phosphorylation deficiency 8; Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen:OMIM
|CLNDSDBID=C3279793:614096:ORPHA319504; C4014588:615889
|CLNHGVS=NC_000006.11:g.44278833dupC
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=612035.0003
|Disease=Combined oxidative phosphorylation deficiency 8; Leukoencephalopathy
|FwdALT=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44278832
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;NSF;REF;ASP;LSD;OM
|VC=DIV
|VP=0x050068001205000002110200
|WGT=1
|dbSNPBuildID=136
|rsid=587777589
|FwdREF=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs587777590,"{{Rsnum
|rsid=587777590
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=AARS2
|position=44313175
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G,T
|CHROM=6
|CLNACC=RCV000132553.2
|CLNALLE=-1
|CLNDBN=Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C4014588:615889
|CLNHGVS=NC_000006.11:g.44280912A>C
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=612035.0004; Q5JTZ9#VAR_071837
|Disease=Leukoencephalopathy
|FwdALT=A,C
|FwdREF=T
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=A
|RSPOS=44280912
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM;NOC
|VC=SNV
|VP=0x050068000a05000002110110
|WGT=1
|dbSNPBuildID=147
|rsid=587777590
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs587777591,"{{Rsnum
|rsid=587777591
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS2
|position=44305072
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=6
|CLNACC=RCV000132554.3
|CLNALLE=1
|CLNDBN=Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C4014588:615889
|CLNHGVS=NC_000006.11:g.44272809G>A
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=612035.0005
|Disease=Leukoencephalopathy
|FwdALT=A
|FwdREF=G
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44272809
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;NSN;REF;ASP;LSD;OM
|VC=SNV
|VP=0x050068000605000002110100
|WGT=1
|dbSNPBuildID=144
|rsid=587777591
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs587777592,"{{Rsnum
|rsid=587777592
|Chromosome=6
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=AARS2
|position=44306367
|Gene_s=AARS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CHROM=6
|CLNACC=RCV000132556.3
|CLNALLE=1
|CLNDBN=Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C4014588:615889
|CLNHGVS=NC_000006.11:g.44274104C>T
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=612035.0007; Q5JTZ9#VAR_071841
|Disease=Leukoencephalopathy
|FwdALT=T
|FwdREF=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=C
|RSPOS=44274104
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;LSD;OM
|VC=SNV
|VP=0x050068000a05040002110100
|WGT=1
|dbSNPBuildID=144
|rsid=587777592
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs746514660,"{{Rsnum
|rsid=746514660
|Chromosome=6
|Orientation=plus
|geno1=(-;-)
|geno2=(-;C)
|geno3=(C;C)
|Gene=AARS2
|position=44311095
|Gene_s=AARS2
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
|Merged=587777589
|Status=Merged
}}{{ClinVar
|ALT=GC
|CHROM=6
|CLNACC=RCV000132552.4; RCV000320263.1
|CLNALLE=1
|CLNDBN=Combined oxidative phosphorylation deficiency 8; Leukoencephalopathy, progressive, with ovarian failure
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen:OMIM
|CLNDSDBID=C3279793:614096:ORPHA319504; CN197313:615889
|CLNHGVS=NC_000006.11:g.44278833dupC
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=612035.0003
|Disease=Combined oxidative phosphorylation deficiency 8; Leukoencephalopathy
|FwdALT=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44278832
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSF;REF;ASP;VLD
|VC=DIV
|VP=0x050000001205040002000200
|WGT=1
|dbSNPBuildID=144
|rsid=746514660
}}"
AARS2,Rs757169781,"{{Rsnum
|rsid=757169781
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=AARS2
|position=44313103
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CHROM=6
|CLNACC=RCV000195876.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44280840A>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=A
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=A
|RSPOS=44280840
|Reversed=0
|SAO=0
|SSR=0
|Tags=SLO;NSM;REF;ASP;VLD
|VC=SNV
|VP=0x050100000a05040002000100
|WGT=1
|dbSNPBuildID=144
|rsid=757169781
}}
{{on chip | 23andMe v5}}"
AARS2,Rs765842125,"{{Rsnum
|rsid=765842125
|Chromosome=6
|Orientation=plus
|geno1=(-;-)
|geno2=(-;A)
|geno3=(A;A)
|Gene=AARS2
|position=44312248
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=GA
|CHROM=6
|CLNACC=RCV000197872.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44279986dupA
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=G
|RSPOS=44279985
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSF;REF;ASP;LSD
|VC=DIV
|VP=0x050060001205000002100200
|WGT=1
|dbSNPBuildID=144
|rsid=765842125
}}
{{on chip | 23andMe v5}}"
AARS2,Rs766771165,"{{Rsnum
|rsid=766771165
|Chromosome=6
|Orientation=plus
|geno1=(-;-)
|geno2=(-;A)
|geno3=(A;A)
|Gene=AARS2
|position=44307280
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=CA
|CHROM=6
|CLNACC=RCV000199735.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44275018dupA
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=C
|RSPOS=44275017
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSF;REF;INT;ASP;LSD
|VC=DIV
|VP=0x050060081205000002100200
|WGT=1
|dbSNPBuildID=144
|rsid=766771165
|FwdREF=-
}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs768351915,"{{Rsnum
|rsid=768351915
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=AARS2
|position=44302059
|Gene_s=AARS2
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=6
|CLNACC=RCV000384046.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44269796C>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|FwdREF=C
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=C
|RSPOS=44269796
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;DSS;ASP;LSD
|VC=SNV
|VP=0x050060100005000002100100
|WGT=1
|dbSNPBuildID=144
|rsid=768351915
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs775065697,"{{Rsnum
|rsid=775065697
|Chromosome=6
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS2
|position=44303159
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=G
|CHROM=6
|CLNACC=RCV000196157.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44270896A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G
|FwdREF=A
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=A
|RSPOS=44270896
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSM;REF;INT;ASP;VLD
|VC=SNV
|VP=0x050000080a05040002000100
|WGT=1
|dbSNPBuildID=144
|rsid=775065697
}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
AARS2,Rs863223862,"{{Rsnum
|rsid=863223862
|Chromosome=6
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=AARS2
|position=44307020
|Gene_s=AARS2
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=T
|CHROM=6
|CLNACC=RCV000199473.2
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000006.11:g.44274757C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=AARS2:57505
|GENE_ID=57505
|GENE_NAME=AARS2
|REF=C
|RSPOS=44274757
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=146
|rsid=863223862
}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs12003906,"{{Rsnum
|rsid=12003906
|Gene=ABCA1
|Chromosome=9
|position=104883196
|Orientation=plus
|GMAF=0.05051
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ABCA1
|StabilizedOrientation=plus
}}{{PMID Auto
|PMID=20031551
|Title=Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
|OA=1
}}"
ABCA1,Rs12686004,"{{Rsnum
|rsid=12686004
|Gene=ABCA1
|Chromosome=9
|position=104891145
|Orientation=plus
|GMAF=0.118
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 15.0 | 82.3
| HCB | 0.7 | 27.9 | 71.3
| JPT | 9.7 | 36.3 | 54.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 10.5 | 89.5
| CHB | 0.7 | 27.9 | 71.3
| CHD | 1.9 | 29.9 | 68.2
| GIH | 5.9 | 36.6 | 57.4
| LWK | 0.0 | 0.9 | 99.1
| MEX | 3.4 | 39.7 | 56.9
| MKK | 0.0 | 7.1 | 92.9
| TSI | 1.0 | 23.8 | 75.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21909109
|Trait=None
|Title=Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.
|RiskAllele=T
|Pval=2E-18
|OR=0.0217
|ORtxt=[0.017-0.027] mg/dL decrease
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854494,"{{Rsnum
|rsid=137854494
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104806276
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0001
|rsnum=137854494
}}{{ClinVar
|rsid=137854494
|Reversed=1
|FwdREF=T
|FwdALT=C
|REF=A
|ALT=G
|RSPOS=107568557
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107568557A>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0001; O95477#VAR_009153
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010091.4
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854495,"{{Rsnum
|rsid=137854495
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104822514
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0007
|rsnum=137854495
}}{{ClinVar
|rsid=137854495
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=107584795
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05040002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107584795G>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0007; O95477#VAR_009151
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010097.4
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;VLD;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854496,"{{Rsnum
|rsid=137854496
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA1
|position=104831048
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0008
|rsnum=137854496
}}{{ClinVar
|rsid=137854496
|Reversed=1
|FwdREF=G
|FwdALT=C,T
|REF=C
|ALT=A,G
|RSPOS=107593329
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05040402110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=2
|CLNHGVS=NC_000009.11:g.107593329C>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0008; O95477#VAR_009147
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease; ABCA1-Related Disorders
|Disease=Tangier disease; ABCA1-Related Disorders
|CLNACC=RCV000010098.3; RCV000381095.1
|Tags=RV;PM;PMC;NSM;REF;ASP;VLD;HD;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C0039292:205400:ORPHA31150; CN239173
|CLNREVSTAT=no_criteria; single
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854497,"{{Rsnum
|rsid=137854497
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104804668
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0013
|rsnum=137854497
}}{{ClinVar
|rsid=137854497
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=107566949
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107566949G>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0013; O95477#VAR_012630
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010104.3
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854498,"{{Rsnum
|rsid=137854498
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104798504
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0017
|rsnum=137854498
}}{{ClinVar
|rsid=137854498
|Reversed=1
|FwdREF=C
|FwdALT=A,T
|REF=G
|ALT=A,T
|RSPOS=107560785
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000b05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107560785G>A
|CLNORIGIN=1
|CLNSIG=5
|Tags=RV;PM;PMC;NSM;REF;SYN;ASP;LSD;OM
|CLNACC=RCV000010108.4
|CLNDBN=Tangier disease, variant
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=600046.0017; O95477#VAR_037970
|Disease=Tangier disease
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854499,"{{Rsnum
|rsid=137854499
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104788469
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0019
|rsnum=137854499
}}{{ClinVar
|rsid=137854499
|Reversed=1
|FwdREF=T
|FwdALT=C
|REF=A
|ALT=G
|RSPOS=107550750
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107550750A>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0019; O95477#VAR_037971
|CLNSIG=5
|CLNCUI=C1704429
|CLNDBN=Familial hypoalphalipoproteinemia
|Disease=Familial hypoalphalipoproteinemia
|CLNACC=RCV000010110.5
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=C1704429:604091:ORPHA425:15346004
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854500,"{{Rsnum
|rsid=137854500
|Chromosome=9
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA1
|position=104814154
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0020
|rsnum=137854500
}}{{ClinVar
|rsid=137854500
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=107576435
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000402110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107576435C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0020; O95477#VAR_009152
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010111.4
|Tags=RV;PM;PMC;NSM;REF;ASP;HD;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854501,"{{Rsnum
|rsid=137854501
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104786940
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0021
|rsnum=137854501
}}{{ClinVar
|rsid=137854501
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=107549221
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268080a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107549221G>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0021; O95477#VAR_012635
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010102.5
|Tags=RV;PM;PMC;S3D;NSM;REF;INT;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs137854502,"{{Rsnum
|rsid=137854502
|Chromosome=9
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA1
|position=104831098
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0023
|rsnum=137854502
}}{{ClinVar
|rsid=137854502
|Reversed=1
|FwdREF=C
|FwdALT=A
|REF=G
|ALT=T
|RSPOS=107593379
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000605000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107593379G>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=600046.0023
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010113.4
|Tags=RV;PM;PMC;NSN;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs146292819,"{{Rsnum
|rsid=146292819
|Chromosome=9
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104794495
|Gene_s=ABCA1
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=G
|CHROM=9
|CLNACC=RCV000277325.1
|CLNALLE=1
|CLNDBN=ABCA1-Related Disorders
|CLNDSDB=MedGen
|CLNDSDBID=CN239173
|CLNHGVS=NC_000009.11:g.107556776T>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|CLNSRC=Illumina
|CLNSRCID=659613
|Disease=ABCA1-Related Disorders
|FwdALT=G
|FwdREF=T
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=T
|RSPOS=107556776
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD
|VC=SNV
|VP=0x050028000a05040402000100
|WGT=1
|dbSNPBuildID=134
|rsid=146292819
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs1800977,"{{Rsnum
|rsid=1800977
|Gene=LOC105376196
|Chromosome=9
|position=104928169
|Orientation=minus
|GMAF=0.3416
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|effect1=
|effect2=
|effect3=
|Gene_s=ABCA1,LOC105376196
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 40.7 | 12.4
| HCB | 46.7 | 44.5 | 8.8
| JPT | 47.3 | 43.8 | 8.9
| YRI | 61.0 | 33.6 | 5.5
| ASW | 54.4 | 35.1 | 10.5
| CHB | 46.7 | 44.5 | 8.8
| CHD | 45.9 | 44.0 | 10.1
| GIH | 34.7 | 42.6 | 22.8
| LWK | 58.7 | 39.4 | 1.8
| MEX | 27.6 | 51.7 | 20.7
| MKK | 51.9 | 42.9 | 5.1
| TSI | 41.2 | 42.2 | 16.7
| HapMapRevision=28
}}The -14C->T polymorphism [[rs1800977]] of the [[ABCA1]] gene was significantly associated with atherothrombotic cerebral infarction in a study of 3,400+ Japanese adults.{{PMID|18566305}}

{{PMID Auto
|PMID=19446537
|Title=Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=21840005
|Title=ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting.
}}

{{PMID Auto
|PMID=25671407
|Title=A Systems Genetics Approach to Dyslipidemia in Children and Adolescents
}}

{{PMID Auto
|PMID=26451383
|Title=Association of ATP-Binding Cassette Transporter A1 Gene Polymorphisms in Type 2 Diabetes Mellitus among Malaysians
|OA=1
}}

{{ClinVar
|ALT=A
|CAF=0.6388; 0.3612
|CHROM=9
|CLNACC=RCV000274172.1; RCV000332240.1
|CLNALLE=1
|CLNDBN=Tangier disease; Familial High Density Lipoprotein Deficiency
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C0039292:205400:ORPHA31150; CN239346
|CLNHGVS=NC_000009.11:g.107690450G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Tangier disease; Familial High Density Lipoprotein Deficiency
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=G
|RSPOS=107690450
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;TPA;PMC;SLO;U5;R5;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x05013842000517053f000100
|WGT=1
|dbSNPBuildID=89
|rsid=1800977
}}

{{PMID Auto
|PMID=31006134
|Title=ABCA1 variants rs2230806 (R219K), rs4149313 (M8831I), and rs9282541 (R230C) are associated with susceptibility to coronary heart disease.
|OA=1
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs1883025,"{{Rsnum
|rsid=1883025
|Gene=ABCA1
|Chromosome=9
|position=104902020
|Orientation=minus
|GMAF=0.2815
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 31.0 | 64.6
| HCB | 3.6 | 35.0 | 61.3
| JPT | 8.8 | 43.4 | 47.8
| YRI | 12.3 | 43.2 | 44.5
| ASW | 15.8 | 49.1 | 35.1
| CHB | 3.6 | 35.0 | 61.3
| CHD | 7.3 | 35.8 | 56.9
| GIH | 14.9 | 48.5 | 36.6
| LWK | 11.8 | 49.1 | 39.1
| MEX | 10.3 | 53.4 | 36.2
| MKK | 21.8 | 48.7 | 29.5
| TSI | 9.8 | 41.2 | 49.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19060906
|Trait=HDL cholesterol
|Title=Common variants at 30 loci contribute to polygenic dyslipidemia
|RiskAllele=T
|Pval=1E-9
|OR=0.08
|ORtxt=[0.04-0.12] SD decrease
|OA=1
}}



{{omim
|id=600046
|rsnum=1883025
}}

{{PMID Auto
|PMID=21738485
|Title=Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study
|OA=1
}}

{{PMID Auto GWAS
|PMID=20686565
|Trait=None
|Title=Biological, clinical and population relevance of 95 loci for blood lipids.
|RiskAllele=T
|Pval=2E-33
|OR=0.9400
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=22247473
|Title=Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models
|OA=1
}}

{{PMID Auto GWAS
|PMID=22399527
|Trait=None
|Title=Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits.
|RiskAllele=T
|Pval=6E-10
|OR=0.1000
|ORtxt=None
|OA=1
}}

{{PMID|17430597|OA=1
}} Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

{{PMID|19951432|OA=1
}} Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.

{{PMID|20160193|OA=1
}} Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.

{{PMID|20339536|OA=1
}} Genome-wide association of lipid-lowering response to statins in combined study populations.

{{PMID|20385819|OA=1
}} Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.

{{PMID|20385826|OA=1
}} Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).



{{PMID Auto
|PMID=24223199
|Title=Association of HDL-Related Loci with Age-Related Macular Degeneration and Plasma Lutein and Zeaxanthin: the Alienor Study
|OA=1
}}

{{PMID Auto
|PMID=24970616
|Title=The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration
}}

{{PMID Auto GWAS
  |PMID=24097068
  |Trait=Cholesterol, total
  |Title=Discovery and refinement of loci associated with lipid levels.
  |RiskAllele=T
  |Pval=6E-53
  |OR=.07
  |ORtxt=[NR] unit decrease
  |OA=1
}}

{{PMID Auto
|PMID=29259020
|Title=Genetic risk factors for late age-related macular degeneration in India.
|OA=1
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2020927,"{{Rsnum
|rsid=2020927
|Gene=ABCA1
|Chromosome=9
|position=104790904
|Orientation=minus
|GMAF=0.3118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 20.4 | 78.8
| HCB | 17.5 | 48.9 | 33.6
| JPT | 11.5 | 48.7 | 39.8
| YRI | 36.1 | 48.3 | 15.6
| ASW | 26.3 | 40.4 | 33.3
| CHB | 17.5 | 48.9 | 33.6
| CHD | 13.8 | 52.3 | 33.9
| GIH | 6.9 | 35.6 | 57.4
| LWK | 34.5 | 56.4 | 9.1
| MEX | 3.4 | 29.3 | 67.2
| MKK | 33.5 | 52.3 | 14.2
| TSI | 2.0 | 21.6 | 76.5
| HapMapRevision=28
}}{{PMID|17510949}}  [[rs2297404]], [[rs2230808]], and [[rs2020927]] haplotype (CAC) was more prevalent in the [[Alzheimer's disease]] group (0.323 in AD vs. 0.202 in control); while haplotype1 (TGG) was over-represented in the healthy controls (0.595 in control vs. 0.493 in AD)

{{PMID|19538231}} Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone.

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2066714,"{{Rsnum
|rsid=2066714
|Gene=ABCA1
|Chromosome=9
|position=104824472
|Orientation=minus
|GMAF=0.3655
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 26.5 | 0.0
| HCB | 5.8 | 39.4 | 54.7
| JPT | 21.4 | 44.6 | 33.9
| YRI | 19.7 | 52.4 | 27.9
| ASW | 26.3 | 52.6 | 21.1
| CHB | 5.8 | 39.4 | 54.7
| CHD | 9.2 | 39.4 | 51.4
| GIH | 74.0 | 22.0 | 4.0
| LWK | 20.0 | 54.5 | 25.5
| MEX | 56.1 | 33.3 | 10.5
| MKK | 32.7 | 51.9 | 15.4
| TSI | 70.6 | 27.5 | 2.0
| HapMapRevision=28
}}{{PMID|17430597|OA=1
}} Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

{{PMID|17855807|OA=1
}} Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.

{{PMID|19041386|OA=1
}} Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

{{PMID|19406964|OA=1
}} Association of genetic variants with chronic kidney disease in Japanese individuals.

{{PMID|19606474|OA=1
}} A survey of ABCA1 sequence variation confirms association with dementia.{{PMID Auto
|PMID=22668585
|Title=Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses.
|OA=1
}}

{{PMID Auto
|PMID=23111454
|Title=Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease.
}}

{{PMID Auto
|PMID=23262498
|Title=Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
}}
{{PMID Auto
|PMID=26243156
|Title=Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents
}}{{ClinVar
|ALT=C
|CAF=0.6432; 0.3568
|CHROM=9
|CLNACC=RCV000310886.1; RCV000398007.1
|CLNALLE=1
|CLNDBN=Tangier disease; Familial High Density Lipoprotein Deficiency
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C0039292:205400:ORPHA31150; CN239346
|CLNHGVS=NC_000009.11:g.107586753T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Tangier disease; Familial High Density Lipoprotein Deficiency
|FwdALT=G
|FwdREF=A
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=T
|RSPOS=107586753
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050128000a0517053f000100
|WGT=1
|dbSNPBuildID=94
|rsid=2066714
}}"
ABCA1,Rs2066715,"{{Rsnum
|rsid=2066715
|Gene=ABCA1
|Chromosome=9
|position=104825752
|Orientation=minus
|GMAF=0.1281
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 16.8 | 83.2
| HCB | 13.9 | 56.2 | 29.9
| JPT | 11.5 | 46.9 | 41.6
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 3.5 | 96.5
| CHB | 13.9 | 56.2 | 29.9
| CHD | 14.8 | 51.9 | 33.3
| GIH | 1.0 | 6.9 | 92.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 3.4 | 94.8
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}

{{PMID Auto
|PMID=21247457
|Title=Genetic variant of V825I in the ATP-binding cassette transporter A1 gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations
|OA=1
}}

{{PMID|17430597|OA=1
}} Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

{{PMID|19041386|OA=1
}} Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

{{PMID|19606474|OA=1
}} A survey of ABCA1 sequence variation confirms association with dementia.



{{PMID Auto
|PMID=23355348
|Title=Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
}}

{{ClinVar
|ALT=T
|CAF=0.8868; 0.1132
|CHROM=9
|CLNACC=RCV000311949.1; RCV000371215.1
|CLNALLE=1
|CLNDBN=Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNDSDB=MedGen; MedGen:OMIM:Orphanet
|CLNDSDBID=CN239346; C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107588033C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Familial High Density Lipoprotein Deficiency; Tangier disease
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=C
|RSPOS=107588033
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050128000a05150537000100
|WGT=1
|dbSNPBuildID=94
|rsid=2066715
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2066718,"{{Rsnum
|rsid=2066718
|StabilizedOrientation=minus
|Chromosome=9
|position=104826974
|Gene_s=ABCA1
|Gene=ABCA1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 2.7 | 97.3
| HCB | 0.0 | 2.9 | 97.1
| JPT | 0.0 | 9.8 | 90.2
| YRI | 0.0 | 19.0 | 81.0
| ASW | 0.0 | 16.1 | 83.9
| CHB | 0.0 | 2.9 | 97.1
| CHD | 0.0 | 2.8 | 97.2
| GIH | 1.0 | 14.9 | 84.2
| LWK | 1.8 | 19.1 | 79.1
| MEX | 3.4 | 13.8 | 82.8
| MKK | 0.6 | 21.8 | 77.6
| TSI | 0.0 | 2.9 | 97.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=29133174
|Title=ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v2}}
{{on chip | FTDNA2}}"
ABCA1,Rs2230805,"{{Rsnum
|rsid=2230805
|StabilizedOrientation=minus
|Chromosome=9
|position=104861748
|Gene_s=ABCA1
|Gene=ABCA1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 30.1 | 66.4
| HCB | 18.2 | 48.2 | 33.6
| JPT | 15.9 | 56.6 | 27.4
| YRI | 22.4 | 47.6 | 29.9
| ASW | 28.1 | 38.6 | 33.3
| CHB | 18.2 | 48.2 | 33.6
| CHD | 11.9 | 48.6 | 39.4
| GIH | 15.8 | 45.5 | 38.6
| LWK | 21.8 | 49.1 | 29.1
| MEX | 8.6 | 36.2 | 55.2
| MKK | 20.5 | 63.5 | 16.0
| TSI | 5.9 | 52.0 | 42.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=29133174
|Title=ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
}}
{{on chip | 23andMe v3}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Affy GenomeWide 6}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | FTDNA2}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2230806,"{{Rsnum
|rsid=2230806
|Gene=ABCA1
|Chromosome=9
|position=104858586
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|GMAF=0.4192
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}[[rs2230806]], also known as Arg219Lys or R219K, is a SNP in the [[ABCA1]] ATP-binding cassette, sub-family A (ABC1), member 1 gene. The [[rs2230806]](G) allele encodes the arginine (R), and the (A) allele encodes the lysine (K).

A meta-analysis published in 2011 comprising 22 studies with 6597 cases and 15,369 controls studied the association between the [[rs2230806]] and risk for [[coronary artery disease]]. Overall, [[rs2230806]](A) significantly associated with a higher HDL-C level in Asians and does lower the risk (odds ratio 0.76, CI: 0.68-0.85, p=3.78e-07) of [[coronary artery disease]] in Asians and Caucasians.{{PMID|21310416}}

{{omim
|desc=CORONARY HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA, PROTECTION AGAINST
|id=600046
|rsnum=2230806
|variant=0024
}}

{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.5 | 33.0 | 62.5
| HCB | 21.2 | 48.2 | 30.7
| JPT | 15.0 | 56.6 | 28.3
| YRI | 61.1 | 35.4 | 3.5
| ASW | 47.4 | 31.6 | 21.1
| CHB | 21.2 | 48.2 | 30.7
| CHD | 14.7 | 47.7 | 37.6
| GIH | 17.8 | 40.6 | 41.6
| LWK | 48.6 | 44.0 | 7.3
| MEX | 13.8 | 39.7 | 46.6
| MKK | 42.9 | 50.6 | 6.4
| TSI | 5.9 | 52.9 | 41.2
| HapMapRevision=28
}}

{{PMID Auto
|PMID=22668585
|Title=Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses
|OA=1
}}

{{ClinVar
|rsid=2230806
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=107620867
|CHROM=9
|GMAF=0.4194
|dbSNPBuildID=105
|SSR=0
|SAO=1
|VP=0x050168000a0517053f110101
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107620867C>T
|CLNORIGIN=1
|CLNSIG=255
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|CAF=0.5603; 0.4397
|CLNACC=RCV000010114.2; RCV000310562.1; RCV000367106.1
|CLNDBN=Coronary heart disease in familial hypercholesterolemia, protection against; Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNDSDB=MedGen; MedGen:OMIM:Orphanet
|CLNDSDBID=C1838721; CN239346; C0039292:205400:ORPHA31150
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=600046.0024; O95477#VAR_012618
|COMMON=1
|Disease=Coronary heart disease in familial hypercholesterolemia; Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNREVSTAT=no_criteria; single
}}

{{PMID|12600718}} ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

{{PMID|16725228}} Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.

{{PMID|17324514|OA=1
}} ABCA1 polymorphisms and Alzheimer's disease.

{{PMID|17430597|OA=1
}} Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

{{PMID|17553166|OA=1
}} The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile.

{{PMID|18974877|OA=1
}} Modifier effects between regulatory and protein-coding variation.

{{PMID|19041386|OA=1
}} Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

{{PMID|19606474|OA=1
}} A survey of ABCA1 sequence variation confirms association with dementia.

{{PMID|20170916}} Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study.

{{PMID|20185793|OA=1
}} ABCA1 gene variants regulate postprandial lipid metabolism in healthy men.

{{PMID|20797885}} Increase in HDL-C concentration by a dietary portfolio with soy protein and soluble fiber is associated with the presence of the ABCA1R230C variant in hyperlipidemic Mexican subjects.

{{PMID Auto
|PMID=23111454
|Title=Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=23021345
|Title=Gene-diet interactions on plasma lipid levels in the Inuit population.
}}

{{PMID Auto
|PMID=23372063
|Title=Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.
}}

{{PMID Auto
|PMID=23533563
|Title=Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study.
|OA=1
}}

{{PMID Auto
|PMID=24854628
|Title=ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment
|OA=1
}}

{{PMID Auto
|PMID=26243156
|Title=Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents
}}

{{PMID Auto
|PMID=26451383
|Title=Association of ATP-Binding Cassette Transporter A1 Gene Polymorphisms in Type 2 Diabetes Mellitus among Malaysians
|OA=1
}}

{{PMID Auto
|PMID=29133174
|Title=ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
}}

{{PMID Auto
|PMID=31006134
|Title=ABCA1 variants rs2230806 (R219K), rs4149313 (M8831I), and rs9282541 (R230C) are associated with susceptibility to coronary heart disease.
|OA=1
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2230808,"{{Rsnum
|rsid=2230808
|Gene=ABCA1
|Chromosome=9
|position=104800523
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.4109
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 36.3 | 61.9
| HCB | 16.8 | 46.7 | 36.5
| JPT | 8.8 | 48.7 | 42.5
| YRI | 83.7 | 15.6 | 0.7
| ASW | 47.4 | 40.4 | 12.3
| CHB | 16.8 | 46.7 | 36.5
| CHD | 11.9 | 51.4 | 36.7
| GIH | 15.8 | 43.6 | 40.6
| LWK | 66.4 | 30.0 | 3.6
| MEX | 5.2 | 43.1 | 51.7
| MKK | 54.5 | 42.3 | 3.2
| TSI | 3.9 | 40.2 | 55.9
| HapMapRevision=28
}}{{PMID|17510949}}  [[rs2297404]], [[rs2230808]], and [[rs2020927]] haplotype (CAC) was more prevalent in the [[Alzheimer's disease]] group (0.323 in AD vs. 0.202 in control); while haplotype1 (TGG) was over-represented in the healthy controls (0.595 in control vs. 0.493 in AD)

{{PMID Auto
|PMID=22668585
|Title=Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses
|OA=1
}}

{{PMID|12600718}} ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

{{PMID|17324514|OA=1
}} ABCA1 polymorphisms and Alzheimer's disease.

{{PMID|17430597|OA=1
}} Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

{{PMID|17553166|OA=1
}} The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile.

{{PMID|19041386|OA=1
}} Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

{{PMID|19606474|OA=1
}} A survey of ABCA1 sequence variation confirms association with dementia.

{{PMID|21839797}} A polymorphism of the ABCA1 gene confers susceptibility to schizophrenia and related brain changes.



{{PMID Auto
|PMID=23111454
|Title=Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=26722555
|Title=Association of ATP-binding cassette transporter A1 gene polymorphisms with plasma lipid variability and coronary heart disease risk.
|OA=1
}}

{{ClinVar
|ALT=C
|CAF=0.4617; 0.5383
|CHROM=9
|CLNACC=RCV000312801.1; RCV000356155.1
|CLNALLE=1
|CLNDBN=Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNDSDB=MedGen; MedGen:OMIM:Orphanet
|CLNDSDBID=CN239346; C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107562804T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Familial High Density Lipoprotein Deficiency; Tangier disease
|FwdALT=G
|FwdREF=A
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=T
|RSPOS=107562804
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050128000a0517053f000101
|WGT=1
|dbSNPBuildID=98
|rsid=2230808
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2249891,"{{Rsnum
|rsid=2249891
|Gene=ABCA1
|Chromosome=9
|position=104861961
|Orientation=plus
|GMAF=0.331
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 81.4 | 16.8 | 1.8
| HCB | 38.7 | 49.6 | 11.7
| JPT | 43.4 | 48.7 | 8.0
| YRI | 6.1 | 38.1 | 55.8
| ASW | 21.1 | 40.4 | 38.6
| CHB | 38.7 | 49.6 | 11.7
| CHD | 45.4 | 48.1 | 6.5
| GIH | 53.0 | 39.0 | 8.0
| LWK | 5.5 | 44.5 | 50.0
| MEX | 62.1 | 31.0 | 6.9
| MKK | 21.3 | 56.8 | 21.9
| TSI | 73.3 | 23.8 | 3.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20855565
|Title=Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2297404,"{{Rsnum
|rsid=2297404
|Gene=ABCA1
|Chromosome=9
|position=104802185
|Orientation=minus
|GMAF=0.09412
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 1.5 | 10.8 | 87.7
| HCB | 4.4 | 37.8 | 57.8
| JPT | 2.3 | 27.3 | 70.5
| YRI | 0.0 | 1.6 | 98.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 37.8 | 57.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|17510949}}  [[rs2297404]], [[rs2230808]], and [[rs2020927]] haplotype (CAC) was more prevalent in the [[Alzheimer's disease]] group (0.323 in AD vs. 0.202 in control); while haplotype1 (TGG) was over-represented in the healthy controls (0.595 in control vs. 0.493 in AD)

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCA1,Rs2422493,"{{Rsnum
|rsid=2422493
|Gene=LOC105376196
|Chromosome=9
|position=104928714
|Orientation=minus
|GMAF=0.4752
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCA1,LOC105376196
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 46.0 | 17.7
| HCB | 33.8 | 49.3 | 16.9
| JPT | 31.0 | 49.6 | 19.5
| YRI | 26.2 | 58.6 | 15.2
| ASW | 21.1 | 52.6 | 26.3
| CHB | 33.8 | 49.3 | 16.9
| CHD | 31.2 | 50.5 | 18.3
| GIH | 26.7 | 37.6 | 35.6
| LWK | 38.2 | 49.1 | 12.7
| MEX | 22.4 | 43.1 | 34.5
| MKK | 17.4 | 52.3 | 30.3
| TSI | 26.5 | 44.1 | 29.4
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19446537
|Title=Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk
}}

{{PMID Auto
|PMID=20571217
|Title=Epistasis Between Intracellular Cholesterol Trafficking-Related Genes (NPC1 and ABCA1) and Alzheimer's Disease Risk
}}

{{PMID Auto
|PMID=17324514
|Title=ABCA1 polymorphisms and Alzheimer's disease.
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=21840005
|Title=ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting.
}}

{{PMID Auto
|PMID=29133174
|Title=ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2515629,"{{Rsnum
|rsid=2515629
|Gene=ABCA1
|Chromosome=9
|position=104832083
|Orientation=minus
|GMAF=0.1391
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 28.3 | 70.8
| HCB | 0.0 | 12.4 | 87.6
| JPT | 2.7 | 16.8 | 80.5
| YRI | 4.1 | 27.9 | 68.0
| ASW | 1.8 | 19.3 | 78.9
| CHB | 0.0 | 12.4 | 87.6
| CHD | 0.0 | 9.2 | 90.8
| GIH | 2.0 | 27.7 | 70.3
| LWK | 1.8 | 35.5 | 62.7
| MEX | 0.0 | 17.2 | 82.8
| MKK | 3.8 | 42.3 | 53.8
| TSI | 2.0 | 34.3 | 63.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21347282
|Trait=None
|Title=Genome-Wide Association Study of Coronary Heart Disease and Its Risk Factors in 8,090 African Americans: The NHLBI CARe Project
|RiskAllele=A
|Pval=5E-7
|OR=0.1184
|ORtxt=[0.07-0.17] SD increase
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2575876,"{{Rsnum
|rsid=2575876
|Gene=ABCA1
|Chromosome=9
|position=104903458
|Orientation=plus
|GMAF=0.2525
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 6.2 | 30.1 | 63.7
| HCB | 3.7 | 32.6 | 63.7
| JPT | 8.8 | 43.4 | 47.8
| YRI | 6.1 | 32.7 | 61.2
| ASW | 5.3 | 40.4 | 54.4
| CHB | 3.7 | 32.6 | 63.7
| CHD | 7.3 | 35.8 | 56.9
| GIH | 13.9 | 45.5 | 40.6
| LWK | 9.1 | 40.0 | 50.9
| MEX | 10.3 | 55.2 | 34.5
| MKK | 14.1 | 46.2 | 39.7
| TSI | 8.8 | 43.1 | 48.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22286219
|Trait=None
|Title=Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|RiskAllele=
|Pval=2E-11
|OR=0.1400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2740483,"{{Rsnum
|rsid=2740483
|StabilizedOrientation=minus
|Chromosome=9
|position=104928254
|Gene_s=ABCA1,LOC105376196
|Gene=ABCA1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{PMID Auto
|PMID=29133174
|Title=ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease.
}}
{{on chip | 23andMe v3}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v2}}
{{on chip | FTDNA2}}
{{on chip | 23andMe v4}}"
ABCA1,Rs2853578,"{{Rsnum
|rsid=2853578
|Chromosome=9
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA1
|position=104831027
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=600046
|variant=0003
|rsnum=2853578
}}

{{ClinVar
|rsid=2853578
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=107593308
|CHROM=9
|dbSNPBuildID=100
|SSR=0
|SAO=1
|VP=0x050068000a05000102110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107593308T>C
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0003; O95477#VAR_009148
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010093.4
|Tags=RV;PM;PMC;NSM;REF;ASP;GNO;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs2853579,"{{Rsnum
|rsid=2853579
|Gene=ABCA1
|Chromosome=9
|position=104828991
|Orientation=minus
|GMAF=0.3531
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 25.7 | 74.3
| HCB | 54.7 | 40.1 | 5.1
| JPT | 32.7 | 46.9 | 20.4
| YRI | 24.5 | 53.1 | 22.4
| ASW | 17.9 | 48.2 | 33.9
| CHB | 54.7 | 40.1 | 5.1
| CHD | 50.9 | 39.8 | 9.3
| GIH | 4.0 | 21.8 | 74.3
| LWK | 24.5 | 52.7 | 22.7
| MEX | 7.1 | 33.9 | 58.9
| MKK | 12.4 | 50.3 | 37.3
| TSI | 1.0 | 27.5 | 71.6
| HapMapRevision=28
}}{{ClinVar
|ALT=T
|CAF=0.6609; 0.3391
|CHROM=9
|CLNACC=RCV000300380.1; RCV000395968.1
|CLNALLE=1
|CLNDBN=Tangier disease; Familial High Density Lipoprotein Deficiency
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C0039292:205400:ORPHA31150; CN239346
|CLNHGVS=NC_000009.11:g.107591272G>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Tangier disease; Familial High Density Lipoprotein Deficiency
|FwdALT=A
|FwdREF=C
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=G
|RSPOS=107591272
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;SLO;REF;SYN;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x05010000030517053f000100
|WGT=1
|dbSNPBuildID=108
|rsid=2853579
}}"
ABCA1,Rs28587567,"{{Rsnum
|rsid = 28587567
|Status = Merged
|Merged = 2066715
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=9
|position=104825752
|Gene=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 16.8 | 83.2
| HCB | 13.9 | 56.2 | 29.9
| JPT | 11.5 | 46.9 | 41.6
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 3.5 | 96.5
| CHB | 13.9 | 56.2 | 29.9
| CHD | 14.8 | 51.9 | 33.3
| GIH | 1.0 | 6.9 | 92.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 1.7 | 3.4 | 94.8
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}

{{on chip | Affy GenomeWide 6}}"
ABCA1,Rs28933692,"{{Rsnum
|rsid = 28933692
|Gene = ABCA1
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=T
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Chromosome=9
|position=104818830
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{omim
|desc=HIGH DENSITY LIPOPROTEIN DEFICIENCY
|id=600046
|rsnum=28933692
|variant=0018
}}

{{ClinVar
|rsid=28933692
|Reversed=1
|FwdREF=G
|FwdALT=A,T
|REF=C
|ALT=A,T
|RSPOS=107581111
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107581111C>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0018; O95477#VAR_017530
|CLNSIG=5
|CLNCUI=C1704429
|CLNDBN=Familial hypoalphalipoproteinemia
|Disease=Familial hypoalphalipoproteinemia
|CLNACC=RCV000010109.2
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=C1704429:604091:ORPHA425:15346004
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2c}}"
ABCA1,Rs28937313,"{{Rsnum
|rsid = 28937313
|Gene = ABCA1
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|Chromosome=9
|position=104822520
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{omim
|desc=TANGIER DISEASE
|id=600046
|rsnum=28937313
|variant=0014
}}


{{ClinVar
|rsid=28937313
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=107584801
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05040002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000009.11:g.107584801T>C
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0006; 600046.0014; O95477#VAR_009150
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000010096.5
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;VLD;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs28937314,"{{Rsnum
|rsid = 28937314
|Gene = ABCA1
|geno1 = (A;A)
|geno2 = (A;C)
|geno3 = (C;C)
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=C
|Chromosome=9
|position=104822521
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{omim
|desc=TANGIER DISEASE
|id=600046
|rsnum=28937314
|variant=0015
}}


{{ClinVar
|rsid=28937314
|Reversed=1
|FwdREF=A
|FwdALT=C,G
|REF=T
|ALT=C,G
|RSPOS=107584802
|CHROM=9
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA1:19
|GENE_NAME=ABCA1
|GENE_ID=19
|WGT=1
|VC=SNV
|CLNALLE=1; 2
|CLNHGVS=NC_000009.11:g.107584802T>C; NC_000009.11:g.107584802T>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=600046.0015; O95477#VAR_037968
|CLNSIG=5
|CLNCUI=C0039292
|CLNDBN=Tangier disease
|Disease=Tangier disease
|CLNACC=RCV000415392.1; RCV000010106.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs363717,"{{Rsnum
|rsid=363717
|Gene=ABCA1
|Chromosome=9
|position=104782419
|Orientation=minus
|GMAF=0.1515
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 66.4 | 31.9 | 1.8
| HCB | 61.3 | 34.3 | 4.4
| JPT | 68.8 | 28.6 | 2.7
| YRI | 88.4 | 11.6 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 61.3 | 34.3 | 4.4
| CHD | 67.9 | 29.4 | 2.8
| GIH | 77.2 | 22.8 | 0.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 86.2 | 13.8 | 0.0
| MKK | 92.3 | 7.7 | 0.0
| TSI | 62.7 | 33.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21245421
|Title=Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma
}}

{{PMID|17685456|OA=1
}} Examining the effect of linkage disequilibrium between markers on the Type I error rate and power of nonparametric multipoint linkage analysis of two-generation and multigenerational pedigrees in the presence of missing genotype data.

{{PMID|19606474|OA=1
}} A survey of ABCA1 sequence variation confirms association with dementia.

{{PMID Auto
|PMID=26722555
|Title=Association of ATP-binding cassette transporter A1 gene polymorphisms with plasma lipid variability and coronary heart disease risk.
|OA=1
}}

{{ClinVar
|ALT=T
|CAF=0.1424; 0.8576
|CHROM=9
|CLNACC=RCV000296142.1; RCV000394913.1
|CLNALLE=1
|CLNDBN=Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNDSDB=MedGen; MedGen:OMIM:Orphanet
|CLNDSDBID=CN239346; C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107544700C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Familial High Density Lipoprotein Deficiency; Tangier disease
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=C
|RSPOS=107544700
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;U3;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x05012880000515053f000100
|WGT=1
|dbSNPBuildID=79
|rsid=363717
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs387906412,"{{Rsnum
|rsid=387906412
|Chromosome=9
|position=104828949
|Orientation=minus
|geno1=(-;-)
|geno2=(-;CTT)
|geno3=(CTT;CTT)
|Gene=ABCA1
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=C
|CHROM=9
|CLNACC=RCV000010094.5
|CLNALLE=1
|CLNDBN=Familial hypoalphalipoproteinemia
|CLNHGVS=NC_000009.11:g.107591230_107591232delAAG
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0004
|Disease=Familial hypoalphalipoproteinemia
|FwdREF=CTT
|REF=CAAG
|RSPOS=107591229
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;ASP;LSD
|VC=DIV
|VP=0x050068000005000002100200
|WGT=1
|dbSNPBuildID=137
|rsid=387906412
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=C1704429:604091:ORPHA425:15346004
|FwdALT=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs387906413,"{{Rsnum
|rsid=387906413
|Chromosome=9
|position=104830993
|Orientation=minus
|geno1=(-;-)
|geno2=(-;G)
|geno3=(G;G)
|Gene=ABCA1
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=T
|CHROM=9
|CLNACC=RCV000010095.5
|CLNALLE=1
|CLNDBN=Tangier disease
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107593274delC
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0005; 600046.0009
|Disease=Tangier disease
|FwdREF=G
|REF=TC
|RSPOS=107593273
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSF;REF;ASP;LSD;OM
|VC=DIV
|VP=0x050068001205000002110200
|WGT=1
|dbSNPBuildID=137
|rsid=387906413
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|FwdALT=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs387906414,"{{Rsnum
|rsid=387906414
|Chromosome=9
|position=104818781
|Orientation=minus
|geno1=(-;-)
|geno2=(-;TC)
|geno3=(TC;TC)
|Gene=ABCA1
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G
|CHROM=9
|CLNACC=RCV000010101.4
|CLNALLE=1
|CLNDBN=Tangier disease
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107581062_107581063delGA
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0011
|Disease=Tangier disease
|FwdREF=TC
|REF=GGA
|RSPOS=107581061
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSF;REF;ASP;LSD;OM
|VC=DIV
|VP=0x050068001205000002110200
|WGT=1
|dbSNPBuildID=137
|rsid=387906414
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|FwdALT=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs387906415,"{{Rsnum
|rsid=387906415
|Chromosome=9
|position=104814169
|Orientation=minus
|geno1=(-;-)
|geno2=(-;CGCC)
|geno3=(CGCC;CGCC)
|Gene=ABCA1
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=A
|CHROM=9
|CLNACC=RCV000010112.2
|CLNALLE=1
|CLNDBN=Familial hypoalphalipoproteinemia
|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=C1704429:604091:ORPHA425:15346004
|CLNHGVS=NC_000009.11:g.107576450_107576453delGGCG
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0022
|Disease=Familial hypoalphalipoproteinemia
|FwdREF=CCCG
|REF=ACGGG
|RSPOS=107576447
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSF;REF;ASP;LSD;OM
|VC=DIV
|VP=0x050068001205000002110200
|WGT=1
|dbSNPBuildID=137
|rsid=387906415
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|FwdALT=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs3890182,"{{Rsnum
|rsid=3890182
|Gene=ABCA1
|Chromosome=9
|position=104885374
|Orientation=plus
|GMAF=0.1033
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 12.4 | 85.8
| HCB | 0.0 | 13.1 | 86.9
| JPT | 0.0 | 8.8 | 91.2
| YRI | 2.7 | 27.9 | 69.4
| ASW | 0.0 | 21.1 | 78.9
| CHB | 0.0 | 13.1 | 86.9
| CHD | 0.9 | 14.7 | 84.4
| GIH | 0.0 | 13.9 | 86.1
| LWK | 1.8 | 24.5 | 73.6
| MEX | 1.7 | 12.1 | 86.2
| MKK | 5.8 | 41.7 | 52.6
| TSI | 2.0 | 20.6 | 77.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18193044
|Trait=HDL cholesterol
|Title=Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
|RiskAllele=A
|Pval=3E-10
|OR=0.10
|ORtxt=[0.06-0.14]% SD lower
|OA=1
}}

{{omim
|id=600046
|desc=ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
|rsnum=3890182
}}

{{PMID Auto
|PMID=19773416
|Title=A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women
|OA=1
}}
{{PMID Auto GWAS
|PMID=20864672
|Trait=None
|Title=Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease
|RiskAllele=G
|Pval=5E-7
|OR=0.02
|ORtxt=[0.01-0.03] unit increase
|OA=1
}}

{{omim
|id=600046
|rsnum=3890182
|variant=0025
}}

{{PMID Auto
|PMID=18179892
|Title=Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=19060910
|Title=Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.
|OA=1
}}

{{PMID Auto
|PMID=19148283
|Title=Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=19197348
|Title=Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae.
|OA=1
}}

{{PMID Auto
|PMID=19606474
|Title=A survey of ABCA1 sequence variation confirms association with dementia.
|OA=1
}}

{{PMID Auto
|PMID=19951432
|Title=Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.
|OA=1
}}

{{PMID Auto
|PMID=20018036
|Title=Using a latent growth curve model for an integrative assessment of the effects of genetic and environmental factors on multiple phenotypes.
|OA=1
}}

{{PMID Auto
|PMID=20502693
|Title=Genetics and beyond--the transcriptome of human monocytes and disease susceptibility.
|OA=1
}}



{{PMID Auto
|PMID=26252223
|Title=Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 Diabetes
|OA=1
}}

{{ClinVar
|ALT=A,T
|CAF=0.9018; 0.09824
|CHROM=9
|CLNACC=RCV000010115.2
|CLNALLE=1
|CLNDBN=High density lipoprotein cholesterol level quantitative trait locus 13
|CLNDSDB=MedGen
|CLNDSDBID=C2677643
|CLNHGVS=NC_000009.11:g.107647655G>A
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=255
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0025
|COMMON=1
|Disease=High density lipoprotein cholesterol level quantitative trait locus 13
|FwdALT=A,T
|FwdREF=G
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=G
|RSPOS=107647655
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;SLO;INT;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3;MTP;OM
|VC=SNV
|VP=0x050168080005170537030100
|WGT=1
|dbSNPBuildID=108
|rsid=3890182
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs3905000,"{{Rsnum
|rsid=3905000
|Gene=ABCA1
|Chromosome=9
|position=104894789
|Orientation=plus
|GMAF=0.1327
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 13.3 | 85.0
| HCB | 0.0 | 13.1 | 86.9
| JPT | 0.0 | 8.8 | 91.2
| YRI | 3.4 | 36.7 | 59.9
| ASW | 0.0 | 29.8 | 70.2
| CHB | 0.0 | 13.1 | 86.9
| CHD | 0.9 | 14.7 | 84.4
| GIH | 0.0 | 15.8 | 84.2
| LWK | 7.3 | 46.4 | 46.4
| MEX | 1.7 | 17.2 | 81.0
| MKK | 16.0 | 42.9 | 41.0
| TSI | 2.9 | 21.6 | 75.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19060911
|Trait=HDL cholesterol
|Title=Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
|RiskAllele=G
|Pval=9E-13
|OR=0.11
|ORtxt=[NR] SD increase
|OA=1
}}



{{PMID Auto GWAS
|PMID=21116278
|Trait=None
|Title=Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease
|RiskAllele=
|Pval=0.000009
|OR=0.0126
|ORtxt=[NR] unit increase (interaction)
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=19951432
|Title=Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.
|OA=1
}}

{{PMID Auto
|PMID=20502693
|Title=Genetics and beyond--the transcriptome of human monocytes and disease susceptibility.
|OA=1
}}

{{PMID Auto
|PMID=21347282
|Title=Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|OA=1
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149263,"{{Rsnum
|rsid=4149263
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104915008
|Gene_s=ABCA1,LOC102724761
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 33.6 | 61.9
| HCB | 2.9 | 28.5 | 68.6
| JPT | 1.8 | 24.8 | 73.5
| YRI | 1.4 | 25.9 | 72.8
| ASW | 0.0 | 21.1 | 78.9
| CHB | 2.9 | 28.5 | 68.6
| CHD | 1.8 | 25.7 | 72.5
| GIH | 4.0 | 35.6 | 60.4
| LWK | 0.9 | 24.5 | 74.5
| MEX | 5.2 | 25.9 | 69.0
| MKK | 5.8 | 43.6 | 50.6
| TSI | 3.9 | 42.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24024966
  |Trait=Periodontitis (Mean PAL)
  |Title=Genome-wide association study of chronic periodontitis in a general German population.
  |RiskAllele=A
  |Pval=7E-6
  |OR=.06
  |ORtxt=[0.032-0.080] unit decrease
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149268,"{{Rsnum
|rsid=4149268
|Gene=ABCA1
|Chromosome=9
|position=104884939
|Orientation=minus
|GMAF=0.421
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.0 | 39.8 | 52.2
| HCB | 5.1 | 41.6 | 53.3
| JPT | 15.9 | 42.5 | 41.6
| YRI | 51.0 | 42.9 | 6.1
| ASW | 54.4 | 38.6 | 7.0
| CHB | 5.1 | 41.6 | 53.3
| CHD | 8.3 | 44.0 | 47.7
| GIH | 38.0 | 43.0 | 19.0
| LWK | 47.3 | 45.5 | 7.3
| MEX | 15.5 | 39.7 | 44.8
| MKK | 54.5 | 40.4 | 5.1
| TSI | 20.6 | 41.2 | 38.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18193043
|Trait=HDL cholesterol
|Title=Newly identified loci that influence lipid concentrations and risk of coronary artery disease
|RiskAllele=C
|Pval=1E-10
|OR=0.82
|ORtxt=[NR] mg/dl higher
|OA=1
}}

G allele is associated with 0.82mg/dl increase in [[HDL cholesterol]] (good cholesterol). {{PMID|18193043|OA=1}}

{{PMID Auto
|PMID=21738485
|Title=Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study
|OA=1
}}

{{PMID Auto
|PMID=18852197
|Title=Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants.
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=19060910
|Title=Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.
|OA=1
}}

{{PMID Auto
|PMID=19185284
|Title=Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study.
|OA=1
}}

{{PMID Auto
|PMID=19435741
|Title=Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people.
|OA=1
}}

{{PMID Auto
|PMID=19606474
|Title=A survey of ABCA1 sequence variation confirms association with dementia.
|OA=1
}}

{{PMID Auto
|PMID=19802338
|Title=Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
|OA=1
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149274,"{{Rsnum
|rsid=4149274
|Gene=ABCA1
|Chromosome=9
|position=104877133
|Orientation=minus
|GMAF=0.2897
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 62.1 | 36.2 | 1.7
| HCB | 61.1 | 38.9 | 0.0
| JPT | 47.5 | 45.0 | 7.5
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 61.1 | 38.9 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

C allele is associated with 1.51mg/dl increase in [[HDL cholesterol]] (good cholesterol). {{PMID|18193043|OA=1}}

{{PMID Auto
|PMID=19408013
|Title=Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149310,"{{Rsnum
|rsid=4149310
|Gene=ABCA1
|Chromosome=9
|position=104826853
|Orientation=minus
|GMAF=0.4536
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 27.0 | 73.0
| HCB | 57.8 | 35.6 | 6.7
| JPT | 34.1 | 43.2 | 22.7
| YRI | 58.1 | 33.9 | 8.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 57.8 | 35.6 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22916037
  |Trait=Metabolite levels
  |Title=Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.
  |RiskAllele=
  |Pval=2E-10
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{PMID Auto
|PMID=21347282
|Title=Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149311,"{{Rsnum
|rsid=4149311
|Gene=ABCA1
|Chromosome=9
|position=104826496
|Orientation=minus
|GMAF=0.3512
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 25.7 | 74.3
| HCB | 54.0 | 40.1 | 5.8
| JPT | 33.6 | 45.1 | 21.2
| YRI | 25.2 | 52.4 | 22.4
| ASW | 19.3 | 47.4 | 33.3
| CHB | 54.0 | 40.1 | 5.8
| CHD | 50.9 | 39.8 | 9.3
| GIH | 4.0 | 21.8 | 74.3
| LWK | 24.5 | 52.7 | 22.7
| MEX | 8.6 | 34.5 | 56.9
| MKK | 10.9 | 52.6 | 36.5
| TSI | 1.0 | 27.5 | 71.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23049088
  |Trait=Myopia (pathological)
  |Title=A Genome-Wide Association Study Provides Evidence for Association of Chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with High Myopia in the French Population.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  }}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149313,"{{Rsnum
|rsid = 4149313
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Status = Merged
|Merged = 2066714
|Gene = ABCA1
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|Chromosome=9
|position=104824472
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 26.5 | 0.0
| HCB | 5.8 | 39.4 | 54.7
| JPT | 21.4 | 44.6 | 33.9
| YRI | 19.7 | 52.4 | 27.9
| ASW | 26.3 | 52.6 | 21.1
| CHB | 5.8 | 39.4 | 54.7
| CHD | 9.2 | 39.4 | 51.4
| GIH | 74.0 | 22.0 | 4.0
| LWK | 20.0 | 54.5 | 25.5
| MEX | 56.1 | 33.3 | 10.5
| MKK | 32.7 | 51.9 | 15.4
| TSI | 70.6 | 27.5 | 2.0
| HapMapRevision=28
}}

{{PMID Auto
|PMID=22668585
|Title=Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses
|OA=1
}}

{{PMID Auto
|PMID=23111454
|Title=Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=23262498
|Title=Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy
}}

{{PMID Auto
|PMID=31006134
|Title=ABCA1 variants rs2230806 (R219K), rs4149313 (M8831I), and rs9282541 (R230C) are associated with susceptibility to coronary heart disease.
|OA=1
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCA1,Rs4149338,"{{Rsnum
|rsid=4149338
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104783622
|Gene_s=ABCA1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 49.6 | 38.1 | 12.4
| HCB | 8.0 | 43.8 | 48.2
| JPT | 3.5 | 36.3 | 60.2
| YRI | 34.7 | 53.7 | 11.6
| ASW | 43.9 | 43.9 | 12.3
| CHB | 8.0 | 43.8 | 48.2
| CHD | 4.6 | 39.4 | 56.0
| GIH | 38.6 | 51.5 | 9.9
| LWK | 24.5 | 55.5 | 20.0
| MEX | 39.7 | 32.8 | 27.6
| MKK | 20.5 | 51.9 | 27.6
| TSI | 57.8 | 38.2 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=26722555
|Title=Association of ATP-binding cassette transporter A1 gene polymorphisms with plasma lipid variability and coronary heart disease risk.
|OA=1
}}

{{ClinVar
|ALT=A
|CAF=0.5545; 0.4455
|CHROM=9
|CLNACC=RCV000286965.1; RCV000379060.1
|CLNALLE=1
|CLNDBN=Familial High Density Lipoprotein Deficiency; Tangier disease
|CLNDSDB=MedGen; MedGen:OMIM:Orphanet
|CLNDSDBID=CN239346; C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107545903G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Familial High Density Lipoprotein Deficiency; Tangier disease
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=G
|RSPOS=107545903
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;TPA;PMC;SLO;U3;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x05013880000517053f000100
|WGT=1
|dbSNPBuildID=110
|rsid=4149338
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA1,Rs4149339,"{{Rsnum
|rsid=4149339
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA1
|position=104782875
|Gene_s=ABCA1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.6 | 41.4 | 9.9
| HCB | 8.3 | 42.1 | 49.6
| JPT | 3.5 | 35.4 | 61.1
| YRI | 34.2 | 54.1 | 11.6
| ASW | 43.9 | 43.9 | 12.3
| CHB | 8.3 | 42.1 | 49.6
| CHD | 4.6 | 39.4 | 56.0
| GIH | 39.0 | 51.0 | 10.0
| LWK | 25.0 | 53.7 | 21.3
| MEX | 39.7 | 36.2 | 24.1
| MKK | 20.6 | 52.3 | 27.1
| TSI | 60.8 | 35.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=26722555
|Title=Association of ATP-binding cassette transporter A1 gene polymorphisms with plasma lipid variability and coronary heart disease risk.
|OA=1
}}

{{ClinVar
|ALT=A
|CAF=0.5589; 0.4411
|CHROM=9
|CLNACC=RCV000282474.1; RCV000394594.1
|CLNALLE=1
|CLNDBN=Tangier disease; Familial High Density Lipoprotein Deficiency
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C0039292:205400:ORPHA31150; CN239346
|CLNHGVS=NC_000009.11:g.107545156G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=Tangier disease; Familial High Density Lipoprotein Deficiency
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=G
|RSPOS=107545156
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;SLO;U3;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x05012880000517053f000100
|WGT=1
|dbSNPBuildID=110
|rsid=4149339
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}"
ABCA1,Rs7031748,"{{Rsnum
|rsid=7031748
|Chromosome=9
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA1
|Status=Merged
|Merged=2853579
|Gene_s=ABCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|position=104828991
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 25.7 | 74.3
| HCB | 54.7 | 40.1 | 5.1
| JPT | 32.7 | 46.9 | 20.4
| YRI | 24.5 | 53.1 | 22.4
| ASW | 17.9 | 48.2 | 33.9
| CHB | 54.7 | 40.1 | 5.1
| CHD | 50.9 | 39.8 | 9.3
| GIH | 4.0 | 21.8 | 74.3
| LWK | 24.5 | 52.7 | 22.7
| MEX | 7.1 | 33.9 | 58.9
| MKK | 12.4 | 50.3 | 37.3
| TSI | 1.0 | 27.5 | 71.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23049088
  |Trait=Myopia (pathological)
  |Title=A Genome-Wide Association Study Provides Evidence for Association of Chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with High Myopia in the French Population.
  |RiskAllele=
  |Pval=8E-6
  |OR=NR
  |ORtxt=NR
  }}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}"
ABCA1,Rs796051872,"{{Rsnum
|rsid=796051872
|Chromosome=9
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA1
|position=104816142
|Gene_s=ABCA1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G
|CHROM=9
|CLNACC=RCV000010092.4
|CLNALLE=1
|CLNDBN=Tangier disease
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C0039292:205400:ORPHA31150
|CLNHGVS=NC_000009.11:g.107578423C>G
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600046.0002
|Disease=Tangier disease
|FwdALT=C
|FwdREF=G
|GENEINFO=ABCA1:19
|GENE_ID=19
|GENE_NAME=ABCA1
|REF=C
|RSPOS=107578423
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;PMC;DSS;ASP;LSD;OM
|VC=SNV
|VP=0x050068100005000002110100
|WGT=1
|dbSNPBuildID=144
|rsid=796051872
}}"
ABCA12,Rs10210200,"{{Rsnum
|rsid=10210200
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=215064402
|Gene_s=ABCA12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 5.3 | 15.8 | 78.9
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24324551
  |Trait=PR interval in Tripanosoma cruzi seropositivity
  |Title=Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}"
ABCA12,Rs1064793695,"{{Rsnum
|rsid=1064793695
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=2
|position=214932640
|Gene_s=ABCA12,LOC101928103
|Gene=LOC101928103
}}
{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000479920.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215797364_215797365delCT
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=-
|FwdREF=AG
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_ID=101928103; 26154
|GENE_NAME=LOC101928103; ABCA12
|REF=ACT
|RSPOS=215797363
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSF;REF;INT;ASP;LSD
|VC=DIV
|VP=0x050060081205000002100200
|WGT=1
|dbSNPBuildID=150
|rsid=1064793695
}}"
ABCA12,Rs1085308032,"{{Rsnum
|rsid=1085308032
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=2
|position=214947489
|Gene_s=ABCA12,LOC101928103
|Gene=LOC101928103
}}
{{ClinVar
|ALT=T
|CHROM=2
|CLNACC=RCV000490250.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215812213C>T
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_ID=101928103; 26154
|GENE_NAME=LOC101928103; ABCA12
|REF=C
|RSPOS=215812213
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;INT;ASP;LSD
|VC=SNV
|VP=0x050060080a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1085308032
}}"
ABCA12,Rs114863111,"{{Rsnum
|rsid=114863111
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=214987734
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A,T
|CAF=0.9998; 0.0001997
|CHROM=2
|CLNACC=RCV000255106.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215852458G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|COMMON=0
|Disease=not provided
|FwdALT=A,T
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215852458
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;ASP;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050000000605000036000100
|WGT=1
|dbSNPBuildID=132
|rsid=114863111
}}
{{on chip | Ancestry v2c}}"
ABCA12,Rs11891778,"{{Rsnum
|rsid=11891778
|Chromosome=2
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA12
|position=215045850
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 1.6 | 25.8 | 72.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{ClinVar
|ALT=A,C
|CAF=0.9579; 0.04213
|CHROM=2
|CLNACC=RCV000255175.1; RCV000224893.1; RCV000293566.1
|CLNALLE=1; 2
|CLNDBN=not provided; Congenital ichthyosiform erythroderma
|CLNDSDB=MedGen; Human_Phenotype_Ontology:MedGen
|CLNDSDBID=CN221809; HP:0007431:C0079583
|CLNHGVS=NC_000002.11:g.215910574G>A; NC_000002.11:g.215910574G>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|COMMON=1
|Disease=not provided; Congenital ichthyosiform erythroderma
|FwdALT=A,C
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215910574
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;SLO;NSM;NSN;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;LSD
|VC=SNV
|VP=0x050168000e05150537100100
|WGT=1
|dbSNPBuildID=120
|rsid=11891778
|CLNSRC=Illumina
}}"
ABCA12,Rs137853289,"{{Rsnum
|rsid=137853289
|Chromosome=2
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=LOC101928103
|position=214953891
|Gene_s=ABCA12,LOC101928103
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{omim
|id=607800
|variant=0009
|rsnum=137853289
}}{{ClinVar
|rsid=137853289
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=215818615
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068080605000002110100
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_NAME=LOC101928103; ABCA12
|GENE_ID=101928103; 26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215818615G>A
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=607800.0009
|CLNSIG=5
|CLNCUI=C0239849
|CLNDBN=Autosomal recessive congenital ichthyosis 4B; not provided
|Disease=Autosomal recessive congenital ichthyosis 4B; not provided
|CLNACC=RCV000002996.3; RCV000413290.1
|Tags=RV;PM;PMC;NSN;REF;INT;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C0239849:242500; CN221809
|CLNREVSTAT=no_criteria; single
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs199503269,"{{Rsnum
|rsid=199503269
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=2
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=214937608
|Gene_s=ABCA12,LOC101928103
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=A
|CAF=0.9998; 0.0001997
|CHROM=2
|CLNACC=RCV000480311.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215802332G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|COMMON=0
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_ID=101928103; 26154
|GENE_NAME=LOC101928103; ABCA12
|REF=G
|RSPOS=215802332
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;INT;ASP;VLD;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050000080605040036000100
|WGT=1
|dbSNPBuildID=137
|rsid=199503269
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs267606622,"{{Rsnum
|rsid=267606622
|Chromosome=2
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=214990791
|Gene_s=ABCA12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=T
|CHROM=2
|CLNACC=RCV000002997.3
|CLNALLE=1
|CLNDBN=Autosomal recessive congenital ichthyosis 4B
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C0239849:242500
|CLNHGVS=NC_000002.11:g.215855515C>T
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=607800.0010; Q86UK0#VAR_067078
|Disease=Autosomal recessive congenital ichthyosis 4B
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=C
|RSPOS=215855515
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|VC=SNV
|VP=0x050068000a05000002110100
|WGT=1
|dbSNPBuildID=137
|rsid=267606622
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs28940268,"{{Rsnum
|rsid = 28940268
|Gene = ABCA12
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=2
|position=214986563
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA12
|StabilizedOrientation=minus
}}{{omim
|desc=ICHTHYOSIS, LAMELLAR 2
|id=607800
|rsnum=28940268
|variant=0001
}}
{{ClinVar
|rsid=28940268
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=215851287
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA12:26154
|GENE_NAME=ABCA12
|GENE_ID=26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215851287C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0001; Q86UK0#VAR_019599
|CLNSIG=5
|CLNCUI=C1832550
|CLNDBN=Autosomal recessive congenital ichthyosis 4A
|Disease=Autosomal recessive congenital ichthyosis 4A
|CLNACC=RCV000002988.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1832550:601277
|CLNREVSTAT=no_criteria
}}
This is a recessive SNP for congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs28940269,"{{Rsnum
|rsid = 28940269
|Gene = ABCA12
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=2
|position=214986566
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA12
|StabilizedOrientation=minus
}}{{omim
|desc=ICHTHYOSIS, LAMELLAR 2
|id=607800
|rsnum=28940269
|variant=0002
}}


{{ClinVar
|rsid=28940269
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=215851290
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05040426110100
|GENEINFO=ABCA12:26154
|GENE_NAME=ABCA12
|GENE_ID=26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215851290T>C
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0002; Q86UK0#VAR_019598
|CLNSIG=5
|CLNCUI=C1832550
|CLNDBN=Autosomal recessive congenital ichthyosis 4A; not provided
|Disease=Autosomal recessive congenital ichthyosis 4A; not provided
|CLNACC=RCV000002989.3; RCV000255645.1
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;VLD;HD;KGPhase3;LSD;OM
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C1832550:601277; CN221809
|CLNREVSTAT=no_criteria; single
|CAF=0.9998; 0.0001997
|COMMON=0
}}

This is a recessive SNP for congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition. 

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs28940270,"{{Rsnum
|rsid = 28940270
|Gene = ABCA12
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|Chromosome=2
|position=214982225
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA12
|StabilizedOrientation=minus
}}{{omim
|desc=ICHTHYOSIS, LAMELLAR 2
|id=607800
|rsnum=28940270
|variant=0004
}}

{{ClinVar
|rsid=28940270
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=215846949
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA12:26154
|GENE_NAME=ABCA12
|GENE_ID=26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215846949C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0004; Q86UK0#VAR_019600
|CLNSIG=5
|CLNCUI=C1832550
|CLNDBN=Autosomal recessive congenital ichthyosis 4A
|Disease=Autosomal recessive congenital ichthyosis 4A
|CLNACC=RCV000002991.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1832550:601277
|CLNREVSTAT=no_criteria
}}

This is a recessive SNP for congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition. 

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs28940271,"{{Rsnum
|rsid = 28940271
|Gene = ABCA12
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|Chromosome=2
|position=214980608
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA12
|StabilizedOrientation=minus
}}{{omim
|desc=ICHTHYOSIS, LAMELLAR 2
|id=607800
|rsnum=28940271
|variant=0005
}}

{{ClinVar
|rsid=28940271
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=215845332
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA12:26154
|GENE_NAME=ABCA12
|GENE_ID=26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215845332C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0005; Q86UK0#VAR_019601
|CLNSIG=5
|CLNCUI=C1832550
|CLNDBN=Autosomal recessive congenital ichthyosis 4A
|Disease=Autosomal recessive congenital ichthyosis 4A
|CLNACC=RCV000002992.2
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1832550:601277
|CLNREVSTAT=no_criteria
}}

This is a recessive SNP for congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition. 

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs28940568,"{{Rsnum
|rsid = 28940568
|Gene = ABCA12
|geno1 = (A;A)
|geno2 = (A;G)
|geno3 = (G;G)
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|Chromosome=2
|position=214978830
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA12
|StabilizedOrientation=minus
}}{{omim
|desc=ICHTHYOSIS, LAMELLAR 2
|id=607800
|rsnum=28940568
|variant=0003
}}

This is a recessive SNP for congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition. 

{{ClinVar
|rsid=28940568
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=215843554
|CHROM=2
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05040402110100
|GENEINFO=ABCA12:26154
|GENE_NAME=ABCA12
|GENE_ID=26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215843554C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0003; Q86UK0#VAR_019602
|CLNSIG=5
|CLNCUI=C1832550
|CLNDBN=Autosomal recessive congenital ichthyosis 4A
|Disease=Autosomal recessive congenital ichthyosis 4A
|CLNACC=RCV000002990.2
|Tags=RV;PM;PMC;NSM;REF;ASP;VLD;HD;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1832550:601277
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs387906284,"{{Rsnum
|rsid=387906284
|Chromosome=2
|position=214945021
|Orientation=minus
|geno1=(-;-)
|geno2=(-;C)
|geno3=(C;C)
|Gene=LOC101928103
|Gene_s=ABCA12,LOC101928103
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=C
|CHROM=2
|CLNACC=RCV000002993.2; RCV000487023.1
|CLNALLE=1
|CLNDBN=Autosomal recessive congenital ichthyosis 4B; not provided
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C0239849:242500; CN221809
|CLNHGVS=NC_000002.11:g.215809745delG
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=607800.0006
|Disease=Autosomal recessive congenital ichthyosis 4B; not provided
|FwdREF=C
|REF=CG
|RSPOS=215809744
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSF;REF;INT;ASP;VLD;LSD;OM
|VC=DIV
|VP=0x050068081205040002110200
|WGT=1
|dbSNPBuildID=137
|rsid=387906284
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_ID=101928103; 26154
|GENE_NAME=LOC101928103; ABCA12
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; single
|FwdALT=-
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs387906285,"{{Rsnum
|rsid=387906285
|Chromosome=2
|position=214978432
|Orientation=minus
|geno1=(-;-)
|geno2=(-;A)
|geno3=(A;A)
|Gene=ABCA12
|Gene_s=ABCA12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000002994.3
|CLNALLE=1
|CLNDBN=Autosomal recessive congenital ichthyosis 4B
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C0239849:242500
|CLNHGVS=NC_000002.11:g.215843156delT
|CLNSIG=5
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=607800.0007
|Disease=Autosomal recessive congenital ichthyosis 4B
|FwdREF=A
|REF=AT
|RSPOS=215843155
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;NSF;REF;ASP;LSD;OM
|VC=DIV
|VP=0x050068001205000002110200
|WGT=1
|dbSNPBuildID=137
|rsid=387906285
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|FwdALT=-
}}"
ABCA12,Rs726070,"{{Rsnum
|rsid=726070
|Gene=LOC101928103
|Chromosome=2
|position=214948607
|Orientation=minus
|GMAF=0.01974
|Gene_s=ABCA12,LOC101928103
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}
aka c.7093G>A (p.Asp2365Asn)

The variant allele was reported over a decade ago as being a recessive mutation associated with a form of ichthyosis; however, more recent annotations have come to the conclusion that it is actually likely to be benign, in part since it's seen far more frequently than would be expected given how rare the actual condition is.

{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 7.1 | 92.9
| HCB | 0.0 | 3.7 | 96.3
| JPT | 0.0 | 3.5 | 96.5
| YRI | 0.0 | 1.4 | 98.6
| ASW | 0.0 | 3.6 | 96.4
| CHB | 0.0 | 3.7 | 96.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 4.0 | 96.0
| LWK | 0.0 | 0.9 | 99.1
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 0.6 | 99.4
| TSI | 0.0 | 4.9 | 95.1
| HapMapRevision=28
}}{{omim
|id=607800
|variant=0008
|rsnum=726070
}}

{{ClinVar
|rsid=726070
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=215813331
|CHROM=2
|GMAF=0.0197
|dbSNPBuildID=86
|SSR=0
|SAO=1
|VP=0x050368080a05150537110101
|GENEINFO=LOC101928103:101928103; ABCA12:26154
|GENE_NAME=LOC101928103; ABCA12
|GENE_ID=101928103; 26154
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000002.11:g.215813331C>T
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=607800.0008; Q86UK0#VAR_027449
|CLNSIG=3
|CLNCUI=C0239849
|CLNDBN=Autosomal recessive congenital ichthyosis 4B; not specified; Congenital ichthyosiform erythroderma
|Disease=Autosomal recessive congenital ichthyosis 4B; not specified; Congenital ichthyosiform erythroderma
|CLNACC=RCV000002995.5; RCV000250672.1; RCV000293292.1
|Tags=RV;PM;PMC;S3D;SLO;NSM;REF;INT;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|CAF=0.9876; 0.01238
|CLNDSDB=MedGen:OMIM; MedGen; Human_Phenotype_Ontology:MedGen
|CLNDSDBID=C0239849:242500; CN169374; HP:0007431:C0079583
|COMMON=1
|CLNREVSTAT=no_criteria; single
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs755391236,"{{Rsnum
|rsid=755391236
|Chromosome=2
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA12
|position=214997733
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A,C
|CHROM=2
|CLNACC=RCV000254841.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215862457T>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A,C
|FwdREF=T
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=T
|RSPOS=215862457
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSM;NSN;REF;ASP;LSD
|VC=SNV
|VP=0x050060000e05000002100100
|WGT=1
|dbSNPBuildID=144
|rsid=755391236
}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs7560008,"{{Rsnum
|rsid=7560008
|Gene=ABCA12
|Chromosome=2
|position=215011442
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=A
|GMAF=0.001837
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=ABCA12
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}



{{ClinVar
|ALT=T
|CAF=0.001597; 0.9984
|CHROM=2
|CLNACC=RCV000248760.1; RCV000319091.1
|CLNALLE=1
|CLNDBN=not specified; Congenital ichthyosiform erythroderma
|CLNDSDB=MedGen; Human_Phenotype_Ontology:MedGen
|CLNDSDBID=CN169374; HP:0007431:C0079583
|CLNHGVS=NC_000002.11:g.215876166A>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=not specified; Congenital ichthyosiform erythroderma
|FwdALT=T
|FwdREF=A
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=A
|RSPOS=215876166
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;SLO;NSM;REF;ASP;VLD;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050128000a0504053f000100
|WGT=1
|dbSNPBuildID=116
|rsid=7560008
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}"
ABCA12,Rs756771290,"{{Rsnum
|rsid=756771290
|Chromosome=2
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA12
|position=215007788
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CHROM=2
|CLNACC=RCV000255774.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215872512T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=T
|RSPOS=215872512
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSM;REF;ASP;VLD
|VC=SNV
|VP=0x050000000a05040002000100
|WGT=1
|dbSNPBuildID=144
|rsid=756771290
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs757520757,"{{Rsnum
|rsid=757520757
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=215019784
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000255533.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215884508G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215884508
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;ASP
|VC=SNV
|VP=0x050000000605000002000100
|WGT=1
|dbSNPBuildID=144
|rsid=757520757
}}"
ABCA12,Rs761557390,"{{Rsnum
|rsid=761557390
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA12
|position=214966945
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CHROM=2
|CLNACC=RCV000276997.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215831669A>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=C
|FwdREF=A
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=A
|RSPOS=215831669
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;NSN;REF;ASP;LSD
|VC=SNV
|VP=0x050060000605000002100100
|WGT=1
|dbSNPBuildID=144
|rsid=761557390
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs762065937,"{{Rsnum
|rsid=762065937
|Chromosome=2
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA12
|position=215064204
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=G,T
|CHROM=2
|CLNACC=RCV000256128.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215928927C>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G,T
|FwdREF=C
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=C
|RSPOS=215928927
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSM;REF;ASP;VLD;LSD
|VC=SNV
|VP=0x050060000a05040002100100
|WGT=1
|dbSNPBuildID=144
|rsid=762065937
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs763182554,"{{Rsnum
|rsid=763182554
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=2
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA12
|position=215011969
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=C,G
|CHROM=2
|CLNACC=RCV000428022.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215876693A>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=C,G
|FwdREF=A
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=A
|RSPOS=215876693
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;DSS;ASP;LSD
|VC=SNV
|VP=0x050060100005000002100100
|WGT=1
|dbSNPBuildID=144
|rsid=763182554
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs763481375,"{{Rsnum
|rsid=763481375
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=215011631
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000256167.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215876355G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215876355
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;ASP;VLD
|VC=SNV
|VP=0x050000000605040002000100
|WGT=1
|dbSNPBuildID=144
|rsid=763481375
}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs767707248,"{{Rsnum
|rsid=767707248
|Chromosome=2
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA12
|position=215064205
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000255481.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215928928G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215928928
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;ASP
|VC=SNV
|VP=0x050000000605000002000100
|WGT=1
|dbSNPBuildID=144
|rsid=767707248
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA12,Rs886039296,"{{Rsnum
|rsid=886039296
|Chromosome=2
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA12
|position=215018130
|Gene_s=ABCA12
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=A
|CHROM=2
|CLNACC=RCV000255237.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000002.11:g.215882854G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA12:26154
|GENE_ID=26154
|GENE_NAME=ABCA12
|REF=G
|RSPOS=215882854
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSN;REF;ASP;LSD
|VC=SNV
|VP=0x050060000605000002100100
|WGT=1
|dbSNPBuildID=149
|rsid=886039296
}}"
ABCA3,Rs11867129,"{{Rsnum
|rsid=11867129
|Chromosome=16
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2315287
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 77.9 | 21.2 | 0.9
| HCB | 40.9 | 42.3 | 16.8
| JPT | 50.4 | 31.0 | 18.6
| YRI | 83.7 | 15.6 | 0.7
| ASW | 86.0 | 14.0 | 0.0
| CHB | 40.9 | 42.3 | 16.8
| CHD | 40.4 | 44.0 | 15.6
| GIH | 68.3 | 26.7 | 5.0
| LWK | 67.3 | 30.0 | 2.7
| MEX | 37.9 | 44.8 | 17.2
| MKK | 64.1 | 32.7 | 3.2
| TSI | 82.4 | 16.7 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=26522252
|Title=The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs121909181,"{{Rsnum
|rsid=121909181
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA3
|position=2285499
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|id=601615
|rsnum=121909181
|variant=0001
}}{{ClinVar
|rsid=121909181
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=2335500
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000605000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2335500C>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=601615.0001
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008475.3
|Tags=RV;PM;PMC;NSN;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs121909182,"{{Rsnum
|rsid=121909182
|Chromosome=16
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2326027
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|id=601615
|rsnum=121909182
|variant=0002
}}{{ClinVar
|rsid=121909182
|Reversed=1
|FwdREF=T
|FwdALT=C
|REF=A
|ALT=G
|RSPOS=2376028
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2376028A>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601615.0002; Q99758#VAR_023497
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008476.3
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs121909183,"{{Rsnum
|rsid=121909183
|Chromosome=16
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2278348
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|id=601615
|rsnum=121909183
|variant=0003
}}{{ClinVar
|rsid=121909183
|Reversed=1
|FwdREF=T
|FwdALT=C
|REF=A
|ALT=G
|RSPOS=2328349
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2328349A>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601615.0003; Q99758#VAR_023499
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008477.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs121909184,"{{Rsnum
|rsid=121909184
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA3
|position=2299442
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|id=601615
|rsnum=121909184
|variant=0005
}}{{ClinVar
|rsid=121909184
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=2349443
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2349443T>C
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601615.0005; Q99758#VAR_023498
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008479.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs121909185,"{{Rsnum
|rsid=121909185
|Chromosome=16
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2317661
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|id=601615
|rsnum=121909185
|variant=0007
}}{{ClinVar
|rsid=121909185
|Reversed=1
|FwdREF=T
|FwdALT=C
|REF=A
|ALT=G
|RSPOS=2367662
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2367662A>G
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=601615.0007
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008481.3
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs1278044377,"{{Rsnum
|rsid=1278044377
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Orientation=plus
|StabilizedOrientation=plus
|Chromosome=16
|Gene=ABCA3
|position=2326013
|Gene_s=ABCA3
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=151
}}aka c.316C>T"
ABCA3,Rs149989682,"{{Rsnum
|rsid=149989682
|Chromosome=16
|Orientation=plus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2317763
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}
[[rs149989682]], also known as c.875A>T, p.Glu292Val and E292V, represents a rare mutation in the [[ABCA3]] gene on chromosome 16.

Inherited as an autosomal recessive, the [[rs149989682]](A) allele - as oriented in dbSNP orientation - is considered pathogenic in ClinVar (and [[BabySeq]]) for [[surfactant metabolism dysfunction]], pulmonary, type 3, a disorder involving severe neonatal distress that often results in the death of a newborn within the first month.

Note potential for [[ambiguous flip]] confusion.

{{ClinVar
|ALT=A,C
|CAF=0.9992; 0.0007987
|CHROM=16
|CLNACC=RCV000185556.3; RCV000224775.1
|CLNALLE=1
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3; not provided
|CLNDSDB=MedGen:OMIM:Orphanet; MedGen
|CLNDSDBID=C1970456:610921:ORPHA440402; CN221809
|CLNHGVS=NC_000016.9:g.2367764T>A
|CLNORIGIN=33
|CLNREVSTAT=conf; single
|CLNSIG=255
|COMMON=0
|Disease=Surfactant metabolism dysfunction; not provided
|FwdALT=A,C
|FwdREF=T
|GENEINFO=ABCA3:21
|GENE_ID=21
|GENE_NAME=ABCA3
|REF=T
|RSPOS=2367764
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050028000a05040436000100
|WGT=1
|dbSNPBuildID=134
|rsid=149989682
}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs150929,"{{Rsnum
|rsid=150929
|Chromosome=16
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA3
|position=2278649
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 17.0 | 44.6 | 38.4
| HCB | 29.2 | 48.9 | 21.9
| JPT | 32.7 | 41.6 | 25.7
| YRI | 23.3 | 54.1 | 22.6
| ASW | 17.5 | 50.9 | 31.6
| CHB | 29.2 | 48.9 | 21.9
| CHD | 31.2 | 45.9 | 22.9
| GIH | 31.7 | 37.6 | 30.7
| LWK | 18.2 | 56.4 | 25.5
| MEX | 5.2 | 48.3 | 46.6
| MKK | 18.5 | 57.0 | 24.5
| TSI | 18.6 | 48.0 | 33.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=26522252
|Title=The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCA3,Rs17135889,"{{Rsnum
|rsid=17135889
|Chromosome=16
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA3
|position=2337259
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 16.8 | 80.5
| HCB | 3.6 | 27.7 | 68.6
| JPT | 0.0 | 28.6 | 71.4
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 3.5 | 96.5
| CHB | 3.6 | 27.7 | 68.6
| CHD | 0.9 | 22.9 | 76.1
| GIH | 0.0 | 8.9 | 91.1
| LWK | 0.0 | 0.0 | 0.0
| MEX | 3.4 | 25.9 | 70.7
| MKK | 0.0 | 4.5 | 95.5
| TSI | 2.0 | 21.6 | 76.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=26522252
|Title=The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs28936412,"{{Rsnum
|rsid = 28936412
|Gene = ABCA3
|Orientation=minus
|ReferenceAllele=T
|MissenseAllele=C
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=16
|position=2326027
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Status=Merged
|Merged=121909182
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
| id = 601615
| variant = 0002
| desc    = SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3
| rsnum   = 28936412
}}"
ABCA3,Rs28936690,"{{Rsnum
|rsid = 28936690
|Gene = ABCA3
|Orientation=minus
|ReferenceAllele=T
|MissenseAllele=C
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=16
|position=2328352
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|Status=Deleted
|StabilizedOrientation=minus
}}{{omim
| id = 601615
| variant = 0003
| desc    = SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3
| rsnum   = 28936690
}}


{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCA3,Rs28936691,"{{Rsnum
|rsid = 28936691
|Gene = ABCA3
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=C
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Chromosome=16
|position=2278016
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA3
|StabilizedOrientation=minus
}}{{omim
|desc=SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3
|id=601615
|rsnum=28936691
|variant=0004
}}


{{ClinVar
|rsid=28936691
|Reversed=1
|FwdREF=A
|FwdALT=C
|REF=T
|ALT=G
|RSPOS=2328017
|CHROM=16
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA3:21
|GENE_NAME=ABCA3
|GENE_ID=21
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000016.9:g.2328017T>G
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601615.0004; Q99758#VAR_023500
|CLNSIG=5
|CLNCUI=C1970456
|CLNDBN=Surfactant metabolism dysfunction, pulmonary, 3
|Disease=Surfactant metabolism dysfunction
|CLNACC=RCV000008478.3
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM:Orphanet
|CLNDSDBID=C1970456:610921:ORPHA440402
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs4787273,"{{Rsnum
|rsid=4787273
|Chromosome=16
|Orientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2299759
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 45.1 | 42.5 | 12.4
| HCB | 25.5 | 48.9 | 25.5
| JPT | 25.7 | 45.1 | 29.2
| YRI | 98.6 | 1.4 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 25.5 | 48.9 | 25.5
| CHD | 27.5 | 47.7 | 24.8
| GIH | 42.6 | 39.6 | 17.8
| LWK | 96.3 | 3.7 | 0.0
| MEX | 22.4 | 56.9 | 20.7
| MKK | 96.8 | 3.2 | 0.0
| TSI | 51.0 | 36.3 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=26522252
|Title=The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China
}}

{{on chip | Illumina Human 1M}}"
ABCA3,Rs754714105,"{{Rsnum
|rsid=754714105
|Chromosome=16
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA3
|position=2326201
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=147
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CHROM=16
|CLNACC=RCV000221771.1
|CLNALLE=1
|CLNDBN=Pulmonary Surfactant Metabolism Dysfunction
|CLNDSDB=MedGen
|CLNDSDBID=C3711368
|CLNHGVS=NC_000016.9:g.2376202C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=Pulmonary Surfactant Metabolism Dysfunction
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA3:21
|GENE_ID=21
|GENE_NAME=ABCA3
|REF=C
|RSPOS=2376202
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP
|VC=SNV
|VP=0x050028000a05000002000100
|WGT=1
|dbSNPBuildID=144
|rsid=754714105
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA3,Rs876657633,"{{Rsnum
|rsid=876657633
|Chromosome=16
|Orientation=minus
|geno1=(AAGGTGC;AAGGTGC)
|geno2=(AAGGTGC;CCA)
|geno3=(CCA;CCA)
|Gene=ABCA3
|position=2300001
|Gene_s=ABCA3
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=147
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=GTGG
|CHROM=16
|CLNACC=RCV000215018.1
|CLNALLE=1
|CLNDBN=Idiopathic fibrosing alveolitis, chronic form
|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT
|CLNDSDBID=C1800706:178500:ORPHA79126:28168000
|CLNHGVS=NC_000016.9:g.2350002_2350008delinsTGG
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=Idiopathic fibrosing alveolitis
|FwdALT=CCA
|FwdREF=AAGGTGC
|GENEINFO=ABCA3:21
|GENE_ID=21
|GENE_NAME=ABCA3
|REF=GGCACCTT
|RSPOS=2350001
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;INT;ASP;LSD
|VC=DIV
|VP=0x050068080005000002100200
|WGT=1
|dbSNPBuildID=147
|rsid=876657633
}}"
ABCA4,Rs1047376,"{{Rsnum
|rsid=1047376
|Chromosome=1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94041354
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{ClinVar
|ALT=G,T
|CHROM=1
|CLNACC=RCV000408515.1
|CLNALLE=1
|CLNDBN=Stargardt disease 1
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1855465:248200
|CLNHGVS=NC_000001.10:g.94506910A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=Stargardt disease 1
|FwdALT=A,C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94506910
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;G5A;G5;HD;GNO;LSD
|VC=SNV
|VP=0x050268000a05030503100100
|WGT=1
|dbSNPBuildID=86
|rsid=1047376
}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1057517700,"{{Rsnum
|rsid=1057517700
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94062680
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000414682.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94528236G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94528236
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;LSD
|VC=SNV
|VP=0x050060000000000002100100
|WGT=0
|dbSNPBuildID=149
|rsid=1057517700
}}"
ABCA4,Rs1057517701,"{{Rsnum
|rsid=1057517701
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94041328
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000412823.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94506884G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94506884
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;LSD
|VC=SNV
|VP=0x050060000000000002100100
|WGT=0
|dbSNPBuildID=149
|rsid=1057517701
}}"
ABCA4,Rs1057517869,"{{Rsnum
|rsid=1057517869
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94037276
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000413110.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94502832C>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=T
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94502832
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;LSD
|VC=SNV
|VP=0x050060000000000002100100
|WGT=0
|dbSNPBuildID=149
|rsid=1057517869
}}"
ABCA4,Rs1057518767,"{{Rsnum
|rsid=1057518767
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94098874
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000415009.1
|CLNALLE=1
|CLNDBN=Central scotoma; Macular degeneration; Retinal atrophy; Visual impairment
|CLNDSDB=Human_Phenotype_Ontology:MedGen; Human_Phenotype_Ontology:MedGen:SNOMED_CT
|CLNDSDBID=HP:0000603:C0152191; HP:0000608:C0024437; HP:0001105:CN001038; HP:0000505:C0042798:397540003
|CLNHGVS=NC_000001.10:g.94564430A>T
|CLNORIGIN=0
|CLNREVSTAT=no_criteria
|CLNSIG=4
|Disease=Central scotoma; Macular degeneration; Retinal atrophy; Visual impairment
|FwdALT=A
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94564430
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=149
|rsid=1057518767
}}"
ABCA4,Rs1057518955,"{{Rsnum
|rsid=1057518955
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(-;-)
|geno2=(-;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94019602
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=TC
|CHROM=1
|CLNACC=RCV000414893.1
|CLNALLE=1
|CLNDBN=Retinopathy; Visual impairment
|CLNDSDB=Human_Phenotype_Ontology:MedGen; Human_Phenotype_Ontology:MedGen:SNOMED_CT
|CLNDSDBID=HP:0000488:C0035309; HP:0000505:C0042798:397540003
|CLNHGVS=NC_000001.10:g.94485159dupC
|CLNORIGIN=0
|CLNREVSTAT=single
|CLNSIG=5
|Disease=Retinopathy; Visual impairment
|FwdALT=G
|FwdREF=-
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94485158
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;NSF;REF;ASP;LSD
|VC=DIV
|VP=0x050060001205000002100200
|WGT=1
|dbSNPBuildID=149
|rsid=1057518955
}}"
ABCA4,Rs1057520212,"{{Rsnum
|rsid=1057520212
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94015769
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000430778.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94481325G>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94481325
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1057520212
}}"
ABCA4,Rs1057520213,"{{Rsnum
|rsid=1057520213
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94001071
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000432926.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94466627C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94466627
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1057520213
}}"
ABCA4,Rs1064793004,"{{Rsnum
|rsid=1064793004
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94112968
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000479570.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94578524C>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94578524
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;INT;ASP;LSD
|VC=SNV
|VP=0x050060080005000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793004
}}"
ABCA4,Rs1064793005,"{{Rsnum
|rsid=1064793005
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94103107
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000483659.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94568663C>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=T
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94568663
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSN;REF;ASP;LSD
|VC=SNV
|VP=0x050060000605000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793005
}}"
ABCA4,Rs1064793006,"{{Rsnum
|rsid=1064793006
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94062707
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000486363.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94528263A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94528263
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793006
}}"
ABCA4,Rs1064793007,"{{Rsnum
|rsid=1064793007
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94056801
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000481017.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94522357T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94522357
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793007
}}"
ABCA4,Rs1064793008,"{{Rsnum
|rsid=1064793008
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94056734
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000483929.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94522290A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94522290
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793008
}}"
ABCA4,Rs1064793009,"{{Rsnum
|rsid=1064793009
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94043491
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000486062.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94509047A>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94509047
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;INT;ASP;LSD
|VC=SNV
|VP=0x050060080005000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793009
}}"
ABCA4,Rs1064793010,"{{Rsnum
|rsid=1064793010
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94041342
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000485764.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94506898A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94506898
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793010
}}"
ABCA4,Rs1064793011,"{{Rsnum
|rsid=1064793011
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94040043
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000479551.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94505599C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94505599
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793011
}}"
ABCA4,Rs1064793012,"{{Rsnum
|rsid=1064793012
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94031857
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000483648.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94497413A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94497413
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793012
}}"
ABCA4,Rs1064793013,"{{Rsnum
|rsid=1064793013
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94008300
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000483369.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94473856G>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=A
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94473856
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;INT;ASP;LSD
|VC=SNV
|VP=0x050060080005000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793013
}}"
ABCA4,Rs1064793014,"{{Rsnum
|rsid=1064793014
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94007707
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000486602.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94473263T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94473263
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793014
}}"
ABCA4,Rs1064793015,"{{Rsnum
|rsid=1064793015
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94001104
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000483911.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94466660T>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94466660
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064793015
}}"
ABCA4,Rs1064797091,"{{Rsnum
|rsid=1064797091
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94031029
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000487474.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94496585G>A
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94496585
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064797091
}}"
ABCA4,Rs1064797113,"{{Rsnum
|rsid=1064797113
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94031778
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000488409.1; RCV000493611.1
|CLNALLE=1; -1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94497334C>G; NC_000001.10:g.94497334C>T
|CLNORIGIN=1
|CLNREVSTAT=single; no_criteria
|CLNSIG=4
|Disease=not provided
|FwdALT=C
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94497334
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1064797113
}}"
ABCA4,Rs1085307968,"{{Rsnum
|rsid=1085307968
|StabilizedOrientation=minus
|Orientation=minus
|Chromosome=1
|position=94021385
|Gene_s=ABCA4
|Gene=ABCA4
}}
{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000489654.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94486941G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94486941
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=150
|rsid=1085307968
}}"
ABCA4,Rs112005636,"{{Rsnum
|rsid=112005636
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=1
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA4
|position=93996107
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=G,T
|CHROM=1
|CLNACC=RCV000487635.1
|CLNALLE=2
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94461663A>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=G,T
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94461663
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;SLO;DSS;ASP;GNO;LSD
|VC=SNV
|VP=0x050160100005000102100100
|WGT=1
|dbSNPBuildID=132
|rsid=112005636
}}"
ABCA4,Rs113106943,"{{Rsnum
|rsid=113106943
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94021848
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CAF=0.9996; 0.0003994
|CHROM=1
|CLNACC=RCV000152705.3; RCV000285181.1; RCV000323858.1; RCV000376503.1; RCV000381856.1; RCV000408525.1; RCV000416254.1
|CLNALLE=1
|CLNDBN=not specified; Retinitis Pigmentosa, Recessive; Stargardt Disease, Recessive; Macular degeneration; Cone-Rod Dystrophy, Recessive; Stargardt disease 1; not provided
|CLNDSDB=MedGen; Human_Phenotype_Ontology:MedGen; MedGen:OMIM
|CLNDSDBID=CN169374; CN239466; CN239312; HP:0000608:C0024437; CN239309; C1855465:248200; CN221809
|CLNHGVS=NC_000001.10:g.94487404C>T
|CLNORIGIN=1
|CLNREVSTAT=mult; single
|CLNSIG=4
|CLNSRC=Illumina
|CLNSRCID=108891
|COMMON=1
|Disease=not specified; Retinitis Pigmentosa; Stargardt Disease; Macular degeneration; Cone-Rod Dystrophy; Stargardt disease 1; not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94487404
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050028000a05040436000100
|WGT=1
|dbSNPBuildID=132
|rsid=113106943
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs121909203,"{{Rsnum
|rsid=121909203
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94051698
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Status=Merged
|Merged=76157638
|Gene_s=ABCA4
|StabilizedOrientation=plus
}}{{omim
|id=601691
|rsnum=121909203
|variant=0001
}}"
ABCA4,Rs121909204,"{{Rsnum
|rsid=121909204
|Chromosome=1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94043443
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=121909204
|variant=0003
}}{{ClinVar
|rsid=121909204
|Reversed=1
|FwdREF=C
|FwdALT=T
|REF=G
|ALT=A
|RSPOS=94508999
|CHROM=1
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94508999G>A
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=601691.0003
|CLNSIG=5
|CLNCUI=C1855465
|CLNDBN=Stargardt disease 1
|Disease=Stargardt disease 1
|CLNACC=RCV000008331.4
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1855465:248200
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs121909205,"{{Rsnum
|rsid=121909205
|Gene=ABCA4
|Chromosome=1
|position=94120994
|Orientation=minus
|GMAF=0.0009183
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=121909205
|variant=0021
}}{{ClinVar
|rsid=121909205
|Reversed=1
|FwdREF=C
|FwdALT=A,T
|REF=G
|ALT=A,T
|RSPOS=94586550
|CHROM=1
|GMAF=0.0009
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050168000b05040436110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94586550G>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601691.0021; P78363#VAR_008398
|CLNSIG=255
|CLNCUI=C1855465
|CLNDBN=Stargardt disease 1; not provided
|Disease=Stargardt disease 1; not provided
|CLNACC=RCV000008356.4; RCV000085719.1
|Tags=RV;PM;PMC;SLO;NSM;REF;SYN;ASP;VLD;HD;KGPhase1;KGPhase3;LSD;OM
|CAF=0.9996; 0.0003994
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C1855465:248200; CN221809
|COMMON=0
|CLNREVSTAT=conf; no_assertion
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs121909206,"{{Rsnum
|rsid=121909206
|Chromosome=1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA4
|position=94015766
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=121909206
|variant=0031
}}{{ClinVar
|rsid=121909206
|Reversed=1
|FwdREF=C
|FwdALT=A
|REF=G
|ALT=T
|RSPOS=94481322
|CHROM=1
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05000002110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94481322G>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=601691.0031
|CLNSIG=5
|CLNCUI=C1858806; C1855465
|CLNDBN=Cone-rod dystrophy 3; Stargardt disease 1
|Disease=Cone-rod dystrophy 3; Stargardt disease 1
|CLNACC=RCV000008367.2; RCV000008368.4
|Tags=RV;PM;PMC;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1858806:604116; C1855465:248200
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs121909207,"{{Rsnum
|rsid=121909207
|Chromosome=1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94014665
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=121909207
|variant=0034
}}{{ClinVar
|rsid=121909207
|Reversed=1
|FwdREF=C
|FwdALT=G
|REF=G
|ALT=C
|RSPOS=94480221
|CHROM=1
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050068000a05040402110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94480221G>C
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=601691.0034; P78363#VAR_012594
|CLNSIG=5
|CLNCUI=C1855465
|CLNDBN=Stargardt disease 1
|Disease=Stargardt disease 1
|CLNACC=RCV000008373.4
|Tags=RV;PM;PMC;NSM;REF;ASP;VLD;HD;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1855465:248200
|CLNREVSTAT=no_criteria
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs141823837,"{{Rsnum
|rsid=141823837
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=1
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94060739
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=T
|CHROM=1
|CLNACC=RCV000484928.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94526295C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94526295
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSM;REF;ASP
|VC=SNV
|VP=0x050000000a05000002000100
|WGT=1
|dbSNPBuildID=134
|rsid=141823837
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs142253670,"{{Rsnum
|rsid=142253670
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94008252
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CAF=0.9998; 0.0001997
|CHROM=1
|CLNACC=RCV000408510.1
|CLNALLE=1
|CLNDBN=Stargardt disease 1
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1855465:248200
|CLNHGVS=NC_000001.10:g.94473808C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|COMMON=0
|Disease=Stargardt disease 1
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94473808
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD;KGPhase3
|VC=SNV
|VP=0x050028000a05040426000100
|WGT=1
|dbSNPBuildID=134
|rsid=142253670
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs144310835,"{{Rsnum
|rsid=144310835
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=1
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA4
|position=94098885
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=A,T
|CAF=0.9982; 0.0007987; 0.0009984
|CHROM=1
|CLNACC=RCV000481221.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94564441C>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|COMMON=1
|Disease=not provided
|FwdALT=A,T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94564441
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSM;REF;ASP;VLD;KGPhase3
|VC=SNV
|VP=0x050000000a05040026000100
|WGT=1
|dbSNPBuildID=134
|rsid=144310835
}}"
ABCA4,Rs145525174,"{{Rsnum
|rsid=145525174
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94063218
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CAF=0.9994; 0.000599
|CHROM=1
|CLNACC=RCV000174239.1; RCV000286087.1; RCV000343411.1; RCV000378123.1; RCV000390005.1; RCV000408576.1; RCV000416079.1
|CLNALLE=1
|CLNDBN=not specified; Stargardt Disease, Recessive; Retinitis Pigmentosa, Recessive; Cone-Rod Dystrophy, Recessive; Macular degeneration; Stargardt disease 1; not provided
|CLNDSDB=MedGen; Human_Phenotype_Ontology:MedGen; MedGen:OMIM
|CLNDSDBID=CN169374; CN239312; CN239466; CN239309; HP:0000608:C0024437; C1855465:248200; CN221809
|CLNHGVS=NC_000001.10:g.94528774C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|CLNSRC=UniProtKB (protein)
|CLNSRCID=P78363#VAR_012522
|COMMON=1
|Disease=not specified; Stargardt Disease; Retinitis Pigmentosa; Cone-Rod Dystrophy; Macular degeneration; Stargardt disease 1; not provided
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94528774
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD;KGPhase3
|VC=SNV
|VP=0x050028000a05040426000100
|WGT=1
|dbSNPBuildID=134
|rsid=145525174
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs145961131,"{{Rsnum
|rsid=145961131
|Chromosome=1
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94062608
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CHROM=1
|CLNACC=RCV000256006.1
|CLNALLE=1
|CLNDBN=not provided
|CLNDSDB=MedGen
|CLNDSDBID=CN221809
|CLNHGVS=NC_000001.10:g.94528164G>A
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=G
|RSPOS=94528164
|Reversed=0
|SAO=0
|SSR=0
|Tags=NSN;REF;ASP
|VC=SNV
|VP=0x050000000605000002000100
|WGT=1
|dbSNPBuildID=134
|rsid=145961131
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs150774447,"{{Rsnum
|rsid=150774447
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94111579
|Gene_s=ABCA4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A,T
|CHROM=1
|CLNACC=RCV000085409.1; RCV000132585.1; RCV000085408.2; RCV000210980.3; RCV000335021.1; RCV000401237.1
|CLNALLE=1; 2
|CLNDBN=not provided; Stargardt disease 1; Retinitis pigmentosa 19; Cone-rod dystrophy 3
|CLNDSDB=MedGen; MedGen:OMIM
|CLNDSDBID=CN221809; C1855465:248200; C1866422:601718; C1858806:604116
|CLNHGVS=NC_000001.10:g.94577135C>A; NC_000001.10:g.94577135C>T
|CLNORIGIN=0; 1
|CLNREVSTAT=no_assertion; no_criteria; single; conf
|CLNSIG=255
|CLNSRC=UniProtKB (protein)
|Disease=not provided; Stargardt disease 1; Retinitis pigmentosa 19; Cone-rod dystrophy 3
|FwdALT=A,T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94577135
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;SLO;NSM;REF;ASP;VLD;HD;LSD;OM
|VC=SNV
|VP=0x050168000a05040402110100
|WGT=1
|dbSNPBuildID=134
|rsid=150774447
|CLNSRCID=P78363#VAR_008400
}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs17110736,"{{Rsnum
|rsid=17110736
|Gene=ABCA4
|Chromosome=1
|position=93997213
|Orientation=plus
|GMAF=0.1433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA4
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 8.8 | 90.3
| HCB | 1.5 | 20.4 | 78.1
| JPT | 0.9 | 20.4 | 78.8
| YRI | 8.8 | 50.3 | 40.8
| ASW | 10.5 | 42.1 | 47.4
| CHB | 1.5 | 20.4 | 78.1
| CHD | 1.8 | 23.9 | 74.3
| GIH | 0.0 | 11.9 | 88.1
| LWK | 8.2 | 49.1 | 42.7
| MEX | 0.0 | 8.6 | 91.4
| MKK | 9.0 | 42.9 | 48.1
| TSI | 1.0 | 15.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21546767
|Trait=None
|Title=Genome-wide association scan for survival on dialysis in african-americans with type 2 diabetes.
|RiskAllele=
|Pval=0.000005
|OR=2.0800
|ORtxt=[1.52-2.86]
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v5}}"
ABCA4,Rs1762111,"{{Rsnum
|rsid=1762111
|Chromosome=1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94021934
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{ClinVar
|ALT=G
|CAF=0.9996; 0.0003994
|CHROM=1
|CLNACC=RCV000085664.1; RCV000254911.2; RCV000314956.1; RCV000335992.1; RCV000407014.1; RCV000408556.1
|CLNALLE=1
|CLNDBN=not provided; not specified; ABCA4-Related Disorders; Cone-Rod Dystrophy, Recessive; Retinitis Pigmentosa, Recessive; Stargardt disease 1
|CLNDSDB=MedGen; MedGen:OMIM
|CLNDSDBID=CN221809; CN169374; CN239167; CN239309; CN239466; C1855465:248200
|CLNHGVS=NC_000001.10:g.94487490A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|CLNSRC=UniProtKB (protein)
|CLNSRCID=P78363#VAR_008458
|COMMON=0
|Disease=not provided; not specified; ABCA4-Related Disorders; Cone-Rod Dystrophy; Retinitis Pigmentosa; Stargardt disease 1
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94487490
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;HD;GNO;KGPhase1;KGPhase3;LSD
|VC=SNV
|VP=0x050168000a05040537100100
|WGT=1
|dbSNPBuildID=89
|rsid=1762111
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1800552,"{{Rsnum
|rsid=1800552
|Chromosome=1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA4
|position=94010821
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=T
|CAF=0.9996; 0.0003994
|CHROM=1
|CLNACC=RCV000085752.1; RCV000408593.1
|CLNALLE=1
|CLNDBN=not provided; Stargardt disease 1
|CLNDSDB=MedGen; MedGen:OMIM
|CLNDSDBID=CN221809; C1855465:248200
|CLNHGVS=NC_000001.10:g.94476377C>T
|CLNORIGIN=1
|CLNREVSTAT=no_assertion; single
|CLNSIG=4
|CLNSRC=UniProtKB (protein)
|CLNSRCID=P78363#VAR_008473
|COMMON=0
|Disease=not provided; Stargardt disease 1
|FwdALT=A
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94476377
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;HD;KGPhase1;KGPhase3;LSD
|VC=SNV
|VP=0x050168000a05040436100100
|WGT=1
|dbSNPBuildID=89
|rsid=1800552
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1800553,"{{Rsnum
|rsid=1800553
|Gene=ABCA4
|Chromosome=1
|position=94008251
|Orientation=minus
|GMAF=0.002296
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=1800553
|variant=0007
}}{{ClinVar
|rsid=1800553
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=94473807
|CHROM=1
|GMAF=0.0023
|dbSNPBuildID=89
|SSR=0
|SAO=1
|VP=0x050168000a05040536110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94473807C>T
|CLNSRC=HGMD; OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=CM970016; 601691.0007; P78363#VAR_008475
|CLNSIG=255
|CLNCUI=C1855465; C1858806
|CLNDBN=MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO; Stargardt disease 1; Cone-rod dystrophy 3; not provided; ABCA4-Related Disorders
|Disease=MACULAR DEGENERATION; Stargardt disease 1; Cone-rod dystrophy 3; not provided; ABCA4-Related Disorders
|CLNACC=RCV000008339.4; RCV000008340.12; RCV000008341.4; RCV000078670.5; RCV000197749.1; RCV000273328.1
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|CAF=0.9968; 0.003195
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C1855465:248200; C1858806:604116; CN221809; CN239167
|COMMON=1
|CLNREVSTAT=no_criteria; conf; single
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1800555,"{{Rsnum
|rsid=1800555
|Gene=ABCA4
|Chromosome=1
|position=93998061
|Orientation=minus
|GMAF=0.006887
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.4 | 95.6
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.8 | 98.2
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|id=601691
|rsnum=1800555
|variant=0006
}}

{{ClinVar
|rsid=1800555
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=94463617
|CHROM=1
|GMAF=0.0069
|dbSNPBuildID=89
|SSR=0
|SAO=1
|VP=0x050168000a05040537110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.10:g.94463617C>T
|CLNORIGIN=1
|CLNSIG=255
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|CAF=0.996; 0.003994
|CLNACC=RCV000008336.4; RCV000085827.1; RCV000243384.2; RCV000268191.1; RCV000323169.1; RCV000359301.1; RCV000362825.1
|CLNDBN=MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO; not provided; not specified; Stargardt Disease, Recessive; Cone-Rod Dystrophy, Recessive; Macular degeneration; Retinitis Pigmentosa, Recessive
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNSRCID=601691.0006; P78363#VAR_008491
|COMMON=1
|Disease=MACULAR DEGENERATION; not provided; not specified; Stargardt Disease; Cone-Rod Dystrophy; Macular degeneration; Retinitis Pigmentosa
|CLNDSDB=MedGen; Human_Phenotype_Ontology:MedGen
|CLNDSDBID=CN221809; CN169374; CN239312; CN239309; HP:0000608:C0024437; CN239466
|CLNREVSTAT=no_criteria; no_assertion; mult; single
}}



{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1800728,"{{Rsnum
|rsid=1800728
|Chromosome=1
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94011395
|Gene_s=ABCA4
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=G
|CHROM=1
|CLNACC=RCV000008366.3; RCV000078669.4; RCV000177965.3; RCV000210325.1; RCV000210327.1; RCV000255513.2
|CLNALLE=1
|CLNDBN=Cone-rod dystrophy 3; not provided; Stargardt disease 1; Bull's eye maculopathy; Retinal dystrophy; not specified
|CLNDSDB=MedGen:OMIM; MedGen; Human_Phenotype_Ontology:MedGen; MedGen:Orphanet:SNOMED_CT
|CLNDSDBID=C1858806:604116; CN221809; C1855465:248200; HP:0011504:C0730330; C0854723:ORPHA71862:314407005; CN169374
|CLNHGVS=NC_000001.10:g.94476951A>G
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; conf; single
|CLNSIG=255
|CLNSRC=HGMD; OMIM Allelic Variant
|CLNSRCID=CS057513; 601691.0030
|Disease=Cone-rod dystrophy 3; not provided; Stargardt disease 1; Bull's eye maculopathy; Retinal dystrophy; not specified
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94476951
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;SLO;INT;ASP;VLD;LSD
|VC=SNV
|VP=0x050168080005040002100100
|WGT=1
|dbSNPBuildID=89
|rsid=1800728
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1801269,"{{Rsnum
|rsid=1801269
|Chromosome=1
|Orientation=minus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94041345
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=minus
}}{{ClinVar
|ALT=A
|CAF=0.9994; 0.000599
|CHROM=1
|CLNACC=RCV000085576.1; RCV000408578.1
|CLNALLE=1
|CLNDBN=not provided; Stargardt disease 1
|CLNDSDB=MedGen; MedGen:OMIM
|CLNDSDBID=CN221809; C1855465:248200
|CLNHGVS=NC_000001.10:g.94506901C>A
|CLNORIGIN=1
|CLNREVSTAT=no_assertion; single
|CLNSIG=4
|CLNSRC=UniProtKB (protein)
|CLNSRCID=P78363#VAR_008439
|COMMON=0
|Disease=not provided; Stargardt disease 1
|FwdALT=T
|FwdREF=G
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94506901
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;PMC;S3D;SLO;NSM;REF;ASP;VLD;HD;KGPhase1;KGPhase3;LSD
|VC=SNV
|VP=0x050368000a05040436100100
|WGT=1
|dbSNPBuildID=89
|rsid=1801269
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1801581,"{{Rsnum
|rsid=1801581
|Gene=ABCA4
|Chromosome=1
|position=94047009
|Orientation=minus
|GMAF=0.01469
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCA4
|StabilizedOrientation=minus
}}{{omim
|id=601691
|rsnum=1801581
|variant=0035
}}

{{ClinVar
|rsid=1801581
|Reversed=1
|FwdREF=G
|FwdALT=A,T
|REF=C
|ALT=A,T
|RSPOS=94512565
|CHROM=1
|GMAF=0.0147
|dbSNPBuildID=89
|SSR=0
|SAO=1
|VP=0x050168000a0514053e110100
|GENEINFO=ABCA4:24
|GENE_NAME=ABCA4
|GENE_ID=24
|WGT=1
|VC=SNV
|CLNALLE=2
|CLNHGVS=NC_000001.10:g.94512565C>T
|CLNSRC=HGMD; OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=CM024629; 601691.0035; P78363#VAR_008428
|CLNSIG=255
|CLNCUI=C1855465
|CLNDBN=MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO; Stargardt disease 1; not provided; not specified; Macular degeneration; Cone-Rod Dystrophy, Recessive; Retinitis Pigmentosa, Recessive; Stargardt Disease, Recessive
|Disease=MACULAR DEGENERATION; Stargardt disease 1; not provided; not specified; Macular degeneration; Cone-Rod Dystrophy; Retinitis Pigmentosa; Stargardt Disease
|CLNACC=RCV000008374.4; RCV000008375.4; RCV000085512.3; RCV000152706.4; RCV000294335.1; RCV000349295.1; RCV000392936.1; RCV000399411.1
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;VLD;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|CAF=0.9846; 0.01538
|CLNDSDB=MedGen:OMIM; MedGen; Human_Phenotype_Ontology:MedGen
|CLNDSDBID=C1855465:248200; CN221809; CN169374; HP:0000608:C0024437; CN239309; CN239466; CN239312
|COMMON=1
|CLNREVSTAT=no_criteria; no_assertion; mult; single
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs1931575,"{{Rsnum
|rsid=1931575
|Gene=ABCA4
|Chromosome=1
|position=94067458
|Orientation=minus
|GMAF=0.3361
|Gene_s=ABCA4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 60.2 | 34.5 | 5.3
| HCB | 14.6 | 45.3 | 40.1
| JPT | 16.8 | 44.2 | 38.9
| YRI | 66.7 | 31.3 | 2.0
| ASW | 63.2 | 31.6 | 5.3
| CHB | 14.6 | 45.3 | 40.1
| CHD | 12.0 | 52.8 | 35.2
| GIH | 36.6 | 52.5 | 10.9
| LWK | 58.2 | 34.5 | 7.3
| MEX | 63.8 | 29.3 | 6.9
| MKK | 52.6 | 39.1 | 8.3
| TSI | 56.9 | 33.3 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Palmitoleic acid (16:1n-7) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=T
  |Pval=2E-6
  |OR=.02
  |ORtxt=unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs200692438,"{{Rsnum
|rsid=200692438
|Chromosome=1
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=ABCA4
|position=94060733
|Gene_s=ABCA4
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=146
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000194199.1; RCV000408459.1
|CLNALLE=1
|CLNDBN=Cone-rod dystrophy 3; Stargardt disease 1
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1858806:604116; C1855465:248200
|CLNHGVS=NC_000001.10:g.94526289A>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=4
|Disease=Cone-rod dystrophy 3; Stargardt disease 1
|FwdALT=C
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94526289
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSM;REF;ASP;VLD;HD
|VC=SNV
|VP=0x050028000a05040402000100
|WGT=1
|dbSNPBuildID=137
|rsid=200692438
}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs200967229,"{{Rsnum
|rsid=200967229
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94030427
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=T
|CAF=0.9998; 0.0001997
|CHROM=1
|CLNACC=RCV000408571.1
|CLNALLE=1
|CLNDBN=Stargardt disease 1
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1855465:248200
|CLNHGVS=NC_000001.10:g.94495983C>T
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|COMMON=0
|Disease=Stargardt disease 1
|FwdALT=T
|FwdREF=C
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=C
|RSPOS=94495983
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;DSS;ASP;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050028100005000036000100
|WGT=1
|dbSNPBuildID=137
|rsid=200967229
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs201223321,"{{Rsnum
|rsid=201223321
|StabilizedOrientation=plus
|Orientation=plus
|Chromosome=1
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94055132
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ClinVar
|ALT=G,T
|CHROM=1
|CLNACC=RCV000225582.1; RCV000481787.1
|CLNALLE=2
|CLNDBN=Retinal dystrophy; not provided
|CLNDSDB=MedGen:Orphanet:SNOMED_CT; MedGen
|CLNDSDBID=C0854723:ORPHA71862:314407005; CN221809
|CLNHGVS=NC_000001.10:g.94520688A>T
|CLNORIGIN=1
|CLNREVSTAT=no_criteria; single
|CLNSIG=4
|Disease=Retinal dystrophy; not provided
|FwdALT=G,T
|FwdREF=A
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=A
|RSPOS=94520688
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050060000a05000002100100
|WGT=1
|dbSNPBuildID=137
|rsid=201223321
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs201471607,"{{Rsnum
|rsid=201471607
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94046943
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000408500.1; RCV000413621.1
|CLNALLE=1
|CLNDBN=Stargardt disease 1; not provided
|CLNDSDB=MedGen:OMIM; MedGen
|CLNDSDBID=C1855465:248200; CN221809
|CLNHGVS=NC_000001.10:g.94512499T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=Stargardt disease 1; not provided
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94512499
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;S3D;NSM;REF;ASP;VLD;HD
|VC=SNV
|VP=0x050228000a05040402000100
|WGT=1
|dbSNPBuildID=137
|rsid=201471607
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA4,Rs201738997,"{{Rsnum
|rsid=201738997
|Chromosome=1
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=ABCA4
|position=94121045
|Gene_s=ABCA4
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=C
|CHROM=1
|CLNACC=RCV000085454.2; RCV000408483.1; RCV000408532.1
|CLNALLE=1
|CLNDBN=not provided; Stargardt disease 1
|CLNDSDB=MedGen; MedGen:OMIM
|CLNDSDBID=CN221809; C1855465:248200
|CLNHGVS=NC_000001.10:g.94586601T>C
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=5
|Disease=not provided; Stargardt disease 1
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCA4:24
|GENE_ID=24
|GENE_NAME=ABCA4
|REF=T
|RSPOS=94586601
|Reversed=0
|SAO=1
|SSR=0
|Tags=PM;PMC;SLO;NSM;REF;ASP;LSD
|VC=SNV
|VP=0x050168000a05000002100100
|WGT=1
|dbSNPBuildID=137
|rsid=201738997
}}

{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs10419707,"{{Rsnum
|rsid=10419707
|Chromosome=19
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=CNN2
|position=1038446
|Gene_s=ABCA7,CNN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 17.7 | 80.5
| HCB | 2.2 | 21.2 | 76.6
| JPT | 2.7 | 29.2 | 68.1
| YRI | 4.8 | 31.3 | 63.9
| ASW | 3.5 | 35.1 | 61.4
| CHB | 2.2 | 21.2 | 76.6
| CHD | 0.0 | 35.2 | 64.8
| GIH | 2.0 | 24.8 | 73.3
| LWK | 9.1 | 32.7 | 58.2
| MEX | 0.0 | 13.8 | 86.2
| MKK | 3.8 | 33.3 | 62.8
| TSI | 1.0 | 21.6 | 77.5
| HapMapRevision=28
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs113809142,"{{Rsnum
|rsid=113809142
|Orientation=plus
|StabilizedOrientation=plus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Summary=Alzheimer association
|Chromosome=19
|Gene=ABCA7
|position=1056245
|Gene_s=ABCA7
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
}}[[rs113809142]], also known as c.4416+2T>G, is one of several loss-of-function [[ABCA7]] mutations associated with [[Alzheimer's disease]] initially in Icelanders, and then replicated in other populations.{{PMID|25807283}}


Carriers of one rare [[rs113809142]](G) allele are at roughly more than twice the risk for developing late-onset [[Alzheimer's disease]] compared to people having the most common genotype (T;T); the odds ratio is 4.47, p=3.4 × 10e−7.{{PMID|25807283}}"
ABCA7,Rs115550680,"{{Rsnum
|rsid=115550680
|Gene=ABCA7
|Chromosome=19
|position=1050421
|Orientation=plus
|GMAF=0.01837
|Gene_s=ABCA7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=plus
}}

A 2013 meta-analysis comprising a total of ~2,000 African-Americans with late-onset [[Alzheimer's disease]] found that [[rs115550680]](G) was associated with higher risk for the disorder in this population (OR 1.79, CI: 1.47-2.12, p = 2.2 × 10e-9). This SNP was is in (80-90%) linkage disequilibrium with SNPs previously associated with Alzheimer disease in Europeans.{{PMID|23571587|OA=1}}

In 2016, a publication reported that a 44-base pair deletion ([[rs142076058]]) co-segregated with both Alzheimer's and [[rs115550680]](G).This deletion is common in African-American Alzheimer cases (15.2%) and controls (9.74%), but is rare (0.12%) in a non-Hispanic white cohort. The deleted allele could result in defective protein function and be an ethnic-specific pathogenic alteration.{{PMID|27231719|OA=1}}


{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs200538373,"{{Rsnum
|rsid=200538373
|Orientation=plus
|StabilizedOrientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Summary=Alzheimer association
|Chromosome=19
|Gene=ABCA7
|position=1061893
|Gene_s=ABCA7
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
}}[[rs200538373]], also known as c.5570+5G>C, is one of several loss-of-function [[ABCA7]] mutations associated with [[Alzheimer's disease]] initially in Icelanders, and then replicated in other populations.{{PMID|25807283}}

Carriers of one rare [[rs200538373]](C) allele are at roughly twice the risk for developing late-onset [[Alzheimer's disease]] compared to people having the most common genotype (G;G); the odds ratio is 1.91, p=3.8 × 10e−6.{{PMID|25807283}}
{{PMID Auto
|PMID=28655137
|Title=Alzheimer's Disease Genetics and ABCA7 Splicing.
|OA=1
}}"
ABCA7,Rs3752228,"{{Rsnum
|rsid=3752228
|Gene=ABCA7
|Chromosome=19
|position=1041165
|Orientation=plus
|GMAF=0.07117
|Gene_s=ABCA7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 91.2 | 8.8 | 0.0
| HCB | 86.5 | 12.0 | 1.5
| JPT | 90.3 | 8.0 | 1.8
| YRI | 79.5 | 19.2 | 1.4
| ASW | 80.7 | 19.3 | 0.0
| CHB | 86.5 | 12.0 | 1.5
| CHD | 84.3 | 15.7 | 0.0
| GIH | 89.1 | 10.9 | 0.0
| LWK | 64.2 | 31.1 | 4.7
| MEX | 98.2 | 1.8 | 0.0
| MKK | 70.3 | 26.5 | 3.2
| TSI | 94.1 | 5.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24439028
|Title=A search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}"
ABCA7,Rs3752246,"{{Rsnum
|rsid=3752246
|Gene=ABCA7
|Chromosome=19
|position=1056493
|Orientation=plus
|GMAF=0.1763
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ABCA7
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 64.6 | 32.3 | 3.1
| HCB | 59.1 | 29.5 | 11.4
| JPT | 29.5 | 54.5 | 15.9
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 59.1 | 29.5 | 11.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21460841
|Trait=None
|Title=Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|RiskAllele=G
|Pval=6E-7
|OR=1.1500
|ORtxt=[1.09-1.21]
|OA=1
}}



{{PMID Auto
|PMID=23556446
|Title=Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=23669301
|Title=Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention.
|OA=1
}}

{{PMID Auto
|PMID=26141617
|Title=Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
}}

{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs3764650,"{{Rsnum
|rsid=3764650
|Gene=ABCA7
|Chromosome=19
|position=1046521
|Orientation=plus
|GMAF=0.1997
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ABCA7
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 2.7 | 15.9 | 81.4
| HCB | 3.6 | 45.3 | 51.1
| JPT | 17.7 | 45.1 | 37.2
| YRI | 8.8 | 41.5 | 49.7
| ASW | 7.0 | 31.6 | 61.4
| CHB | 3.6 | 45.3 | 51.1
| CHD | 11.0 | 46.8 | 42.2
| GIH | 4.0 | 19.8 | 76.2
| LWK | 11.8 | 40.9 | 47.3
| MEX | 0.0 | 6.9 | 93.1
| MKK | 5.8 | 39.1 | 55.1
| TSI | 2.9 | 21.6 | 75.5
| HapMapRevision=28
}}[[Alzheimer's disease]] associated, based on large 2011 study {{doi|10.1038/ng.803}}

""The minor allele of [[Rs3764650]] in ABCA7 was associated with a later age at onset and shorter disease course"" according to http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511432/

{{PMID Auto GWAS
|PMID=21460840
|Trait=None
|Title=Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|RiskAllele=
|Pval=5E-17
|OR=1.2300
|ORtxt=[1.18-1.30]
|OA=1
}}

{{PMID Auto
|PMID=23419238
|Title=Allele-specific polymerase chain reaction for the detection of Alzheimer's disease-related single nucleotide polymorphisms
|OA=1
}}

{{PMID Auto
|PMID=23226438
|Title=Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains
|OA=1
}}

{{PMID Auto
|PMID=23836404
|Title=Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology
|OA=1
}}

{{PMID Auto
|PMID=24141082
|Title=ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status
|OA=1
}}

{{PMID Auto
|PMID=23180304
|Title=Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
}}

{{PMID Auto
|PMID=23669301
|Title=Interaction between two cholesterol metabolism genes influences memory: findings from the Wisconsin Registry for Alzheimer's Prevention.
|OA=1
}}

{{PMID Auto
|PMID=25189118
|Title=Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease
|OA=1
}}

{{PMID Auto
|PMID=26141617
|Title=Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
}}

{{PMID Auto
|PMID=27103528
|Title=Association of genetic risk factors with cognitive decline: the PATH through life project.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs3795064,"{{Rsnum
|rsid=3795064
|Chromosome=19
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=CNN2
|position=1039411
|Gene_s=ABCA7,CNN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 70.7 | 24.1 | 5.2
| HCB | 90.7 | 7.0 | 2.3
| JPT | 88.4 | 11.6 | 0.0
| YRI | 93.2 | 5.1 | 1.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 90.7 | 7.0 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}"
ABCA7,Rs4147918,"{{Rsnum
|rsid=4147918
|StabilizedOrientation=plus
|Chromosome=19
|position=1058177
|Gene_s=ABCA7
|Gene=ABCA7
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 91.2 | 8.8 | 0.0
| HCB | 73.7 | 22.6 | 3.6
| JPT | 76.1 | 22.1 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 73.7 | 22.6 | 3.6
| CHD | 68.8 | 26.6 | 4.6
| GIH | 90.1 | 9.9 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 96.6 | 3.4 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=29064820
|Title=Identification of polymorphisms in cancer patients that differentially affect survival with age.
|OA=1
}}
{{on chip | 23andMe v3}}
{{on chip | Illumina Human 1M}}
{{on chip | Affy GenomeWide 6}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs4147929,"{{Rsnum
|rsid=4147929
|Chromosome=19
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA7
|position=1063444
|Gene_s=ABCA7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=plus
}}[[rs4147929]] is a [[SNP]] in the ATP-binding cassette, sub-family A (ABC1), member 7 [[ABCA7]] gene.

[[rs4147929]] has been reported in a large study (IGAP) to be associated with late onset Alzheimer's disease.
The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 1.15 (CI 1.11-1.19), {{PMID|24443964|OA=1
}}
{{PMID Auto GWAS
  |PMID=24162737
  |Trait=Alzheimer's disease (late onset)
  |Title=Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
  |RiskAllele=A
  |Pval=1E-15
  |OR=1.15
  |ORtxt=[1.11-1.19]
  |OA=1
}}
{{PMID Auto
|PMID=26141617
|Title=Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
}}
{{PMID Auto
|PMID=29872490
|Title=Genome-wide significant risk factors on chromosome 19 and the APOE locus.
|OA=1
}}
{{on chip | Ancestry v2d}}"
ABCA7,Rs547447016,"{{Rsnum
|rsid=547447016
|Chromosome=19
|Orientation=plus
|geno1=(-;-)
|geno2=(-;GGAGCAG)
|geno3=(GGAGCAG;GGAGCAG)
|Gene=ABCA7
|position=1047509
|Gene_s=ABCA7
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}{{ClinVar
|ALT=A
|CAF=0.9994; 0.000599
|CHROM=19
|CLNACC=RCV000210926.1
|CLNALLE=1
|CLNDBN=Alzheimer disease, type 9
|CLNDSDB=Gene:MedGen:OMIM
|CLNDSDBID=450086:C1837149:608907
|CLNHGVS=NC_000019.9:g.1047510_1047515delAGCAGG
|CLNORIGIN=1
|CLNREVSTAT=no_criteria
|CLNSIG=255
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=605414.0001
|COMMON=0
|Disease=Alzheimer disease
|FwdREF=GGAGCAG
|GENEINFO=ABCA7:10347
|GENE_ID=10347
|GENE_NAME=ABCA7
|REF=AGGAGCAG
|RSPOS=1047507
|Reversed=0
|SAO=0
|SSR=0
|Tags=PM;PMC;NSF;REF;ASP;VLD;KGPhase3
|VC=DIV
|VP=0x050028001205040026000200
|WGT=1
|dbSNPBuildID=142
|rsid=547447016
|FwdALT=-
}}"
ABCA7,Rs72973581,"{{Rsnum
|Orientation=plus
|rsid=72973581
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=plus
|Chromosome=19
|Gene=ABCA7
|position=1043104
|Gene_s=ABCA7
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}A sequencing study of 332 sporadic [[Alzheimer's disease]] cases identified this [[ABCA7]] coding variant, [[rs72973581]](A), also known as p.G215S, as conferring a modest but statistically significant protection against the disorder (OR 0.57, CI: 0.41-0.8, p = 0.024).{{PMID|27289440|OA=1}}"
ABCA7,Rs7408475,"{{Rsnum
|rsid=7408475
|Chromosome=19
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCA7
|position=1050131
|Gene_s=ABCA7
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=149
|StabilizedOrientation=plus
}}{{PMID|28323831|OA=1}} Alzheimer's disease polygenic hazard score
{{on chip | 23andMe v5}}"
ABCA7,Rs78117248,"{{Rsnum
|rsid=78117248
|Chromosome=19
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCA7
|position=1052854
|Gene_s=ABCA7
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=144
|StabilizedOrientation=plus
}}

Sequencing of the [[ABCA7]] gene in a Belgian cohort of 700+ patients with [[Alzheimer's disease]] led to the association of the rare [[rs78117248]](G) allele with increased risk (odds ratio 2.07, CI: 1.31-3.27, p=0.0016).{{PMID|26141617}}"
ABCB1,Rs1002205,"{{Rsnum
|rsid=1002205
|Gene=ABCB1
|Chromosome=7
|position=87511858
|Orientation=minus
|GMAF=0.2135
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 98.5 | 1.5 | 0.0
| HCB | 35.6 | 42.2 | 22.2
| JPT | 43.2 | 45.5 | 11.4
| YRI | 47.6 | 39.7 | 12.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 35.6 | 42.2 | 22.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23050008
|Title=Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population
|OA=1
}}

{{PMID Auto
|PMID=18504423
|Title=Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.
|OA=1
}}

{{on chip | Ancestry v2}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs10248420,"{{Rsnum
|rsid=10248420
|Gene=ABCB1
|Chromosome=7
|position=87535670
|Orientation=plus
|GMAF=0.3476
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.3 | 31.9 | 0.9
| HCB | 23.5 | 50.7 | 25.7
| JPT | 28.8 | 55.9 | 15.3
| YRI | 11.6 | 49.0 | 39.5
| ASW | 29.8 | 56.1 | 14.0
| CHB | 23.5 | 50.7 | 25.7
| CHD | 33.0 | 47.7 | 19.3
| GIH | 57.4 | 37.6 | 5.0
| LWK | 17.3 | 43.6 | 39.1
| MEX | 60.3 | 31.0 | 8.6
| MKK | 19.5 | 48.1 | 32.5
| TSI | 61.8 | 35.3 | 2.9
| HapMapRevision=28
}}[[rs10248420]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. 

[[rs10248420]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}}. However, this result has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]


{{PMID|19107781}} [[rs10248420]] and [[rs2032583]] associated with colonic disease




{{PMID|15197162|OA=1
}} Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.



{{PMID Auto
|PMID=22722500
|Title=Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs10276036,"{{Rsnum
|rsid=10276036
|Gene=ABCB1
|Chromosome=7
|position=87550882
|Orientation=plus
|GMAF=0.4357
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 16.8 | 56.6 | 26.5
| HCB | 50.4 | 38.0 | 11.7
| JPT | 33.9 | 48.2 | 17.9
| YRI | 2.7 | 27.2 | 70.1
| ASW | 1.8 | 40.4 | 57.9
| CHB | 50.4 | 38.0 | 11.7
| CHD | 45.9 | 45.0 | 9.2
| GIH | 31.7 | 54.5 | 13.9
| LWK | 5.5 | 27.3 | 67.3
| MEX | 15.8 | 59.6 | 24.6
| MKK | 3.2 | 27.6 | 69.2
| TSI | 20.6 | 43.1 | 36.3
| HapMapRevision=28
}}

{{PMID Auto
|PMID=19844206
|Title=Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
|OA=1
}}

{{PMID Auto
|PMID=19961594
|Title=Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene interaction in a case-control study.
|OA=1
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs10280101,"{{Rsnum
|rsid=10280101
|Gene=ABCB1
|Chromosome=7
|position=87524269
|Orientation=plus
|GMAF=0.1299
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 71.7 | 27.4 | 0.9
| HCB | 90.5 | 9.5 | 0.0
| JPT | 82.3 | 15.9 | 1.8
| YRI | 56.5 | 36.1 | 7.5
| ASW | 66.7 | 29.8 | 3.5
| CHB | 90.5 | 9.5 | 0.0
| CHD | 93.6 | 6.4 | 0.0
| GIH | 65.3 | 32.7 | 2.0
| LWK | 63.6 | 29.1 | 7.3
| MEX | 79.3 | 20.7 | 0.0
| MKK | 61.5 | 32.1 | 6.4
| TSI | 71.3 | 27.7 | 1.0
| HapMapRevision=28
}}

{{PMID Auto
|PMID=18382661
|Title=Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
|OA=1
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs1045642,"{{Rsnum
|rsid=1045642
|Gene=ABCB1
|Chromosome=7
|position=87509329
|Orientation=minus
|ReferenceAllele=T
|GMAF=0.3967
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.0 | 55.8 | 29.2
| HCB | 40.0 | 45.2 | 14.8
| JPT | 28.3 | 53.1 | 18.6
| YRI | 80.0 | 18.6 | 1.4
| ASW | 62.5 | 33.9 | 3.6
| CHB | 40.0 | 45.2 | 14.8
| CHD | 35.2 | 55.6 | 9.3
| GIH | 17.8 | 47.5 | 34.7
| LWK | 0.0 | 0.0 | 0.0
| MEX | 25.9 | 56.9 | 17.2
| MKK | 72.1 | 26.0 | 1.9
| TSI | 30.4 | 46.1 | 23.5
| HapMapRevision=28
}}

{{omim
|desc=ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
|id=171050
|rsnum=1045642
|variant=0002
}}

[[rs1045642]], also known as C3435T, is a SNP located in the [[ABCB1]] gene. It is often studied in conjunction with [[rs2032582]]. C3435T has been mentioned by:

* {{PMID|17185560}} A ""Silent"" Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to [[verapamil]])
* {{PMID|17190370}} (R)-[[lansoprazole]] ([[Prevacid]]) concentrations are significantly increased in [[CYP2C19]] extensive metabolizers with ABCB1 C3435T C allele.
* {{PMID|15536457}} In a Korean population, plasma concentrations of [[fexofenadine]] ([[Allegra]]) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects.
* {{PMID|11994059|OA=1
}} In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population.
* {{PMID|20491876}} A meta-analysis including 9 case-control studies (totaling ~2,500 patients) found no association between [[rs1045642]] and epilepsy risk

A study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) [[methadone]] dose groups differed significantly in their [[rs1128503]] status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs [[rs1045642]], [[rs2032582]] and [[rs1128503]], respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026).{{PMID|18424454|OA=1
}}

{{PMID Auto
|PMID=19437139
|Title=ABCB1 single nucleotide polymorphisms in the Brazilian population
}}

{{PMID Auto
|PMID=20664232
|Title=Antidepressants and ABCB1 Gene C3435T Functional Polymorphism: A Naturalistic Study
}}

{{PMID Auto
|PMID=20944127
|Title=Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancer
}}
{{PMID Auto
|PMID=21247447
|Title=CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
|OA=1
}}

{{omim
|id=171050
|rsnum=1045642
|variant=0002
}}

{{omim
|id=610064
|rsnum=1045642
}}

{{PMID Auto
|PMID=21902503
|Title=ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia
}}

{{PMID Auto
|PMID=22015057
|Title=Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
}}

{{PMID Auto
|PMID=22110582
|Title=Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
|OA=1
}}

{{PMID Auto
|PMID=22120734
|Title=Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia
}}

{{PMID Auto
|PMID=21705081
|Title=Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma
}}

{{PMID Auto
|PMID=22176633
|Title=ABCB1/MDR1 polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{PMID Auto
|PMID=21806386
|Title=Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
}}

{{PMID Auto
|PMID=22416375
|Title=[Genetic performance criteria valproate in patients with epilepsy]
}}

{{PMID Auto
|PMID=22630058
|Title=ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese Epileptic Patients
|OA=1
}}

{{PMID|15197162|OA=1
}} Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.

{{PMID|15805193|OA=1
}} Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.

{{PMID|16999857|OA=1
}} ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients.

{{PMID|17146660}} Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.

{{PMID|17366837|OA=1
}} Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada.

{{PMID|17548681}} MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.

{{PMID|17674045}} No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.

{{PMID|17913323}} ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

{{PMID|18182569|OA=1
}} Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.

{{PMID|18213362|OA=1
}} Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array.

{{PMID|18285546|OA=1
}} A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.

{{PMID|18518969|OA=1
}} Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.

{{PMID|18547414|OA=1
}} Genotyping panel for assessing response to cancer chemotherapy.

{{PMID|18698231|OA=1
}} Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

{{PMID|18725235|OA=1
}} Bidirectional translational research: Progress in understanding addictive diseases.

{{PMID|18784455|OA=1
}} The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.

{{PMID|18812236}} No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.

{{PMID|18854777|OA=1
}} Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.

{{PMID|18936436|OA=1
}} Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994.

{{PMID|19155191|OA=1
}} Opiate and cocaine addiction: from bench to clinic and back to the bench.

{{PMID|19193698|OA=1
}} Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.

{{PMID|19197249|OA=1
}} Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain.

{{PMID|19285141|OA=1
}} Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response.

{{PMID|19373654}} ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma.

{{PMID|19694740|OA=1
}} No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

{{PMID|19740399|OA=1
}} Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.

{{PMID|19930591|OA=1
}} Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

{{PMID|20170205}} Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

{{PMID|20214406}} Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

{{PMID|20354687|OA=1
}} Explaining variability in ciclosporin exposure in adult kidney transplant recipients.

{{PMID|20389299|OA=1
}} Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

{{PMID|20533057|OA=1
}} ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.

{{PMID|20859246}} ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

{{PMID|21102498}} Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.

{{PMID|21172166|OA=1
}} Pharmacogenetics of antidepressant response.

{{PMID|21185600}} Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia.

{{PMID|21332314}} Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.

{{PMID|21364332}} Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant.

{{PMID|21468756}} The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.

{{PMID|21544031}} Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.

{{PMID|21553324}} Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.

{{PMID|21827404}} The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.

{{PMID|21840870}} Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

{{PMID|21896346}} Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.

{{PMID|22112610|OA=1
}} Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.

{{PMID|22134106}} ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.

{{PMID|22135187}} Variants in ABCB1, TGFB1, and XRCC1 genes and susceptibility to viral hepatitis A infection in Mexican Americans.

{{PMID|22136368}} Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.

{{PMID|22306099}} Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

{{PMID|22311042}} MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

{{PMID|22396794|OA=1
}} A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.

{{PMID|22434582}} Neither P-gp SNP variants, P-gp expression nor functional P-gp activity predicts MDR in a preliminary study of plasma cell myeloma.

{{PMID|22569204|OA=1
}} PharmGKB summary: phenytoin pathway.

{{PMID Auto
|PMID=22672924
|Title=Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
}}

{{PMID Auto
|PMID=23188198
|Title=ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
|OA=1
}}

{{PMID Auto
|PMID=23279665
|Title=ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{PMID Auto
|PMID=22910404
|Title=Genetic association study of the P300 endophenotype in schizophrenia
}}

{{PMID Auto
|PMID=23546964
|Title=Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant
}}

{{PMID Auto
|PMID=23093106
|Title=Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
}}

{{PMID Auto
|PMID=23786015
|Title=[Pharmacogenetic criteria drug-resistence epilepsy]
}}

{{PMID Auto
|PMID=23803057
|Title=Gene Polymorphisms of OPRM1 A118G and ABCB1 C3435T May Influence Opioid Requirements in Chinese Patients with Cancer Pain
}}

{{PMID Auto
|PMID=23372834
|Title=ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort
|OA=1
}}

{{PMID Auto
|PMID=23926124
|Title=A Functional Common Polymorphism of the ABCB1 Gene Is Associated With Chronic Kidney Disease and Hypertension in Chinese
}}

{{PMID Auto
|PMID=24070710
|Title=Association between MDR1 C3435T polymorphism and risk of breast cancer
}}

{{PMID Auto
|PMID=24086514
|Title=Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=23917080
|Title=ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
|OA=1
}}

{{PMID Auto
|PMID=24380367
|Title=Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
|OA=1
}}

{{PMID Auto
|PMID=24469730
|Title=Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population
}}

{{PMID Auto
|PMID=24499375
|Title=Association of Oxidative Stress Related Genes with Idiopathic Recurrent Miscarriage
}}

{{PMID Auto
|PMID=24577069
|Title=Implication of P-Glycoprotein in Formation of Depression-Prone Personality: Association Study between the C3435T MDR1 Gene Polymorphism and Interpersonal Sensitivity
}}

{{PMID Auto
|PMID=22859359
|Title=ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
}}

{{PMID Auto
|PMID=22875622
|Title=Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy.
|OA=1
}}

{{PMID Auto
|PMID=23107763
|Title=Host genetic risk factors for community-acquired pneumonia.
}}

{{PMID Auto
|PMID=23133420
|Title=Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
|OA=1
}}

{{PMID Auto
|PMID=23133441
|Title=ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.
|OA=1
}}

{{PMID Auto
|PMID=23443032
|Title=Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations.
|OA=1
}}

{{PMID Auto
|PMID=23504525
|Title=Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.
}}

{{PMID Auto
|PMID=23647060
|Title=Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis.
}}

{{PMID Auto
|PMID=23733030
|Title=Pharmacogenetics in major depression: a comprehensive meta-analysis.
}}

{{PMID Auto
|PMID=23896815
|Title=Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury
|OA=1
}}

{{PMID Auto
|PMID=24915124
|Title=Common genetic variants in the glucocorticoid receptor and the 11&#946;-Hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission
}}

{{PMID Auto
|PMID=24918524
|Title=Association study between the MDR1 gene and clinical characteristics in schizophrenia
}}

{{PMID Auto
|PMID=23996099
|Title=ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients
}}

{{PMID Auto
|PMID=25007187
|Title=Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia
}}

{{PMID Auto
|PMID=25217066
|Title=Relationship Between ABCB1 Polymorphisms, Thromboelastography and Risk of Bleeding Events in Clopidogrel-Treated Patients With ST-Elevation Myocardial Infarction
}}

{{PMID Auto
|PMID=25452814
|Title=Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism
|OA=1
}}

{{PMID Auto
|PMID=26109419
|Title=Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study
}}

{{PMID Auto
|PMID=25355168
|Title=Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms
|OA=1
}}

{{PMID Auto
|PMID=25520092
|Title=Lack of association between polymorphisms in genes MTHFR and MDR1 with risk of childhood acute lymphoblastic leukemia
}}

{{PMID Auto
|PMID=26336903
|Title=Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: A case-control study
}}

{{PMID Auto
|PMID=26189305
|Title=ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population
}}

{{PMID Auto
|PMID=26457621
|Title=Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease
|OA=1
}}

{{PMID Auto
|PMID=26489634
|Title=Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients
}}

{{PMID Auto
|PMID=26535684
|Title=VEGF, eNOS, and ABCB1 genetic polymorphisms may increase the risk of osteonecrosis of the femoral head
}}

{{PMID Auto
|PMID=25853335
|Title=Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|OA=1
}}

{{PMID Auto
|PMID=27534401
|Title=Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population.
}}

{{PMID Auto
|PMID=27600024
|Title=Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=27706454
|Title=FREQUENCY OF THE MDR1 GENE POLYMORPHISM RS1045642 (C3435T) IN HCV-HIV CO-INFECTED PATIENTS.
}}

{{ClinVar
|ALT=G,T
|CAF=0.3952; 0.6048
|CHROM=7
|CLNACC=RCV000014699.2; RCV000211142.1; RCV000211170.1; RCV000211173.1; RCV000211266.1; RCV000211276.1; RCV000211291.1; RCV000211300.1; RCV000211363.1; RCV000211388.1; RCV000211389.1; RCV000441548.1
|CLNALLE=1
|CLNDBN=MDR1 POLYMORPHISM; ondansetron response - Efficacy; oxycodone response - Dosage; methadone response - Dosage; methotrexate response - Toxicity/ADR; nevirapine response - Toxicity/ADR; tramadol response - Dosage; morphine response - Dosage; digoxin response - Other; opioids response - Dosage; fentanyl response - Dosage; Non-small cell lung cancer
|CLNDSDB=MedGen; MeSH:MedGen:SNOMED_CT
|CLNDSDBID=CN236569; CN236540; CN236536; CN236607; CN236609; CN236548; CN236537; CN236525; CN236539; CN236531; D002289:C0007131:254637007
|CLNHGVS=NC_000007.13:g.87138645A>G
|CLNORIGIN=3
|CLNREVSTAT=no_criteria; exp; no_assertion
|CLNSIG=6
|CLNSRC=OMIM Allelic Variant; PharmGKB Clinical Annotation
|CLNSRCID=171050.0002; 1183632195; 1296599132; 1444704833; 655386244; 981204372
|COMMON=1
|Disease=MDR1 POLYMORPHISM; ondansetron response - Efficacy; oxycodone response - Dosage; methadone response - Dosage; methotrexate response - Toxicity/ADR; nevirapine response - Toxicity/ADR; tramadol response - Dosage; morphine response - Dosage; digoxin response - Other; opioids response - Dosage; fentanyl response - Dosage; Non-small cell lung cancer
|FwdALT=A,C
|FwdREF=T
|GENEINFO=ABCB1:5243
|GENE_ID=5243
|GENE_NAME=ABCB1
|REF=A
|RSPOS=87138645
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;TPA;PMC;S3D;SLO;REF;SYN;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;OM
|VC=SNV
|VP=0x05037800030515053f010101
|WGT=1
|dbSNPBuildID=86
|rsid=1045642
}}

{{PMID Auto
|PMID=28358842
|Title=The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
|OA=1
}}

{{PMID Auto
|PMID=28792718
|Title=MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results).
}}

{{PMID Auto
|PMID=29282011
|Title=Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
|OA=1
}}

{{PMID Auto
|PMID=30213564
|Title=Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
}}

{{PMID Auto
|PMID=30419834
|Title=Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
|OA=1
}}

{{PMID Auto
|PMID=30508724
|Title=The influence of polymorphisms in the drug transporter, ABCB1 on the toxicity of glucocorticoids in Saudi children with acute lymphoblastic leukaemia.
}}

{{PMID Auto
|PMID=30729282
|Title=The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphoma.
}}

{{PMID Auto
|PMID=30637776
|Title=Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
}}

{{PMID Auto
|PMID=30996113
|Title=Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=31099054
|Title=Membrane-Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population.
}}

{{PMID Auto
|PMID=31113932
|Title=ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
|OA=1
}}

{{PMID Auto
|PMID=30022368
|Title=Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
}}

{{PMID Auto
|PMID=31391850
|Title=Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients.
|OA=1
}}

{{PMID Auto
|PMID=31874497
|Title=[Effect of opioid-related gene polymorphisms on patients with high-dose opioid-tolerant cancer pain].
}}

{{PMID Auto
|PMID=31948121
|Title=The Association between ABCB1 C1236T/C3435T SNPs and H. pylori Infection among Jordanians.
|OA=1
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2d}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs1128501,"{{Rsnum
|rsid=1128501
|Chromosome=7
|Orientation=minus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=ABCB1
|position=87566218
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{omim
|id=171050
|rsnum=1128501
|variant=0001
}}

{{ClinVar
|rsid=1128501
|Reversed=1
|FwdREF=G
|FwdALT=T
|REF=C
|ALT=A
|RSPOS=87195534
|CHROM=7
|dbSNPBuildID=86
|SSR=0
|SAO=1
|VP=0x050268000a05000002110100
|GENEINFO=ABCB1:5243
|GENE_NAME=ABCB1
|GENE_ID=5243
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000007.13:g.87195534C>A
|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)
|CLNORIGIN=1
|CLNSRCID=171050.0001; P08183#VAR_015002
|CLNSIG=5
|CLNCUI=C1861502
|CLNDBN=Colchicine resistance
|Disease=Colchicine resistance
|CLNACC=RCV000014697.19
|Tags=RV;PM;PMC;S3D;NSM;REF;ASP;LSD;OM
|CLNDSDB=MedGen:OMIM
|CLNDSDBID=C1861502:120080
|CLNREVSTAT=no_criteria
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs1128503,"{{Rsnum
|rsid=1128503
|Gene=ABCB1
|Chromosome=7
|position=87550285
|Orientation=minus
|ReferenceAllele=T
|GMAF=0.4219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.5 | 56.6 | 16.8
| HCB | 11.8 | 37.5 | 50.7
| JPT | 17.7 | 47.8 | 34.5
| YRI | 76.2 | 23.1 | 0.7
| ASW | 61.4 | 36.8 | 1.8
| CHB | 11.8 | 37.5 | 50.7
| CHD | 9.2 | 45.0 | 45.9
| GIH | 13.9 | 54.5 | 31.7
| LWK | 78.2 | 20.9 | 0.9
| MEX | 24.1 | 58.6 | 17.2
| MKK | 73.1 | 24.4 | 2.6
| TSI | 36.3 | 43.1 | 20.6
| HapMapRevision=28
}}[[rs1128503]] is a SNP in the transporter P-glycoprotein (P-gp) 170, encoded by the [[ABCB1]] (also known as MDR1) gene. [[Methadone]] is a substrate of this protein, so variants may affect the efficacy and optimal dosage of this drug as used for treating opiate dependence.

A study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) [[methadone]] dose groups differed significantly in their [[rs1128503]] status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs [[rs1045642]], [[rs2032582]] and [[rs1128503]], respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026).{{PMID|18424454|OA=1
}}

{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=19437139
|Title=ABCB1 single nucleotide polymorphisms in the Brazilian population
}}

{{omim
|id=610064
|rsnum=1128503
}}

{{PMID Auto
|PMID=21790905
|Title=CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction
|OA=1
}}

{{PMID Auto
|PMID=22015057
|Title=Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
}}

{{PMID Auto
|PMID=22110582
|Title=Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
|OA=1
}}

{{PMID Auto
|PMID=21705081
|Title=Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma
}}

{{PMID Auto
|PMID=21806386
|Title=Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
}}

{{PMID Auto
|PMID=22358301
|Title=ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients
}}

{{PMID Auto
|PMID=22416375
|Title=[Genetic performance criteria valproate in patients with epilepsy]
}}

{{PMID|15197162|OA=1
}} Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.

{{PMID|16999857|OA=1
}} ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients.

{{PMID|17548681}} MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.

{{PMID|17913323}} ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

{{PMID|18213362|OA=1
}} Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array.

{{PMID|18547414|OA=1
}} Genotyping panel for assessing response to cancer chemotherapy.

{{PMID|18698231|OA=1
}} Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

{{PMID|18725235|OA=1
}} Bidirectional translational research: Progress in understanding addictive diseases.

{{PMID|18812236}} No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.

{{PMID|19155191|OA=1
}} Opiate and cocaine addiction: from bench to clinic and back to the bench.

{{PMID|19285141|OA=1
}} Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response.

{{PMID|19694740|OA=1
}} No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

{{PMID|19740399|OA=1
}} Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.

{{PMID|19844206|OA=1
}} Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.

{{PMID|20170205}} Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

{{PMID|20214406}} Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.

{{PMID|20354687|OA=1
}} Explaining variability in ciclosporin exposure in adult kidney transplant recipients.

{{PMID|20389299|OA=1
}} Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.

{{PMID|20533057|OA=1
}} ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.

{{PMID|21102498}} Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.

{{PMID|21172166|OA=1
}} Pharmacogenetics of antidepressant response.

{{PMID|21553324}} Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.

{{PMID|21840870}} Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

{{PMID|21896346}} Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.

{{PMID|22134106}} ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.

{{PMID|22136368}} Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.

{{PMID|22306099}} Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.

{{PMID|22569204|OA=1
}} PharmGKB summary: phenytoin pathway.

{{PMID Auto
|PMID=23188198
|Title=ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
|OA=1
}}

{{PMID Auto
|PMID=23546964
|Title=Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant
}}

{{PMID Auto
|PMID=23093106
|Title=Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
}}

{{PMID Auto
|PMID=23786015
|Title=[Pharmacogenetic criteria drug-resistence epilepsy]
}}

{{PMID Auto
|PMID=23917080
|Title=ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
|OA=1
}}

{{PMID Auto
|PMID=23133420
|Title=Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
|OA=1
}}

{{PMID Auto
|PMID=23133441
|Title=ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.
|OA=1
}}

{{PMID Auto
|PMID=23443032
|Title=Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations.
|OA=1
}}

{{PMID Auto
|PMID=23462807
|Title=Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
|OA=1
}}

{{PMID Auto
|PMID=23896815
|Title=Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury
|OA=1
}}

{{PMID Auto
|PMID=25007187
|Title=Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia
}}

{{PMID Auto
|PMID=25784996
|Title=ABCB1 (rs1128503) polymorphism and response to chemotherapy in patients with malignant tumors-evidences from a meta-analysis
|OA=1
}}

{{PMID Auto
|PMID=26107754
|Title=Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
}}

{{PMID Auto
|PMID=26107220
|Title=Quantitative Assessment of the Association between ABC Polymorphisms and Osteosarcoma Response: a Meta-analysis
}}

{{PMID Auto
|PMID=25355168
|Title=Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms
|OA=1
}}

{{ClinVar
|ALT=G
|CAF=0.4161; 0.5839
|CHROM=7
|CLNACC=RCV000174498.1
|CLNALLE=1
|CLNDBN=not specified
|CLNDSDB=MedGen
|CLNDSDBID=CN169374
|CLNHGVS=NC_000007.13:g.87179601A>G
|CLNORIGIN=1
|CLNREVSTAT=single
|CLNSIG=2
|COMMON=1
|Disease=not specified
|FwdALT=C
|FwdREF=T
|GENEINFO=ABCB1:5243
|GENE_ID=5243
|GENE_NAME=ABCB1
|REF=A
|RSPOS=87179601
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;TPA;PMC;S3D;SLO;REF;SYN;ASP;VLD;G5A;G5;HD;GNO;KGPhase1;KGPhase3;OM
|VC=SNV
|VP=0x05037800030517053f010101
|WGT=1
|dbSNPBuildID=86
|rsid=1128503
}}

{{PMID Auto
|PMID=27600024
|Title=Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=28358842
|Title=The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
|OA=1
}}

{{PMID Auto
|PMID=28792718
|Title=MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results).
}}

{{PMID Auto
|PMID=29491071
|Title=Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles.
}}

{{PMID Auto
|PMID=30213564
|Title=Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
}}

{{PMID Auto
|PMID=30637776
|Title=Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
}}

{{PMID Auto
|PMID=30022368
|Title=Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs11983225,"{{Rsnum
|rsid=11983225
|Gene=ABCB1
|Chromosome=7
|position=87532204
|Orientation=plus
|GMAF=0.1318
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 27.4 | 71.7
| HCB | 0.0 | 9.5 | 90.5
| JPT | 1.8 | 15.9 | 82.3
| YRI | 8.2 | 36.1 | 55.8
| ASW | 3.5 | 31.6 | 64.9
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 2.0 | 32.7 | 65.3
| LWK | 7.3 | 31.8 | 60.9
| MEX | 0.0 | 20.7 | 79.3
| MKK | 6.4 | 32.1 | 61.5
| TSI | 2.0 | 27.5 | 70.6
| HapMapRevision=28
}}[[rs11983225]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. 

[[rs11983225]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, the result for [[rs11983225]] has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs in this block.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]




{{PMID|15197162|OA=1
}} Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs1202184,"{{Rsnum
|rsid=1202184
|Gene=ABCB1
|Chromosome=7
|position=87584585
|Orientation=minus
|GMAF=0.4536
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 21.2 | 57.5 | 21.2
| HCB | 56.6 | 38.2 | 5.1
| JPT | 37.2 | 49.6 | 13.3
| YRI | 0.0 | 10.2 | 89.8
| ASW | 0.0 | 35.1 | 64.9
| CHB | 56.6 | 38.2 | 5.1
| CHD | 57.8 | 32.1 | 10.1
| GIH | 42.0 | 48.0 | 10.0
| LWK | 0.9 | 11.8 | 87.3
| MEX | 20.7 | 58.6 | 20.7
| MKK | 1.9 | 24.4 | 73.7
| TSI | 27.5 | 44.1 | 28.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=20859246
|Title=ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs1202186,"{{Rsnum
|rsid=1202186
|Gene=ABCB1
|Chromosome=7
|position=87583942
|Orientation=minus
|GMAF=0.2461
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 46.0 | 15.9
| HCB | 97.8 | 2.2 | 0.0
| JPT | 87.6 | 11.5 | 0.9
| YRI | 44.2 | 37.4 | 18.4
| ASW | 49.1 | 38.6 | 12.3
| CHB | 97.8 | 2.2 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 64.4 | 30.7 | 5.0
| LWK | 50.9 | 40.9 | 8.2
| MEX | 67.2 | 31.0 | 1.7
| MKK | 44.2 | 34.0 | 21.8
| TSI | 49.0 | 41.2 | 9.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=18504423
|Title=Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs12720067,"{{Rsnum
|rsid=12720067
|Gene=ABCB1
|Chromosome=7
|position=87540040
|Orientation=minus
|GMAF=0.08081
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 27.4 | 71.7
| HCB | 0.0 | 9.5 | 90.5
| JPT | 1.8 | 15.9 | 82.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 1.8 | 98.2
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 2.0 | 32.7 | 65.3
| LWK | 0.0 | 0.9 | 99.1
| MEX | 0.0 | 20.7 | 79.3
| MKK | 0.0 | 5.1 | 94.9
| TSI | 2.0 | 25.5 | 72.5
| HapMapRevision=28
}}[[rs12720067]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. 

[[rs12720067]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.{{doi|10.1016/j.neuron.2007.11.017}}

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, the result for [[rs12720067]] has to be treated with caution. A large (900 subjects) well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs in this block.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]



{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{PMID Auto
|PMID=18382661
|Title=Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
|OA=1
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs17327442,"{{Rsnum
|rsid=17327442
|Gene=ABCB1
|Chromosome=7
|position=87583674
|Orientation=plus
|GMAF=0.169
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.9 | 17.7 | 81.4
| HCB | 0.0 | 10.9 | 89.1
| JPT | 1.8 | 23.9 | 74.3
| YRI | 13.6 | 32.7 | 53.7
| ASW | 8.8 | 24.6 | 66.7
| CHB | 0.0 | 10.9 | 89.1
| CHD | 1.8 | 16.5 | 81.7
| GIH | 0.0 | 21.8 | 78.2
| LWK | 8.2 | 33.6 | 58.2
| MEX | 8.6 | 39.7 | 51.7
| MKK | 3.2 | 28.8 | 67.9
| TSI | 3.9 | 28.4 | 67.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=18518969
|Title=Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2032582,"{{Rsnum
|rsid=2032582
|Gene=ABCB1
|Chromosome=7
|position=87531302
|Orientation=minus
|ReferenceAllele=T
|MissenseAllele=G
|GMAF=0.3402
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 25.7 | 54.9 | 19.5
| HCB | 19.7 | 51.8 | 28.5
| JPT | 22.1 | 46.9 | 31.0
| YRI | 0.0 | 0.0 | 0.0
| ASW | 80.7 | 17.5 | 1.8
| CHB | 19.7 | 51.8 | 28.5
| CHD | 19.3 | 58.7 | 22.0
| GIH | 8.9 | 50.5 | 40.6
| LWK | 96.3 | 3.7 | 0.0
| MEX | 29.3 | 56.9 | 13.8
| MKK | 82.7 | 16.7 | 0.6
| TSI | 34.3 | 46.1 | 19.6
| HapMapRevision=28
}}
[[rs2032582]], also known as G2677T, is a nonsynonymous SNP located in exon 21 of the [[ABCB1]] gene. G2677 is also known as Ala893Thr. It is often studied in conjunction with [[rs1045642]].

The [[rs2032582]](T) variant allele yields a 2.6 fold higher risk of developing [[lung cancer]], and in particular, the type of lung cancer called squamous cell carcinoma (CI 1.7-4.0, P < .001) in white Spanish smokers. There appears to be little gene dosage effect, since homozygous [[rs2032582(T;T)]] carriers shoulder almost all the risk (odds ratio 6.75 compared to (A;A) homozygotes, CI 3.0-15.2). This risk is also the same in light or heavy smokers. {{PMID|17120199}} 

A study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) [[methadone]] dose groups differed significantly in their [[rs1128503]] status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs [[rs1045642]], [[rs2032582]] and [[rs1128503]], respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026).{{PMID|18424454|OA=1
}}

OMIM also reports an association with [[Crohn's disease]].

{{omim
| id = 171050
| quiet = 1
| variant = 0003
| desc    = CROHN DISEASE, SUSCEPTIBILITY TO
| rsnum   = 2032582
}}

{{PMID Auto
|PMID=20944127
|Title=Two multidrug-resistance (ABCB1) gene polymorphisms as prognostic parameters in women with ovarian cancer
}}
{{PMID Auto
|PMID=21287651
|Title=Different Transport Activity of Human Triallelic MDR1 893Ala/Ser/Thr Variant and its Association with Herb Extracts
}}

{{omim
|id=610064
|rsnum=2032582
}}

{{PMID Auto
|PMID=21902503
|Title=ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia
}}

{{PMID Auto
|PMID=22015057
|Title=Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
}}

{{PMID Auto
|PMID=22110582
|Title=Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients
|OA=1
}}

{{PMID Auto
|PMID=22120734
|Title=Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia
}}

{{PMID Auto
|PMID=21705081
|Title=Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma
}}

{{PMID Auto
|PMID=22176633
|Title=ABCB1/MDR1 polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{PMID Auto
|PMID=21806386
|Title=Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
}}

{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{PMID Auto
|PMID=16103896
|Title=An association study of 43 SNPs in 16 candidate genes with atorvastatin response.
}}

{{PMID Auto
|PMID=16999857
|Title=ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients.
|OA=1
}}

{{PMID Auto
|PMID=17146660
|Title=Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.
}}

{{PMID Auto
|PMID=17548681
|Title=MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.
}}

{{PMID Auto
|PMID=17674045
|Title=No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.
}}

{{PMID Auto
|PMID=18213362
|Title=Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array.
|OA=1
}}

{{PMID Auto
|PMID=18442890
|Title=Association of a polymorphism of ABCB1 with obesity in Japanese individuals.
}}

{{PMID Auto
|PMID=18518969
|Title=Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.
|OA=1
}}

{{PMID Auto
|PMID=18698231
|Title=Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.
|OA=1
}}

{{PMID Auto
|PMID=18725235
|Title=Bidirectional translational research: Progress in understanding addictive diseases.
|OA=1
}}

{{PMID Auto
|PMID=18784455
|Title=The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.
|OA=1
}}

{{PMID Auto
|PMID=18812236
|Title=No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
}}

{{PMID Auto
|PMID=18854777
|Title=Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19155191
|Title=Opiate and cocaine addiction: from bench to clinic and back to the bench.
|OA=1
}}

{{PMID Auto
|PMID=19667110
|Title=Identification of genetic variants associated with response to statin therapy.
}}

{{PMID Auto
|PMID=19694740
|Title=No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.
|OA=1
}}

{{PMID Auto
|PMID=19740399
|Title=Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.
|OA=1
}}

{{PMID Auto
|PMID=20170205
|Title=Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
}}

{{PMID Auto
|PMID=20214406
|Title=Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
}}

{{PMID Auto
|PMID=20354687
|Title=Explaining variability in ciclosporin exposure in adult kidney transplant recipients.
|OA=1
}}

{{PMID Auto
|PMID=20389299
|Title=Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
|OA=1
}}

{{PMID Auto
|PMID=20533057
|Title=ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.
|OA=1
}}

{{PMID Auto
|PMID=21102498
|Title=Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=21185600
|Title=Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia.
}}

{{PMID Auto
|PMID=21468756
|Title=The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
}}

{{PMID Auto
|PMID=21544031
|Title=Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.
}}

{{PMID Auto
|PMID=21553324
|Title=Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.
}}

{{PMID Auto
|PMID=21827404
|Title=The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.
}}

{{PMID Auto
|PMID=21840870
|Title=Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
}}

{{PMID Auto
|PMID=21896346
|Title=Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
}}

{{PMID Auto
|PMID=22112610
|Title=Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
|OA=1
}}

{{PMID Auto
|PMID=22134106
|Title=ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.
}}

{{PMID Auto
|PMID=22136368
|Title=Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
}}

{{PMID Auto
|PMID=22306099
|Title=Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
}}

{{PMID Auto
|PMID=22672924
|Title=Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
}}

{{PMID Auto
|PMID=23188198
|Title=ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
|OA=1
}}

{{PMID Auto
|PMID=23279665
|Title=ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{PMID Auto
|PMID=23546964
|Title=Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant
}}

{{PMID Auto
|PMID=23093106
|Title=Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
}}

{{PMID Auto
|PMID=23556446
|Title=Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease
}}

{{PMID Auto
|PMID=23372834
|Title=ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort
|OA=1
}}

{{PMID Auto
|PMID=23917080
|Title=ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
|OA=1
}}

{{PMID Auto
|PMID=24469730
|Title=Genetic association of the P-glycoprotein gene ABCB1 polymorphisms with the risk for steroid-induced osteonecrosis of the femoral head in Chinese population
}}

{{PMID Auto
|PMID=23133420
|Title=Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin.
|OA=1
}}

{{PMID Auto
|PMID=23133441
|Title=ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.
|OA=1
}}

{{PMID Auto
|PMID=23443032
|Title=Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations.
|OA=1
}}

{{PMID Auto
|PMID=23733030
|Title=Pharmacogenetics in major depression: a comprehensive meta-analysis.
}}

{{PMID Auto
|PMID=24918524
|Title=Association study between the MDR1 gene and clinical characteristics in schizophrenia
}}

{{ClinVar
|ALT=C,T
|CHROM=7
|CLNACC=RCV000152717.3; RCV000211207.1; RCV000211425.1; RCV000152713.3; RCV000429867.1
|CLNALLE=1; 2
|CLNDBN=not specified; ondansetron response - Efficacy; simvastatin response - Efficacy; Ovarian Neoplasms
|CLNDSDB=MedGen; MeSH:MedGen
|CLNDSDBID=CN169374; CN236569; CN236582; D010051:CN236629
|CLNHGVS=NC_000007.13:g.87160618A>C; NC_000007.13:g.87160618A>T
|CLNORIGIN=1; 3
|CLNREVSTAT=single; exp; no_assertion
|CLNSIG=6
|CLNSRC=HGMD; PharmGKB Clinical Annotation; UniProtKB (protein)
|CLNSRCID=CM033585; 1150414901; 1183632200; P08183#VAR_013361; P08183#VAR_013362
|Disease=not specified; ondansetron response - Efficacy; simvastatin response - Efficacy; Ovarian Neoplasms
|FwdALT=A,G
|FwdREF=T
|GENEINFO=ABCB1:5243
|GENE_ID=5243
|GENE_NAME=ABCB1
|REF=A
|RSPOS=87160618
|Reversed=1
|SAO=1
|SSR=0
|Tags=RV;PM;TPA;PMC;S3D;SLO;NSM;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;LSD;OM
|VC=SNV
|VP=0x050378000a0515053f110101
|WGT=1
|dbSNPBuildID=94
|rsid=2032582
|CAF=0.3343; 0.617; 0.04872
|COMMON=1
}}

{{PMID Auto
|PMID=25355168
|Title=Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms
|OA=1
}}

{{PMID Auto
|PMID=25520092
|Title=Lack of association between polymorphisms in genes MTHFR and MDR1 with risk of childhood acute lymphoblastic leukemia
}}

{{PMID Auto
|PMID=26325438
|Title=Influence of ADME genomic variants on tacrolimus/sirolimus blood levels and GVHD after allogeneic hematopoietic cell transplantation
|OA=1
}}

{{PMID Auto
|PMID=26189305
|Title=ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population
}}

{{PMID Auto
|PMID=26457621
|Title=Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease
|OA=1
}}

{{PMID Auto
|PMID=27296832
|Title=ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population.
|OA=1
}}

{{PMID Auto
|PMID=27600024
|Title=Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=28608314
|Title=Polymorphism of the multidrug resistance 1 gene MDR1 G2677T/A (rs2032582) and the risk of drug-resistant epilepsy in the Polish adult population.
}}

{{PMID Auto
|PMID=28792718
|Title=MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results).
}}

{{PMID Auto
|PMID=29491071
|Title=Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles.
}}

{{PMID Auto
|PMID=30213564
|Title=Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan.
}}

{{PMID Auto
|PMID=30996113
|Title=Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.
|OA=1
}}

{{PMID Auto
|PMID=31391850
|Title=Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients.
|OA=1
}}

{{PMID Auto
|PMID=32295184
|Title=MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.
|OA=1
}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs2032583,"{{Rsnum
|rsid=2032583
|Gene=ABCB1
|Chromosome=7
|position=87531245
|Orientation=minus
|GMAF=0.1318
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 27.4 | 71.7
| HCB | 0.0 | 9.5 | 90.5
| JPT | 0.9 | 15.9 | 83.2
| YRI | 8.2 | 35.6 | 56.2
| ASW | 3.5 | 31.6 | 64.9
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 2.0 | 32.7 | 65.3
| LWK | 6.4 | 32.1 | 61.5
| MEX | 0.0 | 20.7 | 79.3
| MKK | 6.4 | 32.1 | 61.5
| TSI | 1.0 | 27.7 | 71.3
| HapMapRevision=28
}}[[rs2032583]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. Clinical studies on antidepressant drug dosage, plasma medication levels and treatment outcome suggest monotonic associations for tricyclic antidepressant drugs {{PMID|3881999}} and threshold models or higher order relationships for selective serotonin reuptake inhibitors {{PMID|28648553}} and newer antidepressant drugs {{PMID|25188033}},{{PMID|30611837}}. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is to be confirmed. 

A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al {{doi|10.1016/j.neuron.2007.11.017}} found that [[rs2032583]](C) carriers treated with [[ABCB1]] substrates had better chances on remission. However,could not be reproduced in a large (~900) -trial with outpatient with major depression treated with the ABCB1 substrate citalopram (STAR-D study, level 1). According to a recent meta analysis {{PMID|25847751}}, the significant association of antidepressant treatment outcome among all studies with this SNP becomes insignificant after Bonferroni correction for multiple comparisons. However, the association remained significant after Bonferroni-correction in a subgroup-analysis of all inpatients.

[[rs2032583]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]


In contrast, {{PMID|25487678}} reported on two SNPs from the block, [[rs2032583]] and [[rs2235040]], that these SNPs are close to Hardy–Weinberg equilibrium (not inherited together) in their 81% white population. Other results from {{PMID|25487678}} are unreliable because they picked an antidepressant sertraline, which is, likely, not an ABCB1 substrate {{PMID|27918249}}, as an example of an ABCB1 substrate and treated a majority of patients in the study with it. 

{{PMID|19107781}} [[rs10248420]] and [[rs2032583]] associated with colonic disease





{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{PMID Auto
|PMID=18424454
|Title=ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
|OA=1
}}

{{PMID Auto
|PMID=19844206
|Title=Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=21827404
|Title=The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.
}}

{{PMID Auto
|PMID=21987299
|Title=Associations between variants in the ABCB1 (MDR1) gene and corticosteroid dependence in children with Crohn's disease.
}}

{{PMID Auto
|PMID=22641028
|Title=ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
}}



{{PMID Auto
|PMID=22672924
|Title=Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
}}

{{PMID Auto
|PMID=23093106
|Title=Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
}}

{{PMID Auto
|PMID=3881999
|Title=Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry
}}

{{PMID Auto
|PMID=28648553
|Title=Escitalopram plasma levels and antidepressant response
}}

{{PMID Auto
|PMID=25188033
|Title=Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid
}}

{{PMID Auto
|PMID=30611837
|Title=Duloxetine plasma level and antidepressant response
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2091766,"{{Rsnum
|rsid=2091766
|Gene=ABCB1
|Chromosome=7
|position=87545188
|Orientation=plus
|GMAF=0.3829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 40.7 | 45.1 | 14.2
| HCB | 55.5 | 35.0 | 9.5
| JPT | 47.8 | 40.7 | 11.5
| YRI | 34.0 | 48.3 | 17.7
| ASW | 22.8 | 63.2 | 14.0
| CHB | 55.5 | 35.0 | 9.5
| CHD | 47.7 | 46.8 | 5.5
| GIH | 66.3 | 27.7 | 5.9
| LWK | 29.1 | 45.5 | 25.5
| MEX | 34.5 | 50.0 | 15.5
| MKK | 28.2 | 45.5 | 26.3
| TSI | 42.2 | 37.3 | 20.6
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs2157926,"{{Rsnum
|rsid=2157926
|StabilizedOrientation=minus
|Chromosome=7
|position=87641184
|Gene_s=ABCB1,RUNDC3B
|Gene=ABCB1
|Orientation=minus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Assembly=GRCh38.p7
|GenomeBuild=38.3
|dbSNPBuild=150
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 90.2 | 9.8 | 0.0
| HCB | 74.2 | 23.5 | 2.3
| JPT | 70.5 | 27.3 | 2.3
| YRI | 38.9 | 48.6 | 12.5
| ASW | 57.4 | 33.3 | 9.3
| CHB | 74.2 | 23.5 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 89.0 | 11.0 | 0.0
| LWK | 30.6 | 47.2 | 22.2
| MEX | 84.2 | 12.3 | 3.5
| MKK | 50.3 | 37.9 | 11.8
| TSI | 86.3 | 11.8 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=29491071
|Title=Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles.
}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2188524,"{{Rsnum
|rsid=2188524
|Gene=ABCB1
|Chromosome=7
|position=87601119
|Orientation=minus
|GMAF=0.03076
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 76.6 | 21.2 | 2.2
| JPT | 76.1 | 23.0 | 0.9
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 76.6 | 21.2 | 2.2
| CHD | 88.1 | 10.1 | 1.8
| GIH | 99.0 | 1.0 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 94.2 | 5.8 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24572589
|Title=Novel and functional ABCB1 gene variant in sporadic Parkinson's disease
}}

{{PMID Auto
|PMID=19107762
|Title=Genetic susceptibility of lung cancer associated with common variants in the 3' untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export.
}}

{{PMID Auto
|PMID=22306099
|Title=Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2214102,"{{Rsnum
|rsid=2214102
|Gene=ABCB1
|Chromosome=7
|position=87600185
|Orientation=minus
|GMAF=0.0404
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 17.7 | 82.3
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 5.0 | 95.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 3.4 | 96.6
| MKK | 0.0 | 6.4 | 93.6
| TSI | 1.0 | 6.9 | 92.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19672706
|Title=Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women
}}

{{PMID Auto
|PMID=20625815
|Title=Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis.
}}

{{PMID Auto
|PMID=23093106
|Title=Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2229107,"{{Rsnum
|rsid=2229107
|Gene=ABCB1
|Chromosome=7
|position=87509343
|Orientation=plus
|GMAF=0.01837
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 1.4 | 12.2 | 86.4
| ASW | 0.0 | 10.5 | 89.5
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 1.8 | 12.7 | 85.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 12.9 | 87.1
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2229109,"{{Rsnum
|rsid=2229109
|Gene=ABCB1
|Chromosome=7
|position=87550493
|Orientation=minus
|GMAF=0.01653
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 5.4 | 94.6
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 3.0 | 97.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.6 | 99.4
| TSI | 1.0 | 12.9 | 86.1
| HapMapRevision=28
}}

{{PMID Auto
|PMID=18547414
|Title=Genotyping panel for assessing response to cancer chemotherapy.
|OA=1
}}

{{PMID Auto
|PMID=19694740
|Title=No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.
|OA=1
}}



{{ClinVar
|ALT=A,T
|CAF=0.9874; 0.01258
|CHROM=7
|CLNACC=RCV000174262.2
|CLNALLE=2
|CLNDBN=not specified
|CLNDSDB=MedGen
|CLNDSDBID=CN169374
|CLNHGVS=NC_000007.13:g.87179809C>T
|CLNORIGIN=1
|CLNREVSTAT=mult
|CLNSIG=2
|COMMON=1
|Disease=not specified
|FwdALT=A,T
|FwdREF=G
|GENEINFO=ABCB1:5243
|GENE_ID=5243
|GENE_NAME=ABCB1
|REF=C
|RSPOS=87179809
|Reversed=1
|SAO=0
|SSR=0
|Tags=RV;PM;TPA;PMC;S3D;SLO;NSM;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3
|VC=SNV
|VP=0x050338000a05150537000101
|WGT=1
|dbSNPBuildID=98
|rsid=2229109
|CLNSRC=UniProtKB (protein)
|CLNSRCID=P08183#VAR_015003
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs2235015,"{{Rsnum
|rsid=2235015
|Gene=ABCB1
|Chromosome=7
|position=87570248
|Orientation=minus
|GMAF=0.202
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 55.8 | 39.8 | 4.4
| HCB | 91.2 | 8.8 | 0.0
| JPT | 82.3 | 15.9 | 1.8
| YRI | 28.1 | 46.6 | 25.3
| ASW | 50.9 | 36.8 | 12.3
| CHB | 91.2 | 8.8 | 0.0
| CHD | 92.6 | 7.4 | 0.0
| GIH | 65.3 | 30.7 | 4.0
| LWK | 35.5 | 49.1 | 15.5
| MEX | 70.7 | 29.3 | 0.0
| MKK | 43.6 | 35.9 | 20.5
| TSI | 65.3 | 30.7 | 4.0
| HapMapRevision=28
}}[[rs2235015]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein (P-glycoprotein - Pgp) that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. Clinical studies on antidepressant drug dosage, plasma medication levels and treatment outcome suggest monotonic associations for tricyclic antidepressant drugs {{PMID|3881999}} and threshold models or higher order relationships for selective serotonin reuptake inhibitors [PMID 28648553] and newer antidepressant drugs {{PMID|25188033}},{{PMID|30611837}}.  However, the link between the increased brain concentrations of antidepressants and a clinically significant response is still to be confirmed. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect on depression outcome and eight - that they do not. However those 18 studies are difficult to compare because they vary within their study design concerning following factors: population (ethnicity, psychiatric condition), tested SNPs, tested antidepressants (Pgp substrates and Pgp non-substrates) and doses, inclusion of drug metabolism monitoring and statistical correction for multiple testing.

A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al {{doi|10.1016/j.neuron.2007.11.017}} found that [[rs2235015]](T) carriers treated with [[ABCB1]] substrates were more likely to remit. However, this result could not be reproduced in a large (N~900) trial with outpatients with major depression treated with the ABCB1 substrate citalopram (STAR-D study, level 1). According to a recent meta analysis {{PMID|25847751}}, no significant association of antidepressant treatment outcome with this SNP among all studies, but the association remained significant in a subgroup-analysis of all inpatients. 

[[rs2235015]] is near the 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below. [[rs2235015]] has an r<sup>2</sup> value of >0.5 with this group {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]



{{PMID Auto
|PMID=18382661
|Title=Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
|OA=1
}}

{{PMID Auto
|PMID=18535201
|Title=A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.
|OA=1
}}

{{PMID Auto
|PMID=21172166
|Title=Pharmacogenetics of antidepressant response.
|OA=1
}}

{{PMID Auto
|PMID=22641028
|Title=ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
}}



{{PMID Auto
|PMID=22672924
|Title=Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas
}}

{{PMID Auto
|PMID=3881999
|Title=Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry
}}


{{PMID Auto
|PMID=28648553
|Title=Escitalopram plasma levels and antidepressant response
}}


{{PMID Auto
|PMID=25188033
|Title=Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid
}}


{{PMID Auto
|PMID=30611837
|Title=Duloxetine plasma level and antidepressant response
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2235035,"{{Rsnum
|rsid=2235035
|Gene=ABCB1
|Chromosome=7
|position=87549770
|Orientation=minus
|GMAF=0.2888
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 53.1 | 42.5 | 4.4
| HCB | 57.7 | 33.6 | 8.8
| JPT | 47.8 | 40.7 | 11.5
| YRI | 66.9 | 28.3 | 4.8
| ASW | 71.4 | 25.0 | 3.6
| CHB | 57.7 | 33.6 | 8.8
| CHD | 49.5 | 45.0 | 5.5
| GIH | 67.3 | 27.7 | 5.0
| LWK | 64.8 | 28.7 | 6.5
| MEX | 39.7 | 46.6 | 13.8
| MKK | 62.1 | 31.4 | 6.5
| TSI | 48.0 | 39.2 | 12.7
| HapMapRevision=28
}}

{{PMID|18474294}} C allele linked to colorectal cancers



{{PMID|15197162|OA=1
}} Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.

{{PMID|15505619}} Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2235040,"{{Rsnum
|rsid=2235040
|Gene=ABCB1
|Chromosome=7
|position=87536434
|Orientation=minus
|GMAF=0.1267
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 27.4 | 71.7
| HCB | 0.0 | 9.5 | 90.5
| JPT | 1.8 | 15.9 | 82.3
| YRI | 7.5 | 33.3 | 59.2
| ASW | 3.5 | 29.8 | 66.7
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 2.0 | 32.7 | 65.3
| LWK | 4.6 | 32.1 | 63.3
| MEX | 0.0 | 20.7 | 79.3
| MKK | 5.8 | 28.4 | 65.8
| TSI | 2.0 | 27.5 | 70.6
| HapMapRevision=28
}}[[rs2235040]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight - that they do not.


A study of ~400 of German psychiatric inpatients with depression conducted in 2007 by Uhr et al. {{doi|10.1016/j.neuron.2007.11.017}} found that [[rs2235040]](A) carriers treated with [[ABCB1]] substrates were more likely to remit. However, this result failed to reproduce in a large (900 outpatient subjects) and better designed double-blind study of a well-researched ABCB1 substrate citalopram in depression (STAR-D study). According to a recent meta analysis {{PMID|25847751}}, no significant association of antidepressant treatment outcome with this SNP. There was a significant association with treatment outcome in the inpatients subsample but data regarding rs2235040 and treatment outcome among inpatients entirely stemmed from the study by Uhr et al.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]


In contrast, {{PMID|25487678}} reported on two SNPs from the block, [[rs2032583]] and [[rs2235040]], that these SNPs are in a weak disequilibrium (not always inherited together) in their 81% white population. Other results from {{PMID|25487678}} are unreliable because the authors used an antidepressant sertraline, which is, likely, not an ABCB1 substrate {{PMID|27918249}}, as an example of an ABCB1 substrate and treated most of the patients in the study with sertraline. 



{{PMID Auto
|PMID=18382661
|Title=Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample.
|OA=1
}}

{{PMID Auto
|PMID=22641028
|Title=ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
}}



{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs2235046,"{{Rsnum
|rsid=2235046
|Gene=ABCB1
|Chromosome=7
|position=87544750
|Orientation=minus
|GMAF=0.4421
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 55.8 | 25.7
| HCB | 48.2 | 39.4 | 12.4
| JPT | 34.5 | 47.8 | 17.7
| YRI | 2.7 | 28.1 | 69.2
| ASW | 3.5 | 42.1 | 54.4
| CHB | 48.2 | 39.4 | 12.4
| CHD | 45.0 | 45.9 | 9.2
| GIH | 35.6 | 51.5 | 12.9
| LWK | 4.5 | 26.4 | 69.1
| MEX | 17.2 | 60.3 | 22.4
| MKK | 3.2 | 30.8 | 66.0
| TSI | 22.5 | 40.2 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19107781
|Title=Associations between ABCB1/MDR1 gene polymorphisms and Crohn's disease: a gene-wide study in a pediatric population
}}

{{PMID Auto
|PMID=19685447
|Title=Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis
}}

{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs2235067,"{{Rsnum
|rsid=2235067
|Gene=ABCB1
|Chromosome=7
|position=87520606
|Orientation=minus
|GMAF=0.1226
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 27.4 | 71.7
| HCB | 0.0 | 9.5 | 90.5
| JPT | 1.8 | 15.9 | 82.3
| YRI | 7.5 | 33.3 | 59.2
| ASW | 5.3 | 28.1 | 66.7
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 6.4 | 93.6
| GIH | 0.0 | 28.7 | 71.3
| LWK | 3.6 | 25.5 | 70.9
| MEX | 0.0 | 20.7 | 79.3
| MKK | 5.8 | 21.8 | 72.4
| TSI | 2.0 | 24.5 | 73.5
| HapMapRevision=28
}}[[rs2235067]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.

[[rs2235067]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, the result for [[rs2235067]]  has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs in this block.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]


{{PMID|18424454|OA=1
}} ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs28364274,"{{Rsnum
|rsid=28364274
|Gene=ABCB1
|Chromosome=7
|position=87504335
|Orientation=minus
|GMAF=0.003673
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 5.3 | 94.7
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 1.8 | 98.2
| MEX | 0.0 | 5.3 | 94.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs28373093,"{{Rsnum
|rsid=28373093
|Gene=RUNDC3B
|Chromosome=7
|position=87714707
|Orientation=plus
|GMAF=0.2961
|Gene_s=ABCB1,RUNDC3B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|StabilizedOrientation=plus
}}{{PMID Auto
|PMID=23050008
|Title=Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population
|OA=1
}}{{PMID Auto
|PMID=18075465
|Title=Promoter polymorphisms and allelic imbalance in ABCB1 expression.
}}"
ABCB1,Rs28401781,"{{Rsnum
|rsid=28401781
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=7
|position=87519012
|Orientation=minus
|Gene=ABCB1
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=minus
}}{{PMID Auto
|PMID=24192121
|Title=ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients
}}

{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs28746504,"{{Rsnum
|rsid=28746504
|Gene=ABCB1
|Chromosome=7
|position=87602095
|Orientation=minus
|GMAF=0.06061
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|StabilizedOrientation=minus
}}{{PMID Auto
|PMID=24572589
|Title=Novel and functional ABCB1 gene variant in sporadic Parkinson's disease
}}"
ABCB1,Rs3213619,"{{Rsnum
|rsid=3213619
|Gene=ABCB1
|Chromosome=7
|position=87600877
|Orientation=minus
|GMAF=0.06015
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 6.2 | 93.8
| HCB | 0.7 | 13.9 | 85.4
| JPT | 0.0 | 11.5 | 88.5
| YRI | 0.0 | 12.2 | 87.8
| ASW | 0.0 | 12.3 | 87.7
| CHB | 0.7 | 13.9 | 85.4
| CHD | 0.0 | 6.4 | 93.6
| GIH | 0.0 | 8.9 | 91.1
| LWK | 0.9 | 21.8 | 77.3
| MEX | 0.0 | 3.4 | 96.6
| MKK | 3.2 | 19.9 | 76.9
| TSI | 1.0 | 4.9 | 94.1
| HapMapRevision=28
}}

{{PMID Auto
|PMID=17146660
|Title=Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.
}}

{{PMID Auto
|PMID=17622943
|Title=Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions.
}}

{{PMID Auto
|PMID=18424454
|Title=ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
|OA=1
}}

{{PMID Auto
|PMID=20354687
|Title=Explaining variability in ciclosporin exposure in adult kidney transplant recipients.
|OA=1
}}

{{PMID Auto
|PMID=20389299
|Title=Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
|OA=1
}}

{{PMID Auto
|PMID=22306099
|Title=Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
}}



{{PMID Auto
|PMID=24572589
|Title=Novel and functional ABCB1 gene variant in sporadic Parkinson's disease
}}

{{PMID Auto
|PMID=24599932
|Title=Replication of Genetic Polymorphisms Reported to be Associated with Taxane-Related Sensory Neuropathy in Early Breast Cancer Patients treated with Paclitaxel
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs34976462,"{{Rsnum
|rsid=34976462
|Gene=ABCB1
|Chromosome=7
|position=87600893
|Orientation=minus
|GMAF=0.002296
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|StabilizedOrientation=minus
}}{{PMID Auto
|PMID=24572589
|Title=Novel and functional ABCB1 gene variant in sporadic Parkinson's disease
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCB1,Rs35023033,"{{Rsnum
|rsid=35023033
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=7
|Orientation=minus
|Gene=ABCB1
|position=87544882
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCB1,Rs35730308,"{{Rsnum
|rsid=35730308
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=7
|Orientation=minus
|Gene=ABCB1
|position=87509442
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCB1,Rs35810889,"{{Rsnum
|rsid=35810889
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=7
|Orientation=minus
|Gene=ABCB1
|position=87585532
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}"
ABCB1,Rs3789243,"{{Rsnum
|rsid=3789243
|Gene=ABCB1
|Chromosome=7
|position=87591570
|Orientation=minus
|GMAF=0.4807
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.6 | 58.9 | 21.4
| HCB | 46.7 | 40.1 | 13.1
| JPT | 33.6 | 49.6 | 16.8
| YRI | 17.9 | 45.5 | 36.6
| ASW | 17.9 | 42.9 | 39.3
| CHB | 46.7 | 40.1 | 13.1
| CHD | 38.5 | 46.8 | 14.7
| GIH | 47.5 | 41.6 | 10.9
| LWK | 33.0 | 53.2 | 13.8
| MEX | 17.2 | 60.3 | 22.4
| MKK | 20.5 | 46.8 | 32.7
| TSI | 25.5 | 51.0 | 23.5
| HapMapRevision=28
}}

A Danish case-control study comprising 373 [[Crohn's disease]] and 541 [[ulcerative colitis]] patients (and 796 healthy controls) concluded that carriers of the homozygous COX-2 and MDR1 intron 3 variant ([[rs3789243]]) had a relatively high risk of CD, odds ratio (95% CI) (OR (95% CI))=2.86 ((1.34-5.88) p=0.006) and 1.39 ((0.99-1.92) p=0.054), respectively, and for UC of 2.63 ((1.33-5.26) p=0.005) and 1.28 ((0.96-1.51) p=0.093), respectively, assuming complete dominance.{{PMID|18819034}}

{{PMID Auto
|PMID=19450124
|Title=Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese
}}

{{PMID Auto
|PMID=19685447
|Title=Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis
}}



{{omim
|desc=ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
|id=171050
|rsnum=3789243
}}

{{omim
|id=612244
|rsnum=3789243
}}

{{PMID Auto
|PMID=22176633
|Title=ABCB1/MDR1 polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}

{{PMID Auto
|PMID=16434479
|Title=ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.
}}

{{PMID Auto
|PMID=17828778
|Title=Role of the PXR gene locus in inflammatory bowel diseases.
}}

{{PMID Auto
|PMID=18424454
|Title=ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.
|OA=1
}}

{{PMID Auto
|PMID=19250544
|Title=The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study.
|OA=1
}}

{{PMID Auto
|PMID=19930591
|Title=Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.
|OA=1
}}

{{PMID Auto
|PMID=21530324
|Title=Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy.
}}



{{PMID Auto
|PMID=23279665
|Title=ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta-analysis of case-control studies
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs3842,"{{Rsnum
|rsid=3842
|Gene=ABCB1
|Chromosome=7
|position=87504050
|Orientation=minus
|GMAF=0.2006
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.2 | 21.2 | 3.5
| HCB | 51.5 | 39.6 | 9.0
| JPT | 0.0 | 0.0 | 0.0
| YRI | 74.7 | 22.6 | 2.7
| ASW | 67.9 | 32.1 | 0.0
| CHB | 51.5 | 39.6 | 9.0
| CHD | 52.3 | 40.2 | 7.5
| GIH | 67.0 | 30.9 | 2.1
| LWK | 59.8 | 30.8 | 9.3
| MEX | 59.6 | 33.3 | 7.0
| MKK | 54.8 | 38.1 | 7.1
| TSI | 76.8 | 21.2 | 2.0
| HapMapRevision=28
}}{{PMID|19107762}}  [[rs3842]] (A;G) and (G;G) was associated with increased risk of developing [[lung cancer]] (odds ratio [OR]. 1.36; 95% confidence interval [95% CI], 1.06-1.76), especially in women (2.5x)

[[rs212090]](A;T) (T;T) increased cancer susceptibility (OR, 1.37; 95% CI, 1.03-1.83)

{{PMID Auto
|PMID=17267408
|Title=Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells.
|OA=1
}}

{{PMID Auto
|PMID=19844206
|Title=Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
|OA=1
}}

{{PMID Auto
|PMID=19916993
|Title=A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.
|OA=1
}}

{{PMID Auto
|PMID=23133441
|Title=ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.
|OA=1
}}

{{PMID Auto
|PMID=23996099
|Title=ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs4148737,"{{Rsnum
|rsid=4148737
|Chromosome=7
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCB1
|position=87541836
|Gene_s=ABCB1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=147
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 46.0 | 15.9
| HCB | 55.5 | 35.0 | 9.5
| JPT | 47.8 | 40.7 | 11.5
| YRI | 34.0 | 49.0 | 17.0
| ASW | 21.1 | 61.4 | 17.5
| CHB | 55.5 | 35.0 | 9.5
| CHD | 47.2 | 47.2 | 5.6
| GIH | 65.3 | 28.7 | 5.9
| LWK | 29.1 | 46.4 | 24.5
| MEX | 34.5 | 48.3 | 17.2
| MKK | 26.9 | 46.8 | 26.3
| TSI | 38.2 | 38.2 | 23.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=27287205
|Title=Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome.
}}
{{on chip | 23andMe v3}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | FTDNA2}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs4148738,"{{Rsnum
|rsid=4148738
|Chromosome=7
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCB1
|position=87533733
|Gene_s=ABCB1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=147
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 23.0 | 57.5 | 19.5
| HCB | 35.8 | 50.4 | 13.9
| JPT | 36.3 | 47.8 | 15.9
| YRI | 79.6 | 18.4 | 2.0
| ASW | 64.9 | 33.3 | 1.8
| CHB | 35.8 | 50.4 | 13.9
| CHD | 30.3 | 58.7 | 11.0
| GIH | 13.9 | 50.5 | 35.6
| LWK | 69.1 | 27.3 | 3.6
| MEX | 31.0 | 58.6 | 10.3
| MKK | 70.5 | 26.9 | 2.6
| TSI | 34.3 | 47.1 | 18.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=27261537
|Title=Pharmacogenetics of [[dabigatran]] etexilate interindividual variability.
}}

{{PMID Auto
|PMID=30455596
|Title=Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study.
|OA=1
}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | Illumina Human 1M}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs4148739,"{{Rsnum
|rsid=4148739
|Gene=ABCB1
|Chromosome=7
|position=87531733
|Orientation=minus
|GMAF=0.1318
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 71.7 | 27.4 | 0.9
| HCB | 90.5 | 9.5 | 0.0
| JPT | 82.3 | 15.9 | 1.8
| YRI | 55.8 | 36.1 | 8.2
| ASW | 64.9 | 31.6 | 3.5
| CHB | 90.5 | 9.5 | 0.0
| CHD | 93.6 | 6.4 | 0.0
| GIH | 65.3 | 32.7 | 2.0
| LWK | 60.9 | 31.8 | 7.3
| MEX | 79.3 | 20.7 | 0.0
| MKK | 61.5 | 32.1 | 6.4
| TSI | 70.6 | 27.5 | 2.0
| HapMapRevision=28
}}
[[rs4148739]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.

[[rs4148739]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, this result has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]

{{PMID Auto
|PMID=24192121
|Title=ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs4148740,"{{Rsnum
|rsid=4148740
|Gene=ABCB1
|Chromosome=7
|position=87522787
|Orientation=minus
|GMAF=0.1299
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 17.9 | 80.4
| HCB | 0.0 | 4.8 | 95.2
| JPT | 2.4 | 9.5 | 88.1
| YRI | 3.9 | 17.6 | 78.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 4.8 | 95.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not. 

[[rs4148740]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.{{PMID|18215618|OA=1}}

When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, the result for [[rs4148740]] has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs in this block.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]



{{PMID Auto
|PMID=15197162
|Title=Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.
|OA=1
}}



{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Ancestry v2}}
{{on chip | HumanOmni1Quad}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs4728702,"{{Rsnum
|rsid=4728702
|Chromosome=7
|Orientation=plus
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene=ABCB1
|position=87551362
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 10.9 | 53.1 | 35.9
| HCB | 48.9 | 40.0 | 11.1
| JPT | 33.3 | 48.9 | 17.8
| YRI | 0.0 | 27.0 | 73.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 48.9 | 40.0 | 11.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25918995
|Title=Genome-wide association data suggest ABCB1 and immune-related gene sets may be involved in adult antisocial behavior
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}"
ABCB1,Rs72552784,"{{Rsnum
|rsid=72552784
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Orientation=plus
|Orientation=plus
|Chromosome=7
|position=87516598
|Gene=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | 23andMe v5}}"
ABCB1,Rs7779562,"{{Rsnum
|rsid=7779562
|Chromosome=7
|Orientation=plus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=ABCB1
|position=87515500
|Gene_s=ABCB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 5.3 | 94.7
| HCB | 21.2 | 51.1 | 27.7
| JPT | 8.0 | 51.3 | 40.7
| YRI | 19.0 | 49.0 | 32.0
| ASW | 17.5 | 40.4 | 42.1
| CHB | 21.2 | 51.1 | 27.7
| CHD | 13.8 | 52.3 | 33.9
| GIH | 0.0 | 11.9 | 88.1
| LWK | 17.3 | 47.3 | 35.5
| MEX | 3.4 | 22.4 | 74.1
| MKK | 12.2 | 44.2 | 43.6
| TSI | 0.0 | 11.8 | 88.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=25217066
|Title=Relationship Between ABCB1 Polymorphisms, Thromboelastography and Risk of Bleeding Events in Clopidogrel-Treated Patients With ST-Elevation Myocardial Infarction
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}"
ABCB1,Rs7787082,"{{Rsnum
|rsid=7787082
|Gene=ABCB1
|Chromosome=7
|position=87527735
|Orientation=plus
|GMAF=0.3678
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=plus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.5 | 32.3 | 66.2
| HCB | 25.9 | 52.6 | 21.5
| JPT | 15.5 | 57.3 | 27.3
| YRI | 47.6 | 44.2 | 8.2
| ASW | 36.8 | 42.1 | 21.1
| CHB | 25.9 | 52.6 | 21.5
| CHD | 19.6 | 49.5 | 30.8
| GIH | 5.0 | 38.0 | 57.0
| LWK | 47.7 | 42.1 | 10.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 37.8 | 47.4 | 14.7
| TSI | 3.0 | 36.4 | 60.6
| HapMapRevision=28
}}[[rs7787082]] is a SNP in the [[ABCB1]] gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier. SNPs in [[ABCB1]] may thus influence the intracerebral concentrations of certain drugs and their efficacy or potential for adverse side effects. However, the link between the increased brain concentrations of antidepressants and a clinically significant response is unconfirmed. In clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect, and the dose of the drug can be adjusted upwards until the patient responds. According to a recent review {{PMID|27918249}}, ten studies reported that ABCB1 SNPs have clinical effect in depression and eight that they do not.  


[[rs7787082]] is one of 9 SNPs found within a tight linkage block (r<sup>2</sup> >= 0.8 ) such that the minor allele at any one of them predicts (with ~80%+ accuracy) that the other SNPs will also be the minor allele. The list of the 9 SNPs is shown below.{{doi|10.1016/j.neuron.2007.11.017}}


When treated for [[depression]] with [[citalopram]], [[paroxetine]], [[amitriptyline]], or [[venlafaxine]] (substrates of the protein encoded by [[ABCB1]]), a highly statistically significant association between the overall genetic variability of these SNPs and the remission was reported by Uhr et al in a study of ~400 German inpatients.{{doi|10.1016/j.neuron.2007.11.017}} However, the result for [[rs7787082]] has to be treated with caution. A well-run, double-blind study of ABCB1 substrate citalopram in depression (STAR-D study) and a following meta-analysis {{PMID|25847751}} failed to replicate several Uhr et al. results for other [[ABCB1]] SNPs in this block.

The 9 SNPs in the linkage block identified are {{doi|10.1016/j.neuron.2007.11.017}}:
* [[rs2235067]]
* [[rs4148740]]
* [[rs2032583]]
* [[rs4148739]]
* [[rs11983225]]
* [[rs2235040]]
* [[rs12720067]]
* [[rs7787082]]
* [[rs10248420]]



{{PMID Auto
|PMID=22722500
|Title=Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
}}

{{PMID Auto
|PMID=26988277
|Title=Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs9282564,"{{Rsnum
|rsid=9282564
|Gene=ABCB1
|Chromosome=7
|position=87600124
|Orientation=minus
|GMAF=0.03811
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=142
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCB1
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 77.9 | 21.2 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 96.0 | 4.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 91.1 | 8.9 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 88.2 | 11.8 | 0.0
| HapMapRevision=28
}}

{{PMID Auto
|PMID=18778477
|Title=Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
|OA=1
}}



{{PMID Auto
|PMID=23133441
|Title=ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.
|OA=1
}}

{{PMID Auto
|PMID=26107754
|Title=Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Ancestry v2}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | 23andMe v5}}
{{on chip | Ancestry v2c}}
{{on chip | Ancestry v2d}}"
ABCB1,Rs956825,"{{Rsnum
|rsid=956825
|Chromosome=7
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCB1
|position=87562959
|Gene_s=ABCB1
|Assembly=GRCh38.p2
|GenomeBuild=38.2
|dbSNPBuild=147
|StabilizedOrientation=minus
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.7 | 47.7 | 44.6
| HCB | 4.5 | 45.5 | 50.0
| JPT | 13.3 | 37.8 | 48.9
| YRI | 3.2 | 31.7 | 65.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.5 | 45.5 | 50.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=25853335
|Title=Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|OA=1
}}"
